>OF309891.1 KR 1020210091180-A/5474: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF309878.1 KR 1020210091180-A/5461: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF309866.1 KR 1020210091180-A/5449: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF309854.1 KR 1020210091180-A/5437: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF309842.1 KR 1020210091180-A/5425: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF309830.1 KR 1020210091180-A/5413: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF309817.1 KR 1020210091180-A/5400: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF309804.1 KR 1020210091180-A/5387: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF309791.1 KR 1020210091180-A/5374: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF309781.1 KR 1020210091180-A/5364: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF309769.1 KR 1020210091180-A/5352: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF309753.1 KR 1020210091180-A/5336: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF309740.1 KR 1020210091180-A/5323: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF309727.1 KR 1020210091180-A/5310: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF309639.1 KR 1020210091180-A/5222: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF309631.1 KR 1020210091180-A/5214: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF309623.1 KR 1020210091180-A/5206: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF309616.1 KR 1020210091180-A/5199: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF309609.1 KR 1020210091180-A/5192: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF309601.1 KR 1020210091180-A/5184: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF309516.1 KR 1020210091180-A/5099: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF309588.1 KR 1020210091180-A/5171: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF309503.1 KR 1020210091180-A/5086: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF309575.1 KR 1020210091180-A/5158: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF309491.1 KR 1020210091180-A/5074: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF309479.1 KR 1020210091180-A/5062: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF309548.1 KR 1020210091180-A/5131: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF309467.1 KR 1020210091180-A/5050: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF309538.1 KR 1020210091180-A/5121: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF309455.1 KR 1020210091180-A/5038: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF309528.1 KR 1020210091180-A/5111: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF309442.1 KR 1020210091180-A/5025: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF309429.1 KR 1020210091180-A/5012: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF309416.1 KR 1020210091180-A/4999: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF309406.1 KR 1020210091180-A/4989: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF309394.1 KR 1020210091180-A/4977: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF309378.1 KR 1020210091180-A/4961: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF309365.1 KR 1020210091180-A/4948: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF309352.1 KR 1020210091180-A/4935: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF309264.1 KR 1020210091180-A/4847: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF309256.1 KR 1020210091180-A/4839: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF309248.1 KR 1020210091180-A/4831: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF309241.1 KR 1020210091180-A/4824: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF309234.1 KR 1020210091180-A/4817: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF309226.1 KR 1020210091180-A/4809: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF309213.1 KR 1020210091180-A/4796: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF309200.1 KR 1020210091180-A/4783: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF309173.1 KR 1020210091180-A/4756: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF309163.1 KR 1020210091180-A/4746: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF309153.1 KR 1020210091180-A/4736: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF309128.1 KR 1020210091180-A/4711: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF309116.1 KR 1020210091180-A/4699: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF309104.1 KR 1020210091180-A/4687: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF309092.1 KR 1020210091180-A/4675: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF309080.1 KR 1020210091180-A/4663: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF309067.1 KR 1020210091180-A/4650: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF309054.1 KR 1020210091180-A/4637: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF309041.1 KR 1020210091180-A/4624: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF309031.1 KR 1020210091180-A/4614: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF309019.1 KR 1020210091180-A/4602: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF309003.1 KR 1020210091180-A/4586: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF308990.1 KR 1020210091180-A/4573: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF308977.1 KR 1020210091180-A/4560: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF309141.1 KR 1020210091180-A/4724: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF308889.1 KR 1020210091180-A/4472: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF308881.1 KR 1020210091180-A/4464: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF308873.1 KR 1020210091180-A/4456: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF308866.1 KR 1020210091180-A/4449: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF308859.1 KR 1020210091180-A/4442: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF308851.1 KR 1020210091180-A/4434: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF308838.1 KR 1020210091180-A/4421: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF308825.1 KR 1020210091180-A/4408: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF308798.1 KR 1020210091180-A/4381: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF308788.1 KR 1020210091180-A/4371: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF308778.1 KR 1020210091180-A/4361: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF308766.1 KR 1020210091180-A/4349: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF349000.1 KR 1020210126155-A/42: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GAGGGTTTTAAG
>OF348999.1 KR 1020210126155-A/41: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
ATGTTGTGGGTA
>OF348998.1 KR 1020210126155-A/40: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GAGTTGGATGAG
>OF348997.1 KR 1020210126155-A/39: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
ATGGGAAAAAGT
>OF348996.1 KR 1020210126155-A/38: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GTTAGTGGGAAA
>OF348995.1 KR 1020210126155-A/37: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
TTTGGGTTTAGG
>OF348994.1 KR 1020210126155-A/36: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GTTGTTATTGTG
>OF348993.1 KR 1020210126155-A/35: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
TGAGAAGGGTAG
>OF348992.1 KR 1020210126155-A/34: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGCGTGGAAAAG
>OF348991.1 KR 1020210126155-A/33: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GAGGGCGAAAAG
>OF348990.1 KR 1020210126155-A/32: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
CGAGAGGAAAAG
>OF348989.1 KR 1020210126155-A/31: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGCCGAGAAAAG
>OF308753.1 KR 1020210091180-A/4336: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF348988.1 KR 1020210126155-A/30: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GTGAGGGAAAAG
>OF348987.1 KR 1020210126155-A/29: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GGGGATGAAAAG
>OF348986.1 KR 1020210126155-A/28: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GAAGGAGAAAAG
>OF348985.1 KR 1020210126155-A/27: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
TGGATGGAAAAG
>OF348984.1 KR 1020210126155-A/26: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGGGTGGATGAC
>OF348983.1 KR 1020210126155-A/25: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGCCGAGATGAC
>OF348982.1 KR 1020210126155-A/24: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGTGGGGAGGAG
>OF348981.1 KR 1020210126155-A/23: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGAGGGGATGAC
>OF348980.1 KR 1020210126155-A/22: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGGGGTGAGGAG
>OF348979.1 KR 1020210126155-A/21: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGGAGTGATGAC
>OF348978.1 KR 1020210126155-A/20: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
GTATCGGATGAC
>OF348977.1 KR 1020210126155-A/19: CHEMICAL COMPOSITIONS AND METHODS OF USING SAME
AGGACAGATGAC
>OF308741.1 KR 1020210091180-A/4324: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF308729.1 KR 1020210091180-A/4312: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF308717.1 KR 1020210091180-A/4300: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF308705.1 KR 1020210091180-A/4288: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF308692.1 KR 1020210091180-A/4275: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF308679.1 KR 1020210091180-A/4262: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF308666.1 KR 1020210091180-A/4249: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF308656.1 KR 1020210091180-A/4239: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF308644.1 KR 1020210091180-A/4227: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF308628.1 KR 1020210091180-A/4211: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF308615.1 KR 1020210091180-A/4198: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF308602.1 KR 1020210091180-A/4185: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF308514.1 KR 1020210091180-A/4097: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF308506.1 KR 1020210091180-A/4089: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF308498.1 KR 1020210091180-A/4081: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF308491.1 KR 1020210091180-A/4074: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF308484.1 KR 1020210091180-A/4067: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF308476.1 KR 1020210091180-A/4059: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF308463.1 KR 1020210091180-A/4046: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF308450.1 KR 1020210091180-A/4033: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF308423.1 KR 1020210091180-A/4006: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF308413.1 KR 1020210091180-A/3996: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF308403.1 KR 1020210091180-A/3986: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF308391.1 KR 1020210091180-A/3974: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF308378.1 KR 1020210091180-A/3961: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF308366.1 KR 1020210091180-A/3949: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF308354.1 KR 1020210091180-A/3937: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF308342.1 KR 1020210091180-A/3925: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF308330.1 KR 1020210091180-A/3913: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF308317.1 KR 1020210091180-A/3900: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF308304.1 KR 1020210091180-A/3887: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF308291.1 KR 1020210091180-A/3874: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF308281.1 KR 1020210091180-A/3864: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF308269.1 KR 1020210091180-A/3852: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF308253.1 KR 1020210091180-A/3836: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF308240.1 KR 1020210091180-A/3823: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF308227.1 KR 1020210091180-A/3810: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF308139.1 KR 1020210091180-A/3722: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF307932.1 KR 1020210091180-A/3515: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF307919.1 KR 1020210091180-A/3502: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF307906.1 KR 1020210091180-A/3489: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF307896.1 KR 1020210091180-A/3479: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF307884.1 KR 1020210091180-A/3467: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF307868.1 KR 1020210091180-A/3451: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF307855.1 KR 1020210091180-A/3438: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF307842.1 KR 1020210091180-A/3425: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF308131.1 KR 1020210091180-A/3714: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF308122.1 KR 1020210091180-A/3705: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF308114.1 KR 1020210091180-A/3697: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF308104.1 KR 1020210091180-A/3687: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF308092.1 KR 1020210091180-A/3675: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF308079.1 KR 1020210091180-A/3662: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF308066.1 KR 1020210091180-A/3649: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF307754.1 KR 1020210091180-A/3337: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF307746.1 KR 1020210091180-A/3329: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF308039.1 KR 1020210091180-A/3622: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF308029.1 KR 1020210091180-A/3612: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF308019.1 KR 1020210091180-A/3602: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF308007.1 KR 1020210091180-A/3590: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF307994.1 KR 1020210091180-A/3577: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF307981.1 KR 1020210091180-A/3564: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF307969.1 KR 1020210091180-A/3552: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF307957.1 KR 1020210091180-A/3540: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF307945.1 KR 1020210091180-A/3528: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF307737.1 KR 1020210091180-A/3320: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF307729.1 KR 1020210091180-A/3312: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF307719.1 KR 1020210091180-A/3302: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF307707.1 KR 1020210091180-A/3290: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF307694.1 KR 1020210091180-A/3277: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF307681.1 KR 1020210091180-A/3264: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF307654.1 KR 1020210091180-A/3237: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF307644.1 KR 1020210091180-A/3227: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF307634.1 KR 1020210091180-A/3217: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF307622.1 KR 1020210091180-A/3205: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF307609.1 KR 1020210091180-A/3192: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF307596.1 KR 1020210091180-A/3179: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF307584.1 KR 1020210091180-A/3167: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF307572.1 KR 1020210091180-A/3155: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF307560.1 KR 1020210091180-A/3143: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF307547.1 KR 1020210091180-A/3130: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF307534.1 KR 1020210091180-A/3117: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF307521.1 KR 1020210091180-A/3104: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF307511.1 KR 1020210091180-A/3094: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF307499.1 KR 1020210091180-A/3082: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF307483.1 KR 1020210091180-A/3066: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF307470.1 KR 1020210091180-A/3053: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF307457.1 KR 1020210091180-A/3040: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF307334.1 KR 1020210091180-A/2917: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF307322.1 KR 1020210091180-A/2905: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF307309.1 KR 1020210091180-A/2892: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF307296.1 KR 1020210091180-A/2879: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF307269.1 KR 1020210091180-A/2852: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF307369.1 KR 1020210091180-A/2952: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF307259.1 KR 1020210091180-A/2842: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF307361.1 KR 1020210091180-A/2944: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF307249.1 KR 1020210091180-A/2832: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF307352.1 KR 1020210091180-A/2935: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF307344.1 KR 1020210091180-A/2927: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF307237.1 KR 1020210091180-A/2820: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF307224.1 KR 1020210091180-A/2807: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF307211.1 KR 1020210091180-A/2794: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF307199.1 KR 1020210091180-A/2782: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF307187.1 KR 1020210091180-A/2770: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF307175.1 KR 1020210091180-A/2758: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF307162.1 KR 1020210091180-A/2745: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF307149.1 KR 1020210091180-A/2732: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF307136.1 KR 1020210091180-A/2719: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF307126.1 KR 1020210091180-A/2709: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF307114.1 KR 1020210091180-A/2697: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF307098.1 KR 1020210091180-A/2681: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF307085.1 KR 1020210091180-A/2668: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF307072.1 KR 1020210091180-A/2655: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF306984.1 KR 1020210091180-A/2567: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF306976.1 KR 1020210091180-A/2559: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF306967.1 KR 1020210091180-A/2550: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF306959.1 KR 1020210091180-A/2542: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF306949.1 KR 1020210091180-A/2532: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF306937.1 KR 1020210091180-A/2520: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF306924.1 KR 1020210091180-A/2507: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF306911.1 KR 1020210091180-A/2494: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF306884.1 KR 1020210091180-A/2467: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF306874.1 KR 1020210091180-A/2457: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF306864.1 KR 1020210091180-A/2447: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF306852.1 KR 1020210091180-A/2435: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF306741.1 KR 1020210091180-A/2324: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF306839.1 KR 1020210091180-A/2422: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF306729.1 KR 1020210091180-A/2312: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF306826.1 KR 1020210091180-A/2409: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF306713.1 KR 1020210091180-A/2296: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF306814.1 KR 1020210091180-A/2397: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF306700.1 KR 1020210091180-A/2283: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF306802.1 KR 1020210091180-A/2385: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF306687.1 KR 1020210091180-A/2270: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF306790.1 KR 1020210091180-A/2373: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF306777.1 KR 1020210091180-A/2360: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF306764.1 KR 1020210091180-A/2347: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF306751.1 KR 1020210091180-A/2334: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF306539.1 KR 1020210091180-A/2122: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF306526.1 KR 1020210091180-A/2109: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF306499.1 KR 1020210091180-A/2082: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF306489.1 KR 1020210091180-A/2072: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF306479.1 KR 1020210091180-A/2062: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF306467.1 KR 1020210091180-A/2050: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF306454.1 KR 1020210091180-A/2037: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF306441.1 KR 1020210091180-A/2024: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF306429.1 KR 1020210091180-A/2012: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF306417.1 KR 1020210091180-A/2000: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF306405.1 KR 1020210091180-A/1988: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF306392.1 KR 1020210091180-A/1975: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF306599.1 KR 1020210091180-A/2182: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF306591.1 KR 1020210091180-A/2174: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF306379.1 KR 1020210091180-A/1962: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF306582.1 KR 1020210091180-A/2165: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF306366.1 KR 1020210091180-A/1949: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF306574.1 KR 1020210091180-A/2157: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF306564.1 KR 1020210091180-A/2147: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF306356.1 KR 1020210091180-A/1939: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF306552.1 KR 1020210091180-A/2135: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF306344.1 KR 1020210091180-A/1927: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF306328.1 KR 1020210091180-A/1911: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF306315.1 KR 1020210091180-A/1898: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF306302.1 KR 1020210091180-A/1885: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF306214.1 KR 1020210091180-A/1797: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF306206.1 KR 1020210091180-A/1789: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF306197.1 KR 1020210091180-A/1780: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF306189.1 KR 1020210091180-A/1772: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF306179.1 KR 1020210091180-A/1762: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF306167.1 KR 1020210091180-A/1750: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF306154.1 KR 1020210091180-A/1737: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF306141.1 KR 1020210091180-A/1724: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF306114.1 KR 1020210091180-A/1697: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF306104.1 KR 1020210091180-A/1687: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF306094.1 KR 1020210091180-A/1677: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF306082.1 KR 1020210091180-A/1665: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF306069.1 KR 1020210091180-A/1652: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF306056.1 KR 1020210091180-A/1639: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF306044.1 KR 1020210091180-A/1627: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF306032.1 KR 1020210091180-A/1615: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF306020.1 KR 1020210091180-A/1603: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF306007.1 KR 1020210091180-A/1590: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF305994.1 KR 1020210091180-A/1577: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF305981.1 KR 1020210091180-A/1564: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF305971.1 KR 1020210091180-A/1554: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF305959.1 KR 1020210091180-A/1542: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF305943.1 KR 1020210091180-A/1526: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF305930.1 KR 1020210091180-A/1513: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF305917.1 KR 1020210091180-A/1500: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF305829.1 KR 1020210091180-A/1412: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF305821.1 KR 1020210091180-A/1404: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF305813.1 KR 1020210091180-A/1396: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF305806.1 KR 1020210091180-A/1389: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF305799.1 KR 1020210091180-A/1382: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF305791.1 KR 1020210091180-A/1374: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF305780.1 KR 1020210091180-A/1363: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF305767.1 KR 1020210091180-A/1350: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF305740.1 KR 1020210091180-A/1323: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF305730.1 KR 1020210091180-A/1313: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF305720.1 KR 1020210091180-A/1303: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF305708.1 KR 1020210091180-A/1291: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF305695.1 KR 1020210091180-A/1278: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF305683.1 KR 1020210091180-A/1266: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF305671.1 KR 1020210091180-A/1254: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF305659.1 KR 1020210091180-A/1242: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF305647.1 KR 1020210091180-A/1230: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF305634.1 KR 1020210091180-A/1217: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF305544.1 KR 1020210091180-A/1127: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF305456.1 KR 1020210091180-A/1039: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF305448.1 KR 1020210091180-A/1031: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF305439.1 KR 1020210091180-A/1022: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF305431.1 KR 1020210091180-A/1014: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF305421.1 KR 1020210091180-A/1004: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF305410.1 KR 1020210091180-A/993: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF305621.1 KR 1020210091180-A/1204: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF305399.1 KR 1020210091180-A/982: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF305608.1 KR 1020210091180-A/1191: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF305386.1 KR 1020210091180-A/969: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF305598.1 KR 1020210091180-A/1181: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF305586.1 KR 1020210091180-A/1169: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF305359.1 KR 1020210091180-A/942: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF305570.1 KR 1020210091180-A/1153: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF305557.1 KR 1020210091180-A/1140: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF305349.1 KR 1020210091180-A/932: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF305339.1 KR 1020210091180-A/922: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF305327.1 KR 1020210091180-A/910: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF305314.1 KR 1020210091180-A/897: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF305301.1 KR 1020210091180-A/884: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF305289.1 KR 1020210091180-A/872: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF305277.1 KR 1020210091180-A/860: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF305265.1 KR 1020210091180-A/848: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF305252.1 KR 1020210091180-A/835: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF305239.1 KR 1020210091180-A/822: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF305226.1 KR 1020210091180-A/809: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF305216.1 KR 1020210091180-A/799: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF305204.1 KR 1020210091180-A/787: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF305188.1 KR 1020210091180-A/771: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF305175.1 KR 1020210091180-A/758: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF305162.1 KR 1020210091180-A/745: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF305074.1 KR 1020210091180-A/657: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF305066.1 KR 1020210091180-A/649: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF305058.1 KR 1020210091180-A/641: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF305051.1 KR 1020210091180-A/634: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF305044.1 KR 1020210091180-A/627: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF305036.1 KR 1020210091180-A/619: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF305023.1 KR 1020210091180-A/606: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF305010.1 KR 1020210091180-A/593: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF304983.1 KR 1020210091180-A/566: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF304951.1 KR 1020210091180-A/534: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF304973.1 KR 1020210091180-A/556: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF304938.1 KR 1020210091180-A/521: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF304963.1 KR 1020210091180-A/546: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF304926.1 KR 1020210091180-A/509: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF304914.1 KR 1020210091180-A/497: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF304902.1 KR 1020210091180-A/485: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF304890.1 KR 1020210091180-A/473: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF304877.1 KR 1020210091180-A/460: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF304864.1 KR 1020210091180-A/447: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF304851.1 KR 1020210091180-A/434: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF304841.1 KR 1020210091180-A/424: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF304829.1 KR 1020210091180-A/412: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF304813.1 KR 1020210091180-A/396: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGAT
>OF304800.1 KR 1020210091180-A/383: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGA
>OF304787.1 KR 1020210091180-A/370: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAG
>OF304699.1 KR 1020210091180-A/282: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTC
>OF304691.1 KR 1020210091180-A/274: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTT
>OF304682.1 KR 1020210091180-A/265: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATT
>OF304674.1 KR 1020210091180-A/257: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCAT
>OF304664.1 KR 1020210091180-A/247: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCA
>OF304652.1 KR 1020210091180-A/235: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGC
>OF304639.1 KR 1020210091180-A/222: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGG
>OF304626.1 KR 1020210091180-A/209: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATG
>OF304599.1 KR 1020210091180-A/182: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGT
>OF304589.1 KR 1020210091180-A/172: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTT
>OF304579.1 KR 1020210091180-A/162: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTC
>OF304567.1 KR 1020210091180-A/150: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCT
>OF304554.1 KR 1020210091180-A/137: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTG
>OF304541.1 KR 1020210091180-A/124: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGT
>OF304529.1 KR 1020210091180-A/112: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTC
>OF304517.1 KR 1020210091180-A/100: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCC
>OF304505.1 KR 1020210091180-A/88: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCA
>OF304492.1 KR 1020210091180-A/75: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAA
>OF304479.1 KR 1020210091180-A/62: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAG
>OF304466.1 KR 1020210091180-A/49: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCC
>OF304456.1 KR 1020210091180-A/39: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCC
>OF304444.1 KR 1020210091180-A/27: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGC
>OF299917.1 KR 1020210087415-A/4: COMPOSITION FOR DELIVERING OF ANTIGEN
TTTTTTGGATTC
>OF299915.1 KR 1020210087415-A/2: COMPOSITION FOR DELIVERING OF ANTIGEN
TTTTGCGGATTC
>OF299914.1 KR 1020210087415-A/1: COMPOSITION FOR DELIVERING OF ANTIGEN
TTTGGCGGATTC
>OF299743.1 KR 1020210131243-A/20: USE OF DOWNREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
GCCGTGTATGAC
>OF299730.1 KR 1020210131243-A/7: USE OF DOWNREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
AGCCGTGTATGA
>OF299699.1 KR 1020210131242-A/20: USE OF UPREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
GCCGTGTATGAC
>OF299686.1 KR 1020210131242-A/7: USE OF UPREGULATED MIRNA FOR DIAGNOSIS AND TREATMENT
AGCCGTGTATGA
>OF298827.1 KR 1020210092150-A/21: Pharmaceutical composition for treating Alzheimer's disease and use thereof
GTTTTAGAGCTA
>OF298744.1 KR 1020210092149-A/145: Cells having high adaptability in hypoxia condition and use thereof
GTTTTAGAGCTA
>OF297573.1 KR 1020210119231-A/11: Recombinant Protein for Animal Neutering and Vaccine Composition Comprising the Same
CACGATGAGCTC
>OF299432.1 KR 1020210123234-A/7: Recombinant nucleocapsid protein for diagnosis and vaccine of COVID-19 and use thereof
CACGATGAGCTC
>pdb|7U84|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 6.0 mM Mn2+ for 600s
CATTATGACGCT
>pdb|7U83|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 3.0 mM Mn2+ for 600s
CATTATGACGCT
>pdb|7U82|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 1.0 mM Mn2+ for 600s
CATTATGACGCT
>pdb|7U81|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 0.5 mM Mn2+ for 600s
CATTATGACGCT
>pdb|7U80|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 0.25 mM Mn2+ for 600s
CATTATGACGCT
>pdb|7U7Z|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 0.12 mM Mn2+ for 600s
CATTATGACGCT
>pdb|7U7Y|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 0.06 mM Mn2+ for 600s
CATTATGACGCT
>pdb|7U7X|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 2.0 mM Mg2+ for 600s
CATTATGACGCT
>pdb|7U7W|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 1.0 mM Mg2+ for 600s
CATTATGACGCT
>pdb|7U7V|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 0.4 mM Mg2+ for 600s
CATTATGACGCT
>pdb|7U7U|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 0.1 mM Mg2+ for 600s
CATTATGACGCT
>pdb|7U7T|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 0.05 mM Mg2+ for 600s
CATTATGACGCT
>pdb|7U7S|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex in 0.025 mM Mg2+ for 600s
CATTATGACGCT
>pdb|7U7R|T Chain T, Human DNA polymerase eta-DNA-dGMPNPP ternary mismatch complex:no Me2+ soaking
CATTATGACGCT
>pdb|7U7L|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 1.0 mM Mg2+ for 300s with flipped-out product
CATTATGACGCT
>pdb|7U7K|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 10.0 mM Mn2+ for 600s
CATTATGACGCT
>pdb|7U7J|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 10.0 mM Mn2+ for 300s
CATTATGACGCT
>pdb|7U7I|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 10.0 mM Mn2+ for 180s
CATTATGACGCT
>pdb|7U7G|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 10.0 mM Mn2+ for 120s
CATTATGACGCT
>pdb|7U7F|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 10.0 mM Mn2+ for 90s
CATTATGACGCT
>pdb|7U7E|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 10.0 mM Mn2+ for 60s
CATTATGACGCT
>pdb|7U7D|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 10.0 mM Mn2+ for 30s
CATTATGACGCT
>pdb|7U7C|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 1.0 mM Mg2+ for 300s
CATTATGACGCT
>pdb|7U7B|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 1.0 mM Mg2+ for 250s
CATTATGACGCT
>pdb|7U7A|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 1.0 mM Mg2+ for 200s
CATTATGACGCT
>pdb|7U79|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 1.0 mM Mg2+ for 140s
CATTATGACGCT
>pdb|7U78|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 1.0 mM Mg2+ for 80s
CATTATGACGCT
>pdb|7U77|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 1.0 mM Mg2+ for 40s
CATTATGACGCT
>pdb|7U76|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 0.5 mM Mn2+ for 1800s then with 10 mM Mn2+ for 300s
CATTATGACGCT
>pdb|7U75|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 0.5 mM Mn2+ for 1800s then with 10 mM Mn2+ for 90s
CATTATGACGCT
>pdb|7U74|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 0.5 mM Mn2+ for 1800s then with 10 mM Mn2+ for 30s
CATTATGACGCT
>pdb|7U73|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:reaction with 0.5 mM Mn2+ for 1800s
CATTATGACGCT
>pdb|7U72|T Chain T, Human DNA polymerase eta-DNA ternary mismatch complex:ground state at pH7.0 (K+ MES) with 1 Ca2+ ion
CATTATGACGCT
>pdb|6GZ3|Bx Chain Bx, tRNA translocation by the eukaryotic 80S ribosome and the impact of GTP hydrolysis, Translocation-intermediate-POST-1 (TI-POST-1)
NTTCGTTAAAGA
>pdb|5L1K|T Chain T, PostInsertion complex of Human DNA Polymerase Eta bypassing an O6-Methyl-2'-deoxyguanosine : dC site
CATGNTGACGCT
>pdb|5L1J|T Chain T, Crystal Structure of Human DNA Polymerase Eta Inserting dTMPNPP Opposite O6-Methyl-2'-deoxyguanosine
CATNATGACGCT
>pdb|2KH5|B Chain B, Solution Structure of cis-5R,6S-thymine glycol opposite complementary adenine in duplex DNA
ACAAACACGCAC
>pdb|2KH5|A Chain A, Solution Structure of cis-5R,6S-thymine glycol opposite complementary adenine in duplex DNA
GTGCGNGTTTGT
>pdb|2KBP|B Chain B, Solution structure of a G-quadruplex of human telomeric RNA
TAGGGTTAGGGT
>pdb|2KBP|A Chain A, Solution structure of a G-quadruplex of human telomeric RNA
TAGGGTTAGGGT
>pdb|2AKG|B Chain B, Thallium form of the G-Quadruplex from Oxytricha Nova, d(G4T4G4)2
GGGGTTTTGGGG
>pdb|2AKG|A Chain A, Thallium form of the G-Quadruplex from Oxytricha Nova, d(G4T4G4)2
GGGGTTTTGGGG
>pdb|2D2L|B Chain B, Crystal Structure of a minimal, all-RNA hairpin ribozyme with a propyl linker (C3) at position U39
CGGTGAGAAGGG
>pdb|2DAU|B Chain B, DICKERSON-DREW DNA DODECAMER, NMR, MINIMIZED AVERAGE STRUCTURE
CGCGAATTCGCG
>pdb|2DAU|A Chain A, DICKERSON-DREW DNA DODECAMER, NMR, MINIMIZED AVERAGE STRUCTURE
CGCGAATTCGCG
>pdb|5L1L|T Chain T, PostInsertion complex of Human DNA Polymerase Eta bypassing an O6-Methyl-2'-deoxyguanosine : dT site
CATGNTGACGCT
>pdb|2KTP|A Chain A, Structure of the 1,N2-ethenodeoxyguanosine lesion opposite a one-base deletion in duplex DNA
CGCATNGAATCC
>pdb|2RQJ|B Chain B, Quadruplex structure of an RNA aptamer against bovine prion protein
GGAGGAGGAGGA
>pdb|2RQJ|A Chain A, Quadruplex structure of an RNA aptamer against bovine prion protein
GGAGGAGGAGGA
>pdb|2KAL|B Chain B, NMR structure of fully methylated GATC site
CGCAGNTCTCGC
>pdb|2KAL|A Chain A, NMR structure of fully methylated GATC site
GCGAGNTCTGCG
>pdb|2K8U|B Chain B, Solution NMR structure of trans-4-hydroxynonenal derived dG adduct of (6S,8R,11S)-configuration matched with dC
GGACTCGCTAGC
>pdb|2K8U|A Chain A, Solution NMR structure of trans-4-hydroxynonenal derived dG adduct of (6S,8R,11S)-configuration matched with dC
GCTAGCGAGTCC
>pdb|2K8T|B Chain B, Solution NMR structure of trans-4-hydroxynonenal derived dG adduct of (6R,8S,11R)-configuration opposite dC
GGACTCGCTAGC
>pdb|2K8T|A Chain A, Solution NMR structure of trans-4-hydroxynonenal derived dG adduct of (6R,8S,11R)-configuration opposite dC
GCTAGCGAGTCC
>pdb|2Z2H|B Chain B, NMR Structure of the IQ-modified Dodecamer CTCG[IQ]GCGCCATC
GATGGCGCCGAG
>pdb|2Z2H|A Chain A, NMR Structure of the IQ-modified Dodecamer CTCG[IQ]GCGCCATC
CTCGGCGCCATC
>pdb|2F87|A Chain A, Solution structure of a GAAG tetraloop in SRP RNA from Pyrococcus furiosus
GGCTGAAGGGCC
>pdb|2NQ4|B Chain B, Solution Structures of a DNA Dodecamer Duplex
GGAGGCCTGAGG
>pdb|2NQ4|A Chain A, Solution Structures of a DNA Dodecamer Duplex
CCTCAGGCCTCC
>PA369847.1 WO 2022004388-A/8: 5' position modified nucleoside and nucleotide using the same
AGCAAAAAACGC
>PA369846.1 WO 2022004388-A/7: 5' position modified nucleoside and nucleotide using the same
AGCAAAAAACGC
>PA369845.1 WO 2022004388-A/6: 5' position modified nucleoside and nucleotide using the same
GCGTTNNNTGCT
>PA369844.1 WO 2022004388-A/5: 5' position modified nucleoside and nucleotide using the same
GCGTTNTTTGCT
>PA369843.1 WO 2022004388-A/4: 5' position modified nucleoside and nucleotide using the same
GCGNNNNNNGCT
>PA369842.1 WO 2022004388-A/3: 5' position modified nucleoside and nucleotide using the same
GCGTTNNNTGCT
>PA369841.1 WO 2022004388-A/2: 5' position modified nucleoside and nucleotide using the same
GCGTTNTTTGCT
>PA369840.1 WO 2022004388-A/1: 5' position modified nucleoside and nucleotide using the same
GCGTTTTTTGCT
>pdb|7THB|G Chain G, Crystal structure of an RNA-5'/DNA-3' strand exchange junction
GTAAGCAGCATC
>pdb|7THB|D Chain D, Crystal structure of an RNA-5'/DNA-3' strand exchange junction
GTAAGCAGCATC
>pdb|7THB|A Chain A, Crystal structure of an RNA-5'/DNA-3' strand exchange junction
GTAAGCAGCATC
>pdb|7V9I|C Chain C, The Monomer mutant of BEN4 domain of protein Bend3 with DNA
ACCGCGTGGGGC
>pdb|7V9I|B Chain B, The Monomer mutant of BEN4 domain of protein Bend3 with DNA
GCCCCACGCGGT
>pdb|6VTX|C Chain C, Crystal structure of human KLF4 zinc finger DNA binding domain in complex with NANOG DNA
GGCACACCCCCT
>pdb|6VTX|B Chain B, Crystal structure of human KLF4 zinc finger DNA binding domain in complex with NANOG DNA
AGGGGGTGTGCC
>pdb|2GLO|C Chain C, Solution structure of the Brinker DNA binding domain in complex with the omb enhancer
GTTGACGCCTCA
>pdb|5L1I|T Chain T, Crystal Structure of Human DNA Polymerase Eta Inserting dCTP Opposite O6-Methyl-2'-deoxyguanosine
CATNATGACGCT
>pdb|5JUM|T Chain T, Crystal Structure of Human DNA Polymerase Eta Inserting dCTP Opposite N-(2'-deoxyguanosin-8- yl)-3-aminobenzanthrone (C8-dG-ABA)
CATNATGACGCT
>pdb|2KKF|C Chain C, Solution structure of MLL CXXC domain in complex with palindromic CPG DNA
CCCTGCGCAGGG
>pdb|2KKF|B Chain B, Solution structure of MLL CXXC domain in complex with palindromic CPG DNA
CCCTGCGCAGGG
>pdb|2KH8|B Chain B, Solution Structure of cis-5R,6S-thymine glycol opposite complementary guanine in duplex DNA
ACAAACGCGCAC
>pdb|2KH8|A Chain A, Solution Structure of cis-5R,6S-thymine glycol opposite complementary guanine in duplex DNA
GTGCGNGTTTGT
>pdb|2KAS|B Chain B, HNE-dG adduct mismatched with dA in basic solution
GGACTAGCTAGC
>pdb|2KAS|A Chain A, HNE-dG adduct mismatched with dA in basic solution
GCTAGCGAGTCC
>pdb|2KAR|B Chain B, HNE-dG adduct mismatched with dA in acidic solution
GGACTAGCTAGC
>pdb|2KAR|A Chain A, HNE-dG adduct mismatched with dA in acidic solution
GCTAGCGAGTCC
>pdb|2K7E|B Chain B, NMR structure of the human tRNALys3 bound to the HIV genome Loop I
CTNTTAANCTGC
>pdb|2K7E|A Chain A, NMR structure of the human tRNALys3 bound to the HIV genome Loop I
GCGGTGTAAAAG
>pdb|2Z2G|B Chain B, NMR Structure of the IQ-modified Dodecamer CTC[IQ]GGCGCCATC
GATGGCGCCGAG
>pdb|2Z2G|A Chain A, NMR Structure of the IQ-modified Dodecamer CTC[IQ]GGCGCCATC
CTCGGCGCCATC
>pdb|2NQ1|B Chain B, Solution Structures of a DNA Dodecamer Duplex
GGAGGCCTGAGG
>pdb|2NQ1|A Chain A, Solution Structures of a DNA Dodecamer Duplex
CCTCAGGCCTCC
>pdb|2HMR|B Chain B, Solution structure of reduced interstrand cross-link arising from S-alpha-methyl-gamma-OH-1,N2-propano-2'-deoxyguanosine in the 5'-CpG-3' DNA sequence
GGACTCNCTAGC
>pdb|2HMR|A Chain A, Solution structure of reduced interstrand cross-link arising from S-alpha-methyl-gamma-OH-1,N2-propano-2'-deoxyguanosine in the 5'-CpG-3' DNA sequence
GCTAGCNAGTCC
>pdb|2HMD|B Chain B, Stereochemistry Modulates Stability of Reduced Inter-Strand Cross-Links Arising From R- and S-alpha-methyl-gamma-OH-1,N2-propano-2'-Deoxyguanine in the 5'-CpG-3' DNA Sequence
GGACTCNCTAGC
>pdb|2HMD|A Chain A, Stereochemistry Modulates Stability of Reduced Inter-Strand Cross-Links Arising From R- and S-alpha-methyl-gamma-OH-1,N2-propano-2'-Deoxyguanine in the 5'-CpG-3' DNA Sequence
GCTAGCNAGTCC
>pdb|2GLO|B Chain B, Solution structure of the Brinker DNA binding domain in complex with the omb enhancer
TGAGGCGTCAAC
>pdb|2EZF|C Chain C, SOLUTION STRUCTURE OF A COMPLEX OF THE THIRD DNA BINDING DOMAIN OF HUMAN HMG-I(Y) BOUND TO DNA DODECAMER CONTAINING THE PRDII SITE OF THE INTERFERON-BETA PROMOTER, NMR, MINIMIZED AVERAGE STRUCTURE
GAGGAATTTCCC
>pdb|2EZF|B Chain B, SOLUTION STRUCTURE OF A COMPLEX OF THE THIRD DNA BINDING DOMAIN OF HUMAN HMG-I(Y) BOUND TO DNA DODECAMER CONTAINING THE PRDII SITE OF THE INTERFERON-BETA PROMOTER, NMR, MINIMIZED AVERAGE STRUCTURE
GGGAAATTCCTC
>pdb|2EZD|C Chain C, SOLUTION STRUCTURE OF A COMPLEX OF THE SECOND DNA BINDING DOMAIN OF HUMAN HMG-I(Y) BOUND TO DNA DODECAMER CONTAINING THE PRDII SITE OF THE INTERFERON-BETA PROMOTER, NMR, MINIMIZED AVERAGE STRUCTURE
GAGGAATTTCCC
>pdb|2EZD|B Chain B, SOLUTION STRUCTURE OF A COMPLEX OF THE SECOND DNA BINDING DOMAIN OF HUMAN HMG-I(Y) BOUND TO DNA DODECAMER CONTAINING THE PRDII SITE OF THE INTERFERON-BETA PROMOTER, NMR, MINIMIZED AVERAGE STRUCTURE
GGGAAATTCCTC
>pdb|7EZJ|p Chain p, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|o Chain o, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|n Chain n, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|m Chain m, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|h Chain h, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|g Chain g, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|f Chain f, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|e Chain e, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|P Chain P, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|O Chain O, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|N Chain N, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|M Chain M, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|H Chain H, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|G Chain G, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|F Chain F, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|7EZJ|E Chain E, Crystal structure of p73 DNA binding domain complex bound with 1 bp and 2 bp spacer DNA response elements.
CAGGCATGCCTG
>pdb|6MHT|D Chain D, TERNARY STRUCTURE OF HHAI METHYLTRANSFERASE WITH ADOHCY AND DNA CONTAINING 4'-THIO-2'DEOXYCYTIDINE AT THE TARGET
NTCAGNGCATGG
>pdb|6MHT|C Chain C, TERNARY STRUCTURE OF HHAI METHYLTRANSFERASE WITH ADOHCY AND DNA CONTAINING 4'-THIO-2'DEOXYCYTIDINE AT THE TARGET
NCATGNGCTGAC
>MY792779.1 Sequence 9 from patent US 11211146
GGATCGAAATGG
>MY787244.1 Sequence 8 from patent US 11208692
NNNACTNNNTGA
>MY787101.1 Sequence 129 from patent US 11208689
GCTGCGTGATGA
>MY777528.1 Sequence 13 from patent US 11208652
TGGCAGAGCCCG
>MY777526.1 Sequence 11 from patent US 11208652
TGGCAGAGCCCG
>MY775819.1 Sequence 679 from patent US 11208638
GTTTTAGAGCTA
>MY775139.1 Sequence 49 from patent US 11208496
GCTAGCTCCAGC
>MY774740.1 Sequence 6 from patent US 11208457
CGGGAAAGCAGA
>MY773666.1 Sequence 6 from patent US 11208430
TCTCTCCCTTCC
>MY772519.1 Sequence 50 from patent US 11207357
CATGAAGAAAAA
>MY772515.1 Sequence 45 from patent US 11207357
CATGAAGAAAAA
>MY770895.1 Sequence 288 from patent US 11207342
CCTCCTCCTCCT
>MY768005.1 Sequence 68 from patent US 11203767
ATTTATCAGATT
>MY768004.1 Sequence 67 from patent US 11203767
AATCTGATAAAT
>MY765670.1 Sequence 25 from patent US 11203750
TTTTTTTTTTTT
>MY765435.1 Sequence 16 from patent US 11203741
AAAAATTGTTGA
>MY765434.1 Sequence 15 from patent US 11203741
NNNATTGTTNNN
>MY764728.1 Sequence 489 from patent US 11203611
CGTCGTGTCGTT
>MY764727.1 Sequence 488 from patent US 11203611
CGTCGTGTCGTT
>MY764726.1 Sequence 487 from patent US 11203611
CGTCGTGTCGTT
>MY764709.1 Sequence 449 from patent US 11203611
CGTCGTGTCGTT
>MY764708.1 Sequence 448 from patent US 11203611
CGTCGTGTCGTT
>MY764707.1 Sequence 447 from patent US 11203611
CGTCGTGTCGTT
>MY764706.1 Sequence 446 from patent US 11203611
CGTCGTGTCGTT
>MY764705.1 Sequence 445 from patent US 11203611
CGTCGTGTCGTT
>MY764703.1 Sequence 443 from patent US 11203611
CGTCGTGTCGTT
>MY764702.1 Sequence 442 from patent US 11203611
CGTCGTGTCGTT
>MY764701.1 Sequence 441 from patent US 11203611
CGTCGTGTCGTT
>MY764700.1 Sequence 440 from patent US 11203611
CGTCGTGTCGTT
>MY764699.1 Sequence 439 from patent US 11203611
CGTCGTGTCGTT
>MY764698.1 Sequence 438 from patent US 11203611
CGTCGTGTCGTT
>MY764697.1 Sequence 437 from patent US 11203611
CGTCGTGTCGTT
>MY764696.1 Sequence 436 from patent US 11203611
CGTCGTGTCGTT
>MY764695.1 Sequence 435 from patent US 11203611
CGTCGTGTCGTT
>MY764694.1 Sequence 434 from patent US 11203611
CGTCGTGTCGTT
>MY764693.1 Sequence 433 from patent US 11203611
CGTCGTGTCGTT
>MY764685.1 Sequence 425 from patent US 11203611
CGTCGTGTCGTT
>MY764604.1 Sequence 344 from patent US 11203611
CGTCGTGTCGTT
>MY764603.1 Sequence 343 from patent US 11203611
CGTCGTGTCGTT
>MY764602.1 Sequence 342 from patent US 11203611
CGTCGTGTCGTT
>MY764601.1 Sequence 341 from patent US 11203611
CGTCGTGTCGTT
>MY764600.1 Sequence 340 from patent US 11203611
CGTCGTGTCGTT
>MY764599.1 Sequence 339 from patent US 11203611
CGTCGTGTCGTT
>MY764585.1 Sequence 325 from patent US 11203611
TGTCGTTCCTTT
>MY764583.1 Sequence 323 from patent US 11203611
CGTCGTGACGTT
>MY764568.1 Sequence 308 from patent US 11203611
CGTCGTGTCGTT
>MY764567.1 Sequence 307 from patent US 11203611
CGTCGTGTCGTT
>MY764528.1 Sequence 268 from patent US 11203611
CGTCGTGTCGTT
>MY764527.1 Sequence 267 from patent US 11203611
CGTCGTGTCGTT
>MY764476.1 Sequence 216 from patent US 11203611
TCGTTTGTCGTT
>MY764454.1 Sequence 190 from patent US 11203611
TCGTCGTTCGTT
>MY764442.1 Sequence 178 from patent US 11203611
TCGTCGTTTTGT
>MY764438.1 Sequence 174 from patent US 11203611
TCGTCGTTTTGT
>MY764058.1 Sequence 101 from patent US 11202839
TAACAAAAGTTG
>MY764057.1 Sequence 100 from patent US 11202839
GAAAAAGGGTTG
>MY764056.1 Sequence 99 from patent US 11202839
CAACTTTTGTTA
>MY764055.1 Sequence 98 from patent US 11202839
CAACCCTTTTTC
>MY764054.1 Sequence 97 from patent US 11202839
CCAACTTTTTTC
>MY764052.1 Sequence 95 from patent US 11202839
CAACTTATGTGC
>MY764051.1 Sequence 94 from patent US 11202839
GAAAAAAGTTGG
>MY764049.1 Sequence 92 from patent US 11202839
GCACATAAGTTG
>MY762283.1 Sequence 8 from patent US 11202793
CTCTTATTTCCC
>MY762282.1 Sequence 7 from patent US 11202793
GGGAAATAAGAG
>MY762276.1 Sequence 1 from patent US 11202793
CTCTTATTTCCC
>MY761593.1 Sequence 1 from patent US 11198885
GTAAGCGCTTAC
>MY761037.1 Sequence 6297 from patent US 11198882
GAGGCGGAGGTG
>MY761036.1 Sequence 6296 from patent US 11198882
CACGGACAGGAG
>MY761028.1 Sequence 6288 from patent US 11198882
CAGCAGGACTCT
>MY761024.1 Sequence 6284 from patent US 11198882
GGGTGGGGGGCA
>MY761012.1 Sequence 6272 from patent US 11198882
GTGTCGAGAGCT
>MY760999.1 Sequence 6259 from patent US 11198882
TATCAGCTCGAG
>MY760995.1 Sequence 6255 from patent US 11198882
TATCCGATCCCG
>MY760980.1 Sequence 6240 from patent US 11198882
TCGGCCATGGGA
>MY760970.1 Sequence 6230 from patent US 11198882
GACGGATCGGAG
>MY760965.1 Sequence 6225 from patent US 11198882
CGTGGGTACGAA
>MY760936.1 Sequence 6196 from patent US 11198882
GGTGACTAAGCT
>MY760927.1 Sequence 6187 from patent US 11198882
AGTCCGCTCGGG
>MY760924.1 Sequence 6184 from patent US 11198882
CATGAGAGGGAT
>MY760922.1 Sequence 6182 from patent US 11198882
GTCGATGCACCG
>MY760833.1 Sequence 5408 from patent US 11198882
AGAGCAGGCGAG
>MY760829.1 Sequence 5404 from patent US 11198882
AGAGGTGTAACC
>MY750054.1 Sequence 103 from patent US 11198867
ATTCACTTTCAT
>MY750053.1 Sequence 102 from patent US 11198867
TTCACTTTCATA
>MY750052.1 Sequence 101 from patent US 11198867
TCACTTTCATAA
>MY750050.1 Sequence 99 from patent US 11198867
CACTTTCATAAT
>MY750048.1 Sequence 97 from patent US 11198867
ACTTTCATAATG
>MY750046.1 Sequence 95 from patent US 11198867
CTTTCATAATGC
>MY750044.1 Sequence 93 from patent US 11198867
TTTCATAATGCT
>MY750042.1 Sequence 91 from patent US 11198867
TTCATAATGCTG
>MY750040.1 Sequence 89 from patent US 11198867
TCATAATGCTGG
>MY748205.1 Sequence 101 from patent US 11197935
TAACAAAAGTTG
>MY748204.1 Sequence 100 from patent US 11197935
GAAAAAGGGTTG
>MY748203.1 Sequence 99 from patent US 11197935
CAACTTTTGTTA
>MY748202.1 Sequence 98 from patent US 11197935
CAACCCTTTTTC
>MY748201.1 Sequence 97 from patent US 11197935
CCAACTTTTTTC
>MY748199.1 Sequence 95 from patent US 11197935
CAACTTATGTGC
>MY748198.1 Sequence 94 from patent US 11197935
GAAAAAAGTTGG
>MY748196.1 Sequence 92 from patent US 11197935
GCACATAAGTTG
>MY747853.1 Sequence 42 from patent US 11197920
GAGCCCGAGGCC
>MY747434.1 Sequence 26 from patent US 11197467
GTTTTAGAGCTA
>MY746341.1 Sequence 101 from patent US 11193168
GACGAACGCACG
>MY746338.1 Sequence 98 from patent US 11193168
ATAGTGTTGTGG
>MY746335.1 Sequence 95 from patent US 11193168
GTTCGTTTATCG
>MY746332.1 Sequence 92 from patent US 11193168
CGGTTTTTTGCG
>MY746329.1 Sequence 89 from patent US 11193168
CGGCGTTCGCGA
>MY746325.1 Sequence 85 from patent US 11193168
ATCGGTTTCGTT
>MY742229.1 Sequence 122 from patent US 11193125
CGCCGCCATTTC
>MY742228.1 Sequence 121 from patent US 11193125
CTGTTAGCCACT
>MY742225.1 Sequence 118 from patent US 11193125
TCTGTTAGCCAC
>MY742224.1 Sequence 117 from patent US 11193125
TTGTGTCTTTCT
>MY742221.1 Sequence 114 from patent US 11193125
CCGCCATTTCTC
>MY742048.1 Sequence 6 from patent US 11193121
GAACNNNNNCTC
>MY742044.1 Sequence 2 from patent US 11193121
CAANNNNNGTGG
>MY741952.1 Sequence 43 from patent US 11193115
GTTTTAGAGCTA
>MY741950.1 Sequence 41 from patent US 11193115
GTTGTGAATTGC
>MY741945.1 Sequence 36 from patent US 11193115
CCTGTGAATAGT
>MY741755.1 Sequence 2825 from patent US 11192982
GAAGACTTAGCA
>MY739624.1 Sequence 16 from patent US 11192939
GAAGCAGTGGTA
>MY739473.1 Sequence 4 from patent US 11192922
TTTTTTTTTTTT
>MY736745.1 Sequence 42 from patent US 11186868
TTTTTTTTTTTT
>MY736308.1 Sequence 122 from patent US 11186850
AAAAATTGTTGA
>MY736307.1 Sequence 120 from patent US 11186850
NNNATTGTTNNN
>MY736054.1 Sequence 679 from patent US 11186849
GTTTTAGAGCTA
>MY734725.1 Sequence 16 from patent US 11186839
GACGTCTCGAGT
>MY731735.1 Sequence 101 from patent US 11185596
TAACAAAAGTTG
>MY731734.1 Sequence 100 from patent US 11185596
GAAAAAGGGTTG
>MY731733.1 Sequence 99 from patent US 11185596
CAACTTTTGTTA
>MY731732.1 Sequence 98 from patent US 11185596
CAACCCTTTTTC
>MY731731.1 Sequence 97 from patent US 11185596
CCAACTTTTTTC
>MY731729.1 Sequence 95 from patent US 11185596
CAACTTATGTGC
>MY731728.1 Sequence 94 from patent US 11185596
GAAAAAAGTTGG
>MY731726.1 Sequence 92 from patent US 11185596
GCACATAAGTTG
>MY727660.1 Sequence 61 from patent US 11180805
TGATCCTAGCAA
>MY727512.1 Sequence 2 from patent US 11180800
CGACGCTCTTCC
>MY722250.1 Sequence 37 from patent US 11180793
AAGGCTAGTCCG
>MY721895.1 Sequence 679 from patent US 11180792
GTTTTAGAGCTA
>MY715158.1 Sequence 8 from patent US 11180756
GCGTTTTTTGCT
>MY715157.1 Sequence 7 from patent US 11180756
AGCAAAAAACGC
>MY714649.1 Sequence 1470 from patent US 11180751
GTGCCAACGCGC
>MY714504.1 Sequence 1325 from patent US 11180751
ATTCGTGAAACG
>MY714500.1 Sequence 1321 from patent US 11180751
ATTCGTGAAACG
>MY714496.1 Sequence 1317 from patent US 11180751
ATTCGTGAAACG
>MY714493.1 Sequence 1314 from patent US 11180751
ATTCGTGAAACG
>MY713978.1 Sequence 233 from patent US 11180743
TTTTTTTTTTTT
>MY713883.1 Sequence 60 from patent US 11180741
TTTTTTTTTTTT
>MY712742.1 Sequence 15 from patent US 11180562
CAGTCTGGCCAG
>MY708720.1 Sequence 94 from patent US 11179339
GGAGGAGGAGGA
>MY708719.1 Sequence 93 from patent US 11179339
GGTGGAGGAGGA
>MY708718.1 Sequence 92 from patent US 11179339
GGAGGTGGAGGA
>MY708717.1 Sequence 91 from patent US 11179339
GGAGGAGGTGGA
>MY708716.1 Sequence 90 from patent US 11179339
GGAGGAGGAGGT
>MY708715.1 Sequence 89 from patent US 11179339
GGAGGTGGAGGT
>MY708714.1 Sequence 88 from patent US 11179339
GGAGGAGGTGGT
>MY708713.1 Sequence 87 from patent US 11179339
GGAGGTGGTGGA
>MY708712.1 Sequence 86 from patent US 11179339
GGTGGAGGAGGT
>MY708711.1 Sequence 85 from patent US 11179339
GGTGGAGGTGGA
>MY708710.1 Sequence 84 from patent US 11179339
GGTGGTGGAGGA
>MY705619.1 Sequence 416 from patent US 11174515
TCTCGTACGTTC
>MY705344.1 Sequence 2 from patent US 11174512
ACTGAGACACAG
>MY705113.1 Sequence 2662 from patent US 11174505
GTGCTTCGGCAC
>MY699654.1 Sequence 124 from patent US 11174474
CCAATAGTAACA
>MY699652.1 Sequence 122 from patent US 11174474
GACGGTGTTCAA
>MY699650.1 Sequence 120 from patent US 11174474
TGTCGTAAGTAA
>MY699644.1 Sequence 114 from patent US 11174474
TTTATTGAACTA
>MY699479.1 Sequence 43 from patent US 11174471
GTTTTAGAGCTA
>MY699477.1 Sequence 41 from patent US 11174471
GTTGTGAATTGC
>MY699472.1 Sequence 36 from patent US 11174471
CCTGTGAATAGT
>MY698878.1 Sequence 123 from patent US 11174470
TTTTTTTTTTTT
>MY680326.1 Sequence 4 from patent US 11168367
CAANNNNNGTGG
>MY680324.1 Sequence 2 from patent US 11168367
CGANNNNNNTGC
>MY680282.1 Sequence 32 from patent US 11168364
CATCAGGATGAA
>MY680227.1 Sequence 11 from patent US 11168363
TTTNTTNNTTTN
>MY680226.1 Sequence 10 from patent US 11168363
AAAAAAAAAAAA
>MY680210.1 Sequence 80 from patent US 11168357
GTCCACGCACGA
>MY680209.1 Sequence 79 from patent US 11168357
CAGCCACTCCGC
>MY680194.1 Sequence 64 from patent US 11168357
CAGCCACTCCGC
>MY680037.1 Sequence 34 from patent US 11168350
GAGCCGGGCTAG
>MY680031.1 Sequence 28 from patent US 11168350
ACGCCGGTAGGT
>MY680030.1 Sequence 27 from patent US 11168350
CGGCGAGGAGTA
>MY680018.1 Sequence 15 from patent US 11168350
TGGCATTCTGGC
>MY678971.1 Sequence 8 from patent US 11168325
GTAAGCACTTTG
>MY678887.1 Sequence 151 from patent US 11168322
VKRBTYTRAAAC
>MY672213.1 Sequence 26 from patent US 11162146
ACAGACCGCCGG
>MY672210.1 Sequence 23 from patent US 11162146
CAGCGGGTTGTT
>MY672102.1 Sequence 14 from patent US 11162142
CCCGGAGGGTCT
>MY672101.1 Sequence 13 from patent US 11162142
TCCTTGGTAGGG
>MY672100.1 Sequence 12 from patent US 11162142
ATCAGGCTCTAC
>MY668107.1 Sequence 702 from patent US 11162102
GGACCTGGGGAC
>MY667403.1 Sequence 118 from patent US 11162101
CAGTAAGTCTGN
>MY667399.1 Sequence 114 from patent US 11162101
GCGCTGTGTCGA
>MY667351.1 Sequence 66 from patent US 11162101
GTTCTCAGTGTG
>MY667332.1 Sequence 47 from patent US 11162101
CGGGTCATAATC
>MY661818.1 Sequence 116 from patent US 11160260
TGTGGAGAATTC
>MY661380.1 Sequence 32 from patent US 11156599
GAATTCCTGCAG
>MY661099.1 Sequence 50 from patent US 11155882
CTCGTTCGTTCT
>MY661095.1 Sequence 46 from patent US 11155882
TCTCGTACGTTC
>MY661094.1 Sequence 45 from patent US 11155882
TCTCGTACGTTC
>MY661093.1 Sequence 44 from patent US 11155882
TCTCGTACGTTC
>MY661092.1 Sequence 43 from patent US 11155882
TCTCGTACGTTC
>MY661088.1 Sequence 39 from patent US 11155882
TCTCGTACGTTC
>MY661087.1 Sequence 38 from patent US 11155882
TCTCGTACGTTC
>MY661082.1 Sequence 29 from patent US 11155882
GTACTTTTGAGA
>MY661081.1 Sequence 28 from patent US 11155882
TCTCAAAAGTAC
>MY661068.1 Sequence 6 from patent US 11155882
TCTCGTACGTTC
>MY660658.1 Sequence 29 from patent US 11155871
GGAAGGAAGGAA
>MY660657.1 Sequence 28 from patent US 11155871
GGAAAGAATGAA
>MY660439.1 Sequence 28 from patent US 11155859
TTCNNANCGTTT
>MY660438.1 Sequence 27 from patent US 11155859
TTCTNANCGTTT
>MY660437.1 Sequence 26 from patent US 11155859
TTCNTANCGTTT
>MY660436.1 Sequence 25 from patent US 11155859
TTCNNAGCGTTT
>MY660435.1 Sequence 24 from patent US 11155859
TTCTTANCGTTT
>MY660434.1 Sequence 23 from patent US 11155859
TTCTNAGCGTTT
>MY660433.1 Sequence 22 from patent US 11155859
TTCNTAGCGTTT
>MY660432.1 Sequence 21 from patent US 11155859
TTCTTAGCGTTT
>MY659144.1 Sequence 53 from patent US 11155816
GTTGACACTGTC
>MY657476.1 Sequence 30 from patent US 11155795
GTTTTAGAGCTA
>MY654852.1 Sequence 33 from patent US 11154622
CGTGCAAAGCGT
>MY654726.1 Sequence 4 from patent US 11154611
TCTAGAAAGCTT
>MY654724.1 Sequence 2 from patent US 11154611
GATCCAAGCTTT
>MY654723.1 Sequence 1 from patent US 11154611
CTAGAAAGCTTG
>MY654518.1 Sequence 19 from patent US 11154575
GGCCAGGCCGGC
>MY653941.1 Sequence 357 from patent US 11149320
TAACACCCTGAT
>MY653940.1 Sequence 356 from patent US 11149320
TAACATCCTGAT
>MY653834.1 Sequence 250 from patent US 11149320
TCAGGGTGTTAA
>MY653833.1 Sequence 249 from patent US 11149320
TCAGGATGTTAA
>MY651139.1 Sequence 81 from patent US 11149289
TAAGACCCTGCA
>MY651137.1 Sequence 79 from patent US 11149289
ATTCTGGGACGT
>MY651129.1 Sequence 71 from patent US 11149289
TGCAGGGTCTTA
>MY651128.1 Sequence 70 from patent US 11149289
TAAGACCCTGCA
>MY651127.1 Sequence 69 from patent US 11149289
ACGTCCCAGAAT
>MY651126.1 Sequence 68 from patent US 11149289
ATTCTGGGACGT
>MY651124.1 Sequence 62 from patent US 11149289
ATTCTGGGACGT
>MY650911.1 Sequence 7416 from patent US 11149287
CGCACGTAATAA
>MY650901.1 Sequence 7406 from patent US 11149287
TGTGTGGAAGAC
>MY650887.1 Sequence 7392 from patent US 11149287
GGAGTAGTTAGG
>MY650873.1 Sequence 7378 from patent US 11149287
ATAATGGAACCC
>MY650865.1 Sequence 7370 from patent US 11149287
ATTGCATAATAA
>MY650862.1 Sequence 7367 from patent US 11149287
ATCATCTGCAAA
>MY650861.1 Sequence 7366 from patent US 11149287
TACTTGCTGGTA
>MY638755.1 Sequence 51 from patent US 11149259
GTTTTAGAGCTA
>MY615554.1 Sequence 64 from patent US 11149092
CGCCCTCGGGCG
>MY615546.1 Sequence 52 from patent US 11149092
CCTCATTAACTC
>MY614950.1 Sequence 50 from patent US 11148145
TAGCAAGGGAAA
>MY614949.1 Sequence 49 from patent US 11148145
TTTCCCTTGCTA
>MY614948.1 Sequence 48 from patent US 11148145
GCCGCTAGACAA
>MY614947.1 Sequence 47 from patent US 11148145
TTGTCTAGCGGC
>MY614946.1 Sequence 46 from patent US 11148145
CCCTAAGTGGAA
>MY614945.1 Sequence 45 from patent US 11148145
TTCCACTTAGGG
>MY614944.1 Sequence 44 from patent US 11148145
CCAAGTCAAGCA
>MY614943.1 Sequence 43 from patent US 11148145
TGCTTGACTTGG
>MY614942.1 Sequence 42 from patent US 11148145
TTATTCCGGGTA
>MY614941.1 Sequence 41 from patent US 11148145
TACCCGGAATAA
>MY614940.1 Sequence 40 from patent US 11148145
GACAGAATCAAC
>MY614939.1 Sequence 39 from patent US 11148145
GTTGATTCTGTC
>MY614938.1 Sequence 38 from patent US 11148145
TGAAACACGACC
>MY614937.1 Sequence 37 from patent US 11148145
GGTCGTGTTTCA
>MY614936.1 Sequence 36 from patent US 11148145
TGGTGAATTAGC
>MY614935.1 Sequence 35 from patent US 11148145
GCTAATTCACCA
>MY614934.1 Sequence 34 from patent US 11148145
AGAGACTATGGC
>MY614933.1 Sequence 33 from patent US 11148145
GCCATAGTCTCT
>MY614932.1 Sequence 32 from patent US 11148145
TCGCTTTATGTC
>MY614931.1 Sequence 31 from patent US 11148145
GACATAAAGCGA
>MY614930.1 Sequence 30 from patent US 11148145
GTGCCGAGAAAG
>MY614929.1 Sequence 29 from patent US 11148145
CTTTCTCGGCAC
>MY614928.1 Sequence 28 from patent US 11148145
TGGCGTTGTAAG
>MY614927.1 Sequence 27 from patent US 11148145
CTTACAACGCCA
>MY614926.1 Sequence 26 from patent US 11148145
TATCTCAAACCG
>MY614925.1 Sequence 25 from patent US 11148145
CGGTTTGAGATA
>MY614924.1 Sequence 24 from patent US 11148145
ACTCTACATTCG
>MY614923.1 Sequence 23 from patent US 11148145
CGAATGTAGAGT
>MY614922.1 Sequence 22 from patent US 11148145
GTATATCGTAGG
>MY614921.1 Sequence 21 from patent US 11148145
CCTACGATATAC
>MY614920.1 Sequence 20 from patent US 11148145
CTGGATTGGATG
>MY614919.1 Sequence 19 from patent US 11148145
CATCCAATCCAG
>MY614918.1 Sequence 18 from patent US 11148145
AATGGACACCTG
>MY614917.1 Sequence 17 from patent US 11148145
CAGGTGTCCATT
>MY614916.1 Sequence 16 from patent US 11148145
TTAAGACCTCTG
>MY614915.1 Sequence 15 from patent US 11148145
CAGAGGTCTTAA
>MY614914.1 Sequence 14 from patent US 11148145
GCTCCCGTTAAT
>MY614913.1 Sequence 13 from patent US 11148145
ATTAACGGGAGC
>MY614912.1 Sequence 12 from patent US 11148145
GGTGGTAATGAT
>MY614911.1 Sequence 11 from patent US 11148145
ATCATTACCACC
>MY614910.1 Sequence 10 from patent US 11148145
GCGTATCCTGAT
>MY614909.1 Sequence 9 from patent US 11148145
ATCAGGATACGC
>MY614908.1 Sequence 8 from patent US 11148145
TGCACTGAACCT
>MY614907.1 Sequence 7 from patent US 11148145
AGGTTCAGTGCA
>MY614906.1 Sequence 6 from patent US 11148145
GGATCTTCTTCT
>MY614905.1 Sequence 5 from patent US 11148145
AGAAGAAGATCC
>MY614904.1 Sequence 4 from patent US 11148145
CAACTGGGACGT
>MY614903.1 Sequence 3 from patent US 11148145
ACGTCCCAGTTG
>MY614902.1 Sequence 2 from patent US 11148145
AACTACCGATGT
>MY614901.1 Sequence 1 from patent US 11148145
ACATCGGTAGTT
>MY613824.1 Sequence 40 from patent US 11147830
GTTTTTGTACTC
>MY613818.1 Sequence 27 from patent US 11147830
AAATCATTTGAG
>MY613817.1 Sequence 26 from patent US 11147830
AATTCATTTGAG
>MY605887.1 Sequence 180 from patent US 11142544
TCGATAGCCGAG
>MY605886.1 Sequence 179 from patent US 11142544
TCGATAGCCTAG
>MY605885.1 Sequence 178 from patent US 11142544
TCGATAGCCAAG
>MY605884.1 Sequence 177 from patent US 11142544
TCGATAGCCCAG
>MY605883.1 Sequence 176 from patent US 11142544
TCGATAGCGCAG
>MY605882.1 Sequence 175 from patent US 11142544
TCGATAGCGTAG
>MY605881.1 Sequence 174 from patent US 11142544
TCGATAGCGAAG
>MY605880.1 Sequence 173 from patent US 11142544
TCGATAGCGGAG
>MY605879.1 Sequence 172 from patent US 11142544
TCGATAGCTGAG
>MY605878.1 Sequence 171 from patent US 11142544
TCGATAGCTCAG
>MY605877.1 Sequence 170 from patent US 11142544
TCGATAGCTAAG
>MY605876.1 Sequence 169 from patent US 11142544
TCGATAGCTTAG
>MY605875.1 Sequence 168 from patent US 11142544
TCGATAGCACAG
>MY605874.1 Sequence 167 from patent US 11142544
TCGATAGCAGAG
>MY605873.1 Sequence 166 from patent US 11142544
TCGATAGCATAG
>MY605872.1 Sequence 165 from patent US 11142544
TCGATAGCAAAG
>MY605871.1 Sequence 164 from patent US 11142544
TCGATAGCCGAA
>MY605870.1 Sequence 163 from patent US 11142544
TCGATAGCCTAA
>MY605869.1 Sequence 162 from patent US 11142544
TCGATAGCCAAA
>MY605868.1 Sequence 161 from patent US 11142544
TCGATAGCCCAA
>MY605867.1 Sequence 160 from patent US 11142544
TCGATAGCGCAA
>MY605866.1 Sequence 159 from patent US 11142544
TCGATAGCGTAA
>MY605865.1 Sequence 158 from patent US 11142544
TCGATAGCGAAA
>MY605864.1 Sequence 157 from patent US 11142544
TCGATAGCGGAA
>MY605863.1 Sequence 156 from patent US 11142544
TCGATAGCTGAA
>MY605862.1 Sequence 155 from patent US 11142544
TCGATAGCTCAA
>MY605861.1 Sequence 154 from patent US 11142544
TCGATAGCTAAA
>MY605860.1 Sequence 153 from patent US 11142544
TCGATAGCTTAA
>MY605859.1 Sequence 152 from patent US 11142544
TCGATAGCACAA
>MY605858.1 Sequence 151 from patent US 11142544
TCGATAGCAGAA
>MY605857.1 Sequence 150 from patent US 11142544
TCGATAGCATAA
>MY605856.1 Sequence 149 from patent US 11142544
TCGATAGCAAAA
>MY605855.1 Sequence 148 from patent US 11142544
TCGACAGTCGAG
>MY605854.1 Sequence 147 from patent US 11142544
TCGACAGTCTAG
>MY605853.1 Sequence 146 from patent US 11142544
TCGACAGTCAAG
>MY605852.1 Sequence 145 from patent US 11142544
TCGACAGTCCAG
>MY605851.1 Sequence 144 from patent US 11142544
TCGACAGTGCAG
>MY605850.1 Sequence 143 from patent US 11142544
TCGACAGTGTAG
>MY605849.1 Sequence 142 from patent US 11142544
TCGACAGTGAAG
>MY605848.1 Sequence 141 from patent US 11142544
TCGACAGTGGAG
>MY605847.1 Sequence 140 from patent US 11142544
TCGACAGTTGAG
>MY605846.1 Sequence 139 from patent US 11142544
TCGACAGTTCAG
>MY605845.1 Sequence 138 from patent US 11142544
TCGACAGTTAAG
>MY605844.1 Sequence 137 from patent US 11142544
TCGACAGTTTAG
>MY605843.1 Sequence 136 from patent US 11142544
TCGACAGTACAG
>MY605842.1 Sequence 135 from patent US 11142544
TCGACAGTAGAG
>MY605841.1 Sequence 134 from patent US 11142544
TCGACAGTATAG
>MY605840.1 Sequence 133 from patent US 11142544
TCGACAGTAAAG
>MY605839.1 Sequence 132 from patent US 11142544
TCGACAGTCGAA
>MY605838.1 Sequence 131 from patent US 11142544
TCGACAGTCTAA
>MY605837.1 Sequence 130 from patent US 11142544
TCGACAGTCAAA
>MY605836.1 Sequence 129 from patent US 11142544
TCGACAGTCCAA
>MY605835.1 Sequence 128 from patent US 11142544
TCGACAGTGCAA
>MY605834.1 Sequence 127 from patent US 11142544
TCGACAGTGTAA
>MY605833.1 Sequence 126 from patent US 11142544
TCGACAGTGAAA
>MY605832.1 Sequence 125 from patent US 11142544
TCGACAGTGGAA
>MY605831.1 Sequence 124 from patent US 11142544
TCGACAGTTGAA
>MY605830.1 Sequence 123 from patent US 11142544
TCGACAGTTCAA
>MY605829.1 Sequence 122 from patent US 11142544
TCGACAGTTAAA
>MY605828.1 Sequence 121 from patent US 11142544
TCGACAGTTTAA
>MY605827.1 Sequence 120 from patent US 11142544
TCGACAGTACAA
>MY605826.1 Sequence 119 from patent US 11142544
TCGACAGTAGAA
>MY605825.1 Sequence 118 from patent US 11142544
TCGACAGTATAA
>MY605824.1 Sequence 117 from patent US 11142544
TCGACAGTAAAA
>MY605823.1 Sequence 116 from patent US 11142544
TCGACAGCCGAG
>MY605822.1 Sequence 115 from patent US 11142544
TCGACAGCCTAG
>MY605821.1 Sequence 114 from patent US 11142544
TCGACAGCCAAG
>MY605820.1 Sequence 113 from patent US 11142544
TCGACAGCCCAG
>MY605819.1 Sequence 112 from patent US 11142544
TCGACAGCGCAG
>MY605818.1 Sequence 111 from patent US 11142544
TCGACAGCGTAG
>MY605817.1 Sequence 110 from patent US 11142544
TCGACAGCGAAG
>MY605816.1 Sequence 109 from patent US 11142544
TCGACAGCGGAG
>MY605815.1 Sequence 108 from patent US 11142544
TCGACAGCTGAG
>MY605814.1 Sequence 107 from patent US 11142544
TCGACAGCTCAG
>MY605813.1 Sequence 106 from patent US 11142544
TCGACAGCTAAG
>MY605812.1 Sequence 105 from patent US 11142544
TCGACAGCTTAG
>MY605811.1 Sequence 104 from patent US 11142544
TCGACAGCACAG
>MY605810.1 Sequence 103 from patent US 11142544
TCGACAGCAGAG
>MY605809.1 Sequence 102 from patent US 11142544
TCGACAGCATAG
>MY605808.1 Sequence 101 from patent US 11142544
TCGACAGCAAAG
>MY605807.1 Sequence 100 from patent US 11142544
TCGACAGCCGAA
>MY605806.1 Sequence 99 from patent US 11142544
TCGACAGCCTAA
>MY605805.1 Sequence 98 from patent US 11142544
TCGACAGCCAAA
>MY605804.1 Sequence 97 from patent US 11142544
TCGACAGCCCAA
>MY605803.1 Sequence 96 from patent US 11142544
TCGACAGCGCAA
>MY605802.1 Sequence 95 from patent US 11142544
TCGACAGCGTAA
>MY605801.1 Sequence 94 from patent US 11142544
TCGACAGCGAAA
>MY605800.1 Sequence 93 from patent US 11142544
TCGACAGCGGAA
>MY605799.1 Sequence 92 from patent US 11142544
TCGACAGCTGAA
>MY605798.1 Sequence 91 from patent US 11142544
TCGACAGCTCAA
>MY605797.1 Sequence 90 from patent US 11142544
TCGACAGCTAAA
>MY605796.1 Sequence 89 from patent US 11142544
TCGACAGCTTAA
>MY605795.1 Sequence 88 from patent US 11142544
TCGACAGCACAA
>MY605794.1 Sequence 87 from patent US 11142544
TCGACAGCAGAA
>MY605793.1 Sequence 86 from patent US 11142544
TCGACAGCATAA
>MY605792.1 Sequence 85 from patent US 11142544
TCGACAGCAAAA
>MY605791.1 Sequence 84 from patent US 11142544
TCGATAGTCGAG
>MY605790.1 Sequence 83 from patent US 11142544
TCGATAGTCTAG
>MY605789.1 Sequence 82 from patent US 11142544
TCGATAGTCAAG
>MY605788.1 Sequence 81 from patent US 11142544
TCGATAGTCCAG
>MY605787.1 Sequence 80 from patent US 11142544
TCGATAGTGCAG
>MY605786.1 Sequence 79 from patent US 11142544
TCGATAGTGTAG
>MY605785.1 Sequence 78 from patent US 11142544
TCGATAGTGAAG
>MY605784.1 Sequence 77 from patent US 11142544
TCGATAGTGGAG
>MY605783.1 Sequence 76 from patent US 11142544
TCGATAGTTGAG
>MY605782.1 Sequence 75 from patent US 11142544
TCGATAGTTCAG
>MY605781.1 Sequence 74 from patent US 11142544
TCGATAGTTAAG
>MY605780.1 Sequence 73 from patent US 11142544
TCGATAGTTTAG
>MY605779.1 Sequence 72 from patent US 11142544
TCGATAGTACAG
>MY605778.1 Sequence 71 from patent US 11142544
TCGATAGTAGAG
>MY605777.1 Sequence 70 from patent US 11142544
TCGATAGTATAG
>MY605776.1 Sequence 69 from patent US 11142544
TCGATAGTAAAG
>MY605775.1 Sequence 68 from patent US 11142544
TCGATAGTCGAA
>MY605774.1 Sequence 67 from patent US 11142544
TCGATAGTCTAA
>MY605773.1 Sequence 66 from patent US 11142544
TCGATAGTCAAA
>MY605772.1 Sequence 65 from patent US 11142544
TCGATAGTCCAA
>MY605771.1 Sequence 64 from patent US 11142544
TCGATAGTGCAA
>MY605770.1 Sequence 63 from patent US 11142544
TCGATAGTGTAA
>MY605769.1 Sequence 62 from patent US 11142544
TCGATAGTGAAA
>MY605768.1 Sequence 61 from patent US 11142544
TCGATAGTGGAA
>MY605767.1 Sequence 60 from patent US 11142544
TCGATAGTTGAA
>MY605766.1 Sequence 59 from patent US 11142544
TCGATAGTTCAA
>MY605765.1 Sequence 58 from patent US 11142544
TCGATAGTTAAA
>MY605764.1 Sequence 57 from patent US 11142544
TCGATAGTTTAA
>MY605763.1 Sequence 56 from patent US 11142544
TCGATAGTACAA
>MY605762.1 Sequence 55 from patent US 11142544
TCGATAGTAGAA
>MY605761.1 Sequence 54 from patent US 11142544
TCGATAGTATAA
>MY605760.1 Sequence 53 from patent US 11142544
TCGATAGTAAAA
>MY605759.1 Sequence 52 from patent US 11142544
TCGANAGNNNAN
>MY605758.1 Sequence 51 from patent US 11142544
AAGATGGCGAAA
>MY603568.1 Sequence 38 from patent US 11141493
AAGGCTAGTCCG
>MY566085.1 Sequence 47 from patent US 11141470
GAGTTCTTTATT
>MY566084.1 Sequence 46 from patent US 11141470
CCTCTCTTGGCA
>MY566083.1 Sequence 45 from patent US 11141470
CGTGGGGAGGCT
>MY566082.1 Sequence 44 from patent US 11141470
GTGGCTCACTCA
>MY566081.1 Sequence 43 from patent US 11141470
GTAGGTGGCAGC
>MY566080.1 Sequence 42 from patent US 11141470
CCCGCTGGCTAG
>MY566079.1 Sequence 41 from patent US 11141470
GTAAGTGAGCTG
>MY566078.1 Sequence 40 from patent US 11141470
GAACTGGACGTG
>MY566077.1 Sequence 39 from patent US 11141470
GGCTGGTTTGCT
>MY566076.1 Sequence 38 from patent US 11141470
CTGCCCTCGCAG
>MY566075.1 Sequence 37 from patent US 11141470
GTATATTCCTCC
>MY566074.1 Sequence 36 from patent US 11141470
CCATTTGGGAAG
>MY566073.1 Sequence 35 from patent US 11141470
GAGAGGAAGCTC
>MY566072.1 Sequence 34 from patent US 11141470
CTTTCTTGCCCA
>MY566071.1 Sequence 33 from patent US 11141470
GGTAAGACCCCT
>MY566070.1 Sequence 32 from patent US 11141470
GACCCTGGACCA
>MY566069.1 Sequence 31 from patent US 11141470
GTGAGTCTGGAG
>MY566068.1 Sequence 30 from patent US 11141470
TTTCTCCCTCCA
>MY566067.1 Sequence 29 from patent US 11141470
GGTGAGTCCGTC
>MY566066.1 Sequence 28 from patent US 11141470
AGAGTGGATGTG
>MY566065.1 Sequence 27 from patent US 11141470
GTCACCCTGACA
>MY566064.1 Sequence 26 from patent US 11141470
CCTTTATCCTAG
>MY566063.1 Sequence 25 from patent US 11141470
GCAAGAGTCCCC
>MY566062.1 Sequence 24 from patent US 11141470
CCCATCTATGAG
>MY566061.1 Sequence 23 from patent US 11141470
CCTCCGGTTTGA
>MY566060.1 Sequence 22 from patent US 11141470
GTGACCTCCAGG
>MY566059.1 Sequence 21 from patent US 11141470
TAGGTGCATCTC
>MY566058.1 Sequence 20 from patent US 11141470
CCCCATCCCAGG
>MY566057.1 Sequence 19 from patent US 11141470
AGAAGGGCTCCC
>MY566056.1 Sequence 18 from patent US 11141470
GTTTCCCTGCAG
>MY566055.1 Sequence 17 from patent US 11141470
GTATTGCAGATG
>MY566054.1 Sequence 16 from patent US 11141470
CTTTCAGAGGAG
>MY566053.1 Sequence 15 from patent US 11141470
CTGTTCCCGAAA
>MY566052.1 Sequence 14 from patent US 11141470
TCTTATTTTAGG
>MY566051.1 Sequence 13 from patent US 11141470
TGAGATGGCAAG
>MY566050.1 Sequence 12 from patent US 11141470
GGTGAAAACGGG
>MY566049.1 Sequence 11 from patent US 11141470
AGCCCTAGATGT
>MY566048.1 Sequence 10 from patent US 11141470
TTGTGTCCCAAC
>MY566047.1 Sequence 9 from patent US 11141470
AGGTGAGTGTCC
>MY566046.1 Sequence 8 from patent US 11141470
ATGACTTCGTAC
>MY565980.1 Sequence 19 from patent US 11141436
GGCCAGGCCGGC
>MY565105.1 Sequence 154 from patent US 11136622
GAAACACTGGTC
>MY564842.1 Sequence 1 from patent US 11136618
ATCAACACTGCA
>MY564504.1 Sequence 152 from patent US 11136597
TCTTCCGAGCAG
>MY564499.1 Sequence 142 from patent US 11136597
TCTTCCGAGCAG
>MY564498.1 Sequence 141 from patent US 11136597
CTGCTCGGAAGA
>MY564424.1 Sequence 30 from patent US 11136597
NTTTNTTTNTNT
>MY564420.1 Sequence 22 from patent US 11136597
TCTCTTTCTTTC
>MY564419.1 Sequence 21 from patent US 11136597
CTTTCTTTCTCT
>MY564415.1 Sequence 15 from patent US 11136597
GAAAGAAAGAGA
>MY563318.1 Sequence 26 from patent US 11136580
TTATTCAACAAA
>MY563127.1 Sequence 30 from patent US 11136576
TGCGTCAGTTCA
>MY563109.1 Sequence 12 from patent US 11136576
TGCGTCAGTTCA
>MY561041.1 Sequence 7 from patent US 11136400
ACATCACTCCGT
>MY560861.1 Sequence 364139 from patent US 11136386
AGGGACCACTGA
>MY560860.1 Sequence 364138 from patent US 11136386
TAGTTAGGCCCA
>MY560855.1 Sequence 364133 from patent US 11136386
TAGAATCCACAA
>MY560853.1 Sequence 364131 from patent US 11136386
TGCAGGTTGGGA
>MY560851.1 Sequence 364129 from patent US 11136386
AGGGACCGCTGA
>MY560847.1 Sequence 364125 from patent US 11136386
CGGGCACAGCTC
>MY560843.1 Sequence 364121 from patent US 11136386
TGCAGATTGGGA
>MY558278.1 Sequence 3 from patent US 11131663
AGGTCGCCGCCC
>MY558277.1 Sequence 2 from patent US 11131663
GGGCGGCGACCT
>MY546467.1 Sequence 17 from patent US 11129890
TCGGCCCTCAAT
>MY545758.1 Sequence 15 from patent US 11129829
CAGGTTTAGTAT
>MY545755.1 Sequence 12 from patent US 11129829
CAGAGTAAGGGG
>PA368552.1 WO 2021256297-A/12: Bridged nucleoside and nucleotide
ACGAGAACATCC
>PA368551.1 WO 2021256297-A/11: Bridged nucleoside and nucleotide
ACGAGAACATCC
>PA368550.1 WO 2021256297-A/10: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368549.1 WO 2021256297-A/9: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368548.1 WO 2021256297-A/8: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368547.1 WO 2021256297-A/7: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368546.1 WO 2021256297-A/6: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368545.1 WO 2021256297-A/5: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368544.1 WO 2021256297-A/4: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368543.1 WO 2021256297-A/3: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368542.1 WO 2021256297-A/2: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA368541.1 WO 2021256297-A/1: Bridged nucleoside and nucleotide
GGATGTTCTCGT
>PA367942.1 JP 2021185812-A/2: TARGET NUCLEIC ACID SEQUENCE DETECTION METHOD, VIRUS DETECTION METHOD, AND VIRUS DETECTION KIT
CACACCTGTAAT
>PA367941.1 JP 2021185812-A/1: TARGET NUCLEIC ACID SEQUENCE DETECTION METHOD, VIRUS DETECTION METHOD, AND VIRUS DETECTION KIT
ATTACAGGTGTG
>pdb|7EDW|B Chain B, DNA duplex containing T-T base pairs in complex with Au(III)
GGACCTTGGTCC
>pdb|7EDW|A Chain A, DNA duplex containing T-T base pairs in complex with Au(III)
GGACCTTGGTCC
>pdb|7EDV|A Chain A, DNA duplex containing C-G-Au-C base triple
GGACCCCGGTCC
>pdb|7EDU|D Chain D, RNA duplex containing C-Au-C base pair
GGACTCGACTCC
>pdb|7EDU|C Chain C, RNA duplex containing C-Au-C base pair
GGACTCGACTCC
>pdb|7EDU|B Chain B, RNA duplex containing C-Au-C base pair
GGACTCGACTCC
>pdb|7EDU|A Chain A, RNA duplex containing C-Au-C base pair
GGACTCGACTCC
>pdb|7EDT|B Chain B, RNA duplex containing CC mispairs
GGACTCCGGNCC
>pdb|7EDT|A Chain A, RNA duplex containing CC mispairs
GGACTCCGGNCC
>pdb|7ECP|D Chain D, RNA duplex containing C-Ag-U
GGGCCCGGTCCC
>pdb|7ECP|C Chain C, RNA duplex containing C-Ag-U
GGGCCCGGTCCC
>pdb|7ECP|B Chain B, RNA duplex containing C-Ag-U
GGGCCCGGTCCC
>pdb|7ECP|A Chain A, RNA duplex containing C-Ag-U
GGGCCCGGTCCC
>pdb|7ECO|D Chain D, RNA duplex containing U-Ag-U base pairs
GGGTCCGGTCCC
>pdb|7ECO|C Chain C, RNA duplex containing U-Ag-U base pairs
GGGTCCGGTCCC
>pdb|7ECO|B Chain B, RNA duplex containing U-Ag-U base pairs
GGGTCCGGTCCC
>pdb|7ECO|A Chain A, RNA duplex containing U-Ag-U base pairs
GGGTCCGGTCCC
>pdb|7ECO|F Chain F, RNA duplex containing U-Ag-U base pairs
GGGTCCGGTCCC
>pdb|7ECO|E Chain E, RNA duplex containing U-Ag-U base pairs
GGGTCCGGTCCC
>pdb|7ECN|D Chain D, RNA duplex containing C-Ag-A base pairs
GGGCCCGGACCC
>pdb|7ECN|C Chain C, RNA duplex containing C-Ag-A base pairs
GGGCCCGGACCC
>pdb|7ECN|B Chain B, RNA duplex containing C-Ag-A base pairs
GGGCCCGGACCC
>pdb|7ECN|A Chain A, RNA duplex containing C-Ag-A base pairs
GGGCCCGGACCC
>pdb|7ECM|D Chain D, RNA duplex containing C-A base pair
GGGCCCGGACCC
>pdb|7ECM|C Chain C, RNA duplex containing C-A base pair
GGGCCCGGACCC
>pdb|7ECM|B Chain B, RNA duplex containing C-A base pair
GGGCCCGGACCC
>pdb|7ECM|A Chain A, RNA duplex containing C-A base pair
GGGCCCGGACCC
>pdb|7ECL|L Chain L, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|K Chain K, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|J Chain J, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|I Chain I, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|H Chain H, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|G Chain G, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|F Chain F, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|E Chain E, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|D Chain D, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|C Chain C, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|B Chain B, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECL|A Chain A, RNA duplex containing C-Ag-A and U-Ag-A base pair
GGACTNGAATCC
>pdb|7ECK|L Chain L, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|K Chain K, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|J Chain J, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|I Chain I, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|H Chain H, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|G Chain G, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|F Chain F, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|E Chain E, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|D Chain D, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|C Chain C, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|B Chain B, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECK|A Chain A, RNA duplex containing C-Ag-A and U-Ag-A base pairs
GGACTNGAATCC
>pdb|7ECJ|C Chain C, RNA duplex containing C-A base pairs
GGACTNGAATCC
>pdb|7ECJ|B Chain B, RNA duplex containing C-A base pairs
GGACTNGAATCC
>pdb|7ECJ|A Chain A, RNA duplex containing C-A base pairs
GGACTNGAATCC
>pdb|2P7C|C Chain C, Solution structure of the bacillus licheniformis BlaI monomeric form in complex with the blaP half-operator.
NTGTAATACTTT
>pdb|2P7C|A Chain A, Solution structure of the bacillus licheniformis BlaI monomeric form in complex with the blaP half-operator.
NAAGTATTACAT
>pdb|7EAY|L Chain L, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|K Chain K, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|J Chain J, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|I Chain I, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|H Chain H, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|G Chain G, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|F Chain F, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|E Chain E, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|D Chain D, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|C Chain C, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|B Chain B, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAY|A Chain A, DNA containing Cu(II)-mediated 4-N-carboxymethylcytosine base pairs
GGACCNNGGTCC
>pdb|7EAQ|B Chain B, DNA quadruplex composed of i-motif and Z-DNA
CGCGACCTCGCG
>pdb|7EAQ|A Chain A, DNA quadruplex composed of i-motif and Z-DNA
CGCGACCTCGCG
>pdb|1S9O|B Chain B, Solution structure of the nitrous acid induced DNA interstrand cross-linked dodecamer duplex CGCTAC(G)TAGCG with the cross-linked guanines denoted (G)
CGCTACGTAGCG
>pdb|1ZIH|A Chain A, GCAA RNA TETRALOOP, NMR, 10 STRUCTURES
GGGCGCAAGCCT
>pdb|1ZIG|A Chain A, GAGA RNA TETRALOOP, NMR, 10 STRUCTURES
GGGCGAGAGCCT
>pdb|1ZIF|A Chain A, GAAA RNA TETRALOOP, NMR, 10 STRUCTURES
GGGCGAAAGCCT
>pdb|1RNG|A Chain A, SOLUTION STRUCTURE OF THE CUUG HAIRPIN: A NOVEL RNA TETRALOOP MOTIF
GGCGCTTGCGTC
>pdb|1X30|B Chain B, NMR Solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTGCAGTC
>pdb|1X30|A Chain A, NMR Solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTGCAGTC
>pdb|1X2Z|B Chain B, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTGCAGTC
>pdb|1X2Z|A Chain A, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTGCAGTC
>pdb|1X2Y|B Chain B, NMR Solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTGCAGTC
>pdb|1X2Y|A Chain A, NMR Solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTGCAGTC
>pdb|1X2X|B Chain B, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTGCAGTC
>pdb|1X2X|A Chain A, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTGCAGTC
>pdb|1X2V|B Chain B, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTACAGTC
>pdb|1X2V|A Chain A, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTACAGTC
>pdb|1X2U|B Chain B, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTACAGTC
>pdb|1X2U|A Chain A, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTACAGTC
>pdb|1X2S|B Chain B, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTACAGTC
>pdb|1X2S|A Chain A, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTACAGTC
>pdb|1X2O|B Chain B, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTACAGTC
>pdb|1X2O|A Chain A, NMR solution structures of a DNA dodecamer containing a tandem GT mismatches using NOE and residual dipolar couplings
GACTGTACAGTC
>pdb|1ZYH|B Chain B, Structure of a Supercoiling Responsive DNA site
CAACCCTGGTTG
>pdb|1ZYH|A Chain A, Structure of a Supercoiling Responsive DNA site
CAACCAGGGTTG
>pdb|1ZYG|B Chain B, Structure of a Supercoiling Responsive DNA Site
CAACCCGGGTTG
>pdb|1ZYG|A Chain A, Structure of a Supercoiling Responsive DNA Site
CAACCCGGGTTG
>pdb|1ZYF|B Chain B, Structure of a Supercoiling Responsive DNA Site
CAACCATGGTTG
>pdb|1ZYF|A Chain A, Structure of a Supercoiling Responsive DNA Site
CAACCATGGTTG
>pdb|1S9O|A Chain A, Solution structure of the nitrous acid induced DNA interstrand cross-linked dodecamer duplex CGCTAC(G)TAGCG with the cross-linked guanines denoted (G)
CGCTACGTAGCG
>pdb|1S9N|B Chain B, Solution structure of the nitrous acid (G)-(G) cross-linked DNA dodecamer duplex GCATCC(G)GATGC
GCATCCGGATGC
>pdb|1S9N|A Chain A, Solution structure of the nitrous acid (G)-(G) cross-linked DNA dodecamer duplex GCATCC(G)GATGC
GCATCCGGATGC
>pdb|1R2L|B Chain B, A parallel stranded DNA duplex with an A-G mismatch base-pair
NCTATGAAATCC
>pdb|1R2L|A Chain A, A parallel stranded DNA duplex with an A-G mismatch base-pair
NNATAATTTANN
>pdb|1TUQ|B Chain B, NMR Structure Analysis of the B-DNA Dodecamer CTCtCACGTGGAG with a tricyclic cytosin base analogue
NTCNACGTGGAG
>pdb|1TUQ|A Chain A, NMR Structure Analysis of the B-DNA Dodecamer CTCtCACGTGGAG with a tricyclic cytosin base analogue
NTCNACGTGGAG
>pdb|1UAB|B Chain B, NMR structure of hemimethylated GATC site
CGCAGNTCTCGC
>pdb|1UAB|A Chain A, NMR structure of hemimethylated GATC site
GCGAGATCTGCG
>pdb|1RVI|B Chain B, SOLUTION STRUCTURE OF THE DNA DODECAMER CGTTTTAAAACG
CGTTTTAAAACG
>pdb|1RVI|A Chain A, SOLUTION STRUCTURE OF THE DNA DODECAMER CGTTTTAAAACG
CGTTTTAAAACG
>pdb|1RVH|B Chain B, SOLUTION STRUCTURE OF THE DNA DODECAMER GCAAAATTTTGC
GCAAAATTTTGC
>pdb|1RVH|A Chain A, SOLUTION STRUCTURE OF THE DNA DODECAMER GCAAAATTTTGC
GCAAAATTTTGC
>pdb|1QSX|B Chain B, SOLUTION NMR STRUCTURE OF THE 2:1 HOECHST 33258-D(CTTTTGCAAAAG)2 COMPLEX
CTTTTGCAAAAG
>pdb|1QSX|A Chain A, SOLUTION NMR STRUCTURE OF THE 2:1 HOECHST 33258-D(CTTTTGCAAAAG)2 COMPLEX
CTTTTGCAAAAG
>pdb|1QSK|B Chain B, NMR-DERIVED SOLUTION STRUCTURE OF A FIVE-ADENINE BULGE LOOP WITHIN A DNA DUPLEX
CGTAGCCGATGC
>pdb|1SJK|B Chain B, A DUPLEX DNA WITH AN ABASIC SITE IN A DA TRACT, ALPHA FORM, NMR, MINIMIZED AVERAGE STRUCTURE
CGCATTNTTGCG
>pdb|1SJK|A Chain A, A DUPLEX DNA WITH AN ABASIC SITE IN A DA TRACT, ALPHA FORM, NMR, MINIMIZED AVERAGE STRUCTURE
CGCAAAAATGCG
>pdb|1QDK|B Chain B, THE NMR STUDY OF DNA QUADRUPLEX STRUCTURE, (12MER) DNA
GGGGTTTTGGGG
>pdb|1QDK|A Chain A, THE NMR STUDY OF DNA QUADRUPLEX STRUCTURE, (12MER) DNA
GGGGTTTTGGGG
>pdb|1QDI|B Chain B, THE NMR STUDY OF DNA QUADRUPLEX STRUCTURE, (12MER) DNA
GGGGTTTTGGGG
>pdb|1QDI|A Chain A, THE NMR STUDY OF DNA QUADRUPLEX STRUCTURE, (12MER) DNA
GGGGTTTTGGGG
>pdb|1FYY|B Chain B, HPRT GENE MUTATION HOTSPOT WITH A BPDE2(10R) ADDUCT
TGCCCTTGACTA
>pdb|1FYY|A Chain A, HPRT GENE MUTATION HOTSPOT WITH A BPDE2(10R) ADDUCT
TAGTCAAGGGCA
>pdb|1JUU|A Chain A, NMR Structure of a Parallel Stranded DNA Duplex at Atomic Resolution
NCATAATTTACC
>pdb|1MYQ|B Chain B, An intramolecular quadruplex of (GGA)(4) triplet repeat DNA with a G:G:G:G tetrad and a G(:A):G(:A):G(:A):G heptad, and its dimeric interaction
GGAGGAGGAGGA
>pdb|1MYQ|A Chain A, An intramolecular quadruplex of (GGA)(4) triplet repeat DNA with a G:G:G:G tetrad and a G(:A):G(:A):G(:A):G heptad, and its dimeric interaction
GGAGGAGGAGGA
>pdb|7OMG|P Chain P, Crystal structure of KOD DNA Polymerase in a ternary complex with an Uracil containing template
GACCACGGCCAN
>pdb|7OMB|P Chain P, Crystal structure of KOD DNA Polymerase in a ternary complex with a p/t duplex containing an extended 5' single stranded template overhang
GACCACGGCCAN
>pdb|1JO1|B Chain B, N7-Guanine Adduct of 2,7-diaminomitosene with DNA
GTGGTATACCAC
>pdb|1JO1|A Chain A, N7-Guanine Adduct of 2,7-diaminomitosene with DNA
GTGGTATACCAC
>pdb|1ELH|A Chain A, NMR ANALYSIS OF HELIX I FROM THE 5S RNA OF ESCHERICHIA COLI
TTGCCTGGCGGC
>pdb|1EEK|2 Chain 2, SOLUTION STRUCTURE OF A NONPOLAR, NON HYDROGEN BONDED BASE PAIR SURROGATE IN DNA.
GGTAACNATGCG
>pdb|1EEK|1 Chain 1, SOLUTION STRUCTURE OF A NONPOLAR, NON HYDROGEN BONDED BASE PAIR SURROGATE IN DNA.
CGCATNGTTACC
>pdb|1DUF|B Chain B, THE NMR STRUCTURE OF DNA DODECAMER DETERMINED IN AQUEOUS DILUTE LIQUID CRYSTALLINE PHASE
CGCGAATTCGCG
>pdb|1DUF|A Chain A, THE NMR STRUCTURE OF DNA DODECAMER DETERMINED IN AQUEOUS DILUTE LIQUID CRYSTALLINE PHASE
CGCGAATTCGCG
>pdb|1D6D|B Chain B, SOLUTION DNA STRUCTURE CONTAINING (A-A)-T TRIADS INTERDIGITATED BETWEEN A-T BASE PAIRS AND GGGG TETRADS; NMR, 8 STRUCT.
AAGGTTTTAAGG
>pdb|1D6D|A Chain A, SOLUTION DNA STRUCTURE CONTAINING (A-A)-T TRIADS INTERDIGITATED BETWEEN A-T BASE PAIRS AND GGGG TETRADS; NMR, 8 STRUCT.
AAGGTTTTAAGG
>pdb|1COC|B Chain B, SOLUTION-STATE STRUCTURE OF A DNA DODECAMER DUPLEX CONTAINING A CIS-SYN THYMINE CYCLOBUTANE DIMER.
CTTAATTCGTGC
>pdb|1COC|A Chain A, SOLUTION-STATE STRUCTURE OF A DNA DODECAMER DUPLEX CONTAINING A CIS-SYN THYMINE CYCLOBUTANE DIMER.
GCACGAATTAAG
>pdb|1AJT|A Chain A, FIVE-NUCLEOTIDE BULGE LOOP FROM TETRAHYMENA THERMOPHILA GROUP I INTRON, NMR, 1 STRUCTURE
GGTAATAAGCTC
>pdb|1AJL|A Chain A, FIVE-NUCLEOTIDE BULGE LOOP FROM TETRAHYMENA THERMOPHILA GROUP I INTRON
GGTAATAAGCTC
>pdb|171D|B Chain B, SOLUTION STRUCTURE OF A DNA DODECAMER CONTAINING THE ANTI-NEOPLASTIC AGENT ARABINOSYLCYTOSINE: COMBINED USE OF NMR, RESTRAINED MOLECULAR DYNAMICS AND FULL RELAXATION MATRIX REFINEMENT
CGCGAATTCGCG
>pdb|171D|A Chain A, SOLUTION STRUCTURE OF A DNA DODECAMER CONTAINING THE ANTI-NEOPLASTIC AGENT ARABINOSYLCYTOSINE: COMBINED USE OF NMR, RESTRAINED MOLECULAR DYNAMICS AND FULL RELAXATION MATRIX REFINEMENT
CGCGAATTCGCG
>pdb|170D|B Chain B, SOLUTION STRUCTURE OF A DNA DODECAMER CONTAINING THE ANTI-NEOPLASTIC AGENT ARABINOSYLCYTOSINE: COMBINED USE OF NMR, RESTRAINED MOLECULAR DYNAMICS AND FULL RELAXATION MATRIX REFINEMENT
CGCGAATTNGCG
>pdb|170D|A Chain A, SOLUTION STRUCTURE OF A DNA DODECAMER CONTAINING THE ANTI-NEOPLASTIC AGENT ARABINOSYLCYTOSINE: COMBINED USE OF NMR, RESTRAINED MOLECULAR DYNAMICS AND FULL RELAXATION MATRIX REFINEMENT
CGCGAATTNGCG
>pdb|1AFX|A Chain A, UGAA EUKARYOTIC RIBOSOMAL RNA TETRALOOP, NMR, 13 STRUCTURES
GGTGTGAACACC
>pdb|1PGC|B Chain B, NMR Solution Structure of an Oxaliplatin 1,2-d(GG) Intrastrand Cross-Link in a DNA Dodecamer Duplex
GGAGGCCTGAGG
>pdb|1PGC|A Chain A, NMR Solution Structure of an Oxaliplatin 1,2-d(GG) Intrastrand Cross-Link in a DNA Dodecamer Duplex
CCTCAGGCCTCC
>pdb|1PG9|B Chain B, NMR Solution Structure of an Oxaliplatin 1,2-d(GG) Intrastrand Cross-Link in a DNA Dodecamer Duplex
GGAGGCCTGAGG
>pdb|1PG9|A Chain A, NMR Solution Structure of an Oxaliplatin 1,2-d(GG) Intrastrand Cross-Link in a DNA Dodecamer Duplex
CCTCAGGCCTCC
>pdb|1OQ2|B Chain B, NMR structure of hemimethylated GATC site
CGCAGNTCTCGC
>pdb|1OQ2|A Chain A, NMR structure of hemimethylated GATC site
GCGAGATCTGCG
>pdb|1OPQ|B Chain B, NMR structure of unmethylated GATC site
CGCAGATCTCGC
>pdb|1OPQ|A Chain A, NMR structure of unmethylated GATC site
GCGAGATCTGCG
>pdb|1P96|B Chain B, Solution Structure of a Wedge-Shaped Synthetic Molecule at a Two-Base Bulge Site in DNA
GTCCGATGCGTG
>pdb|1NAJ|B Chain B, High resolution NMR Structure Of DNA Dodecamer Determined In Aqueous Dilute Liquid Crystalline Phase
CGCGAATTCGCG
>pdb|1NAJ|A Chain A, High resolution NMR Structure Of DNA Dodecamer Determined In Aqueous Dilute Liquid Crystalline Phase
CGCGAATTCGCG
>pdb|1JS5|B Chain B, Solution Structure of dAAUAA DNA Bulge
CGTAGCCGATGC
>pdb|1JRW|B Chain B, Solution Structure of dAATAA DNA Bulge
CGTAGCCGATGC
>pdb|1JS7|B Chain B, Solution Structure of dAAUAA DNA Bulge
CGTAGCCGATGC
>pdb|1JRV|B Chain B, SOLUTION STRUCTURE OF DAATAA DNA BULGE
CGTAGCCGATGC
>pdb|1JUU|B Chain B, NMR Structure of a Parallel Stranded DNA Duplex at Atomic Resolution
NCTATTAAATCC
>pdb|1K8S|B Chain B, BULGED ADENOSINE IN AN RNA DUPLEX
GCGGCACCTGCC
>pdb|1GIP|B Chain B, THE NMR STRUCTURE OF DNA DODECAMER DETERMINED IN AQUEOUS DILUTE LIQUID CRYSTALLINE PHASE
CGCGAATTCGCG
>pdb|1GIP|A Chain A, THE NMR STRUCTURE OF DNA DODECAMER DETERMINED IN AQUEOUS DILUTE LIQUID CRYSTALLINE PHASE
CGCGAATTCGCG
>pdb|1IG4|C Chain C, Solution Structure of the Methyl-CpG-Binding Domain of Human MBD1 in Complex with Methylated DNA
GTATCNGGATAC
>pdb|1IG4|B Chain B, Solution Structure of the Methyl-CpG-Binding Domain of Human MBD1 in Complex with Methylated DNA
GTATCNGGATAC
>pdb|1G14|B Chain B, NMR SOLUTION STRUCTURE OF THE DNA DODECAMER GGCAAGAAACGG
CCGTTTCTTGCC
>pdb|1G14|A Chain A, NMR SOLUTION STRUCTURE OF THE DNA DODECAMER GGCAAGAAACGG
GGCAAGAAACGG
>pdb|1FZX|B Chain B, NMR SOLUTION STRUCTURE OF THE DNA DODECAMER GGCAAAAAACGG
CCGTTTTTTGCC
>pdb|1FZX|A Chain A, NMR SOLUTION STRUCTURE OF THE DNA DODECAMER GGCAAAAAACGG
GGCAAAAAACGG
>pdb|1CX5|B Chain B, ANTISENSE DNA/RNA HYBRID CONTAINING MODIFIED BACKBONE
GCGCAAAACGCG
>pdb|1CX5|A Chain A, ANTISENSE DNA/RNA HYBRID CONTAINING MODIFIED BACKBONE
CGCGTTNTGCGC
>pdb|1CS2|B Chain B, NMR STRUCTURES OF B-DNA D(CTACTGCTTTAG).D(CTAAAGCAGTAG)
CTAAAGCAGTAG
>pdb|1CS2|A Chain A, NMR STRUCTURES OF B-DNA D(CTACTGCTTTAG).D(CTAAAGCAGTAG)
CTACTGCTTTAG
>pdb|1K4X|B Chain B, POTASSIUM FORM OF OXY-1.5 QUADRUPLEX DNA
GGGGTTTTGGGG
>pdb|1K4X|A Chain A, POTASSIUM FORM OF OXY-1.5 QUADRUPLEX DNA
GGGGTTTTGGGG
>pdb|1BJD|B Chain B, SOLUTION STRUCTURE OF A DNA DODECAMER CONTAINING SINGLE G*T MISMATCHES USING RELAXATION MATRIX ANALYSIS AND RESTRAINED MOLECULAR DYNAMICS, NMR, 1 STRUCTURE
CGTGACGTTACG
>pdb|1BJD|A Chain A, SOLUTION STRUCTURE OF A DNA DODECAMER CONTAINING SINGLE G*T MISMATCHES USING RELAXATION MATRIX ANALYSIS AND RESTRAINED MOLECULAR DYNAMICS, NMR, 1 STRUCTURE
CGTGACGTTACG
>pdb|1BHR|B Chain B, 2'-DEOXY-ISOGUANOSINE BASE PAIRED TO THYMIDINE, NMR, MINIMIZED AVERAGE STRUCTURE
CGCNAATTTGCG
>pdb|1BHR|A Chain A, 2'-DEOXY-ISOGUANOSINE BASE PAIRED TO THYMIDINE, NMR, MINIMIZED AVERAGE STRUCTURE
CGCNAATTTGCG
>pdb|1A8W|B Chain B, A K+ CATION-INDUCED CONFORMATIONAL SWITCH WITHIN A LOOP SPANNING SEGMENT OF A DNA QUADRUPLEX CONTAINING G-G-G-C REPEATS, NMR, 8 STRUCTURES
GGGCTTTTGGGC
>pdb|1A8W|A Chain A, A K+ CATION-INDUCED CONFORMATIONAL SWITCH WITHIN A LOOP SPANNING SEGMENT OF A DNA QUADRUPLEX CONTAINING G-G-G-C REPEATS, NMR, 8 STRUCTURES
GGGCTTTTGGGC
>pdb|1A8N|B Chain B, SOLUTION STRUCTURE OF A NA+ CATION STABILIZED DNA QUADRUPLEX CONTAINING G.G.G.G AND G.C.G.C TETRADS FORMED BY G-G-G-C REPEATS OBSERVED IN AAV AND HUMAN CHROMOSOME 19, NMR, 8 STRUCTURES
GGGCTTTTGGGC
>pdb|1A8N|A Chain A, SOLUTION STRUCTURE OF A NA+ CATION STABILIZED DNA QUADRUPLEX CONTAINING G.G.G.G AND G.C.G.C TETRADS FORMED BY G-G-G-C REPEATS OBSERVED IN AAV AND HUMAN CHROMOSOME 19, NMR, 8 STRUCTURES
GGGCTTTTGGGC
>pdb|1BBX|B Chain B, NON-SPECIFIC PROTEIN-DNA INTERACTIONS IN THE SSO7D-DNA COMPLEX, NMR, 1 STRUCTURE
CTAGCGCGCTAG
>pdb|1BBX|A Chain A, NON-SPECIFIC PROTEIN-DNA INTERACTIONS IN THE SSO7D-DNA COMPLEX, NMR, 1 STRUCTURE
CTAGCGCGCTAG
>pdb|1AX6|A Chain A, SOLUTION STRUCTURE OF THE [AF]-C8-DG ADDUCT OPPOSITE A-2 DELETION SITE IN THE NARI HOT SPOT SEQUENCE CONTEXT; NMR, 6 STRUCTURES
CTCGGCGCCATC
>pdb|1DAU|B Chain B, Analog of dickerson-drew DNA dodecamer with 6'-alpha-methyl carbocyclic thymidines, NMR, minimized average structure
CGCGAANNCGCG
>pdb|1DAU|A Chain A, Analog of dickerson-drew DNA dodecamer with 6'-alpha-methyl carbocyclic thymidines, NMR, minimized average structure
CGCGAANNCGCG
>pdb|132D|B Chain B, SOLUTION STRUCTURE OF THE TN AN DNA DUPLEX GCCGTTAACGGC CONTAINING THE HPA I RESTRICTION SITE
NCCGTTAACGGC
>pdb|132D|A Chain A, SOLUTION STRUCTURE OF THE TN AN DNA DUPLEX GCCGTTAACGGC CONTAINING THE HPA I RESTRICTION SITE
NCCGTTAACGGC
>pdb|103D|B Chain B, THE UNUSUAL STRUCTURE OF THE HUMAN CENTROMERE (GGA)2 MOTIF: UNPAIRED GUANOSINE RESIDUES STACKED BETWEEN SHEARED G(DOT)A PAIRS
GTGGAATGGAAC
>pdb|103D|A Chain A, THE UNUSUAL STRUCTURE OF THE HUMAN CENTROMERE (GGA)2 MOTIF: UNPAIRED GUANOSINE RESIDUES STACKED BETWEEN SHEARED G(DOT)A PAIRS
GTGGAATGGAAC
>pdb|156D|B Chain B, REFINED SOLUTION STRUCTURE OF THE DIMERIC QUADRUPLEX FORMED FROM THE OXYTRICHA TELOMERIC OLIGONUCLEOTIDE D(GGGGTTTTGGGG)
GGGGTTTTGGGG
>pdb|156D|A Chain A, REFINED SOLUTION STRUCTURE OF THE DIMERIC QUADRUPLEX FORMED FROM THE OXYTRICHA TELOMERIC OLIGONUCLEOTIDE D(GGGGTTTTGGGG)
GGGGTTTTGGGG
>pdb|7LCD|T Chain T, Crystal structure of human polymerase eta complexed with syn N7-acetophenoneguanine
CATNCTCACACT
>pdb|7VCK|A Chain A, NMR solution structures of a hairpin formed by GGCCTG repeats
GGCCTGGGCCTG
>PA344180.1 JP 2021525509-A/90: DIVERSE ANTIGEN BINDING DOMAINS, NOVEL PLATFORMS AND OTHER ENHANCEMENTS FOR CELLULAR THERAPY
CGCGCCAAGAGA
>PA344179.1 JP 2021525509-A/89: DIVERSE ANTIGEN BINDING DOMAINS, NOVEL PLATFORMS AND OTHER ENHANCEMENTS FOR CELLULAR THERAPY
AGGGCCAAGCGA
>PA344178.1 JP 2021525509-A/88: DIVERSE ANTIGEN BINDING DOMAINS, NOVEL PLATFORMS AND OTHER ENHANCEMENTS FOR CELLULAR THERAPY
CGGGCCAAGAGA
>PA344177.1 JP 2021525509-A/87: DIVERSE ANTIGEN BINDING DOMAINS, NOVEL PLATFORMS AND OTHER ENHANCEMENTS FOR CELLULAR THERAPY
AGCGGATCTGGC
>PA344176.1 JP 2021525509-A/86: DIVERSE ANTIGEN BINDING DOMAINS, NOVEL PLATFORMS AND OTHER ENHANCEMENTS FOR CELLULAR THERAPY
TCTGGATCTGGA
>PA344084.1 JP 2021525076-A/45: SHARED ANTIGENS
GTGAGCTGGCGG
>PA343672.1 JP 2021523719-A/28: CCCTC-BINDING FACTOR VARIANTS
CAAGCGTGGTGC
>PA343671.1 JP 2021523719-A/27: CCCTC-BINDING FACTOR VARIANTS
CCAGCGTGGTGC
>PA343663.1 JP 2021523719-A/19: CCCTC-BINDING FACTOR VARIANTS
CCAGCGTGGTGC
>PA343661.1 JP 2021523719-A/17: CCCTC-BINDING FACTOR VARIANTS
CGAGGAGGGGAC
>PA343659.1 JP 2021523719-A/15: CCCTC-BINDING FACTOR VARIANTS
CAAGGAGGGGAC
>PA343657.1 JP 2021523719-A/13: CCCTC-BINDING FACTOR VARIANTS
CGAGCGTGGTGC
>PA343654.1 JP 2021523719-A/10: CCCTC-BINDING FACTOR VARIANTS
CAAGCGTGGTGC
>PA339992.1 JP 2021153405-A/5: A method for evaluating influenza virus infectivity by PCR
AGCAAAAGCAGG
>PA339991.1 JP 2021153405-A/4: A method for evaluating influenza virus infectivity by PCR
AGCGAAAGCAGG
>pdb|6X9K|D Chain D, Human DNMT1(729-1600) Bound to Zebularine-Containing 12mer dsDNA and Inhibitor GSK3685032A
GCAGGNGGCCTC
>pdb|6X9K|C Chain C, Human DNMT1(729-1600) Bound to Zebularine-Containing 12mer dsDNA and Inhibitor GSK3685032A
GAGGCNGCCTGC
>pdb|6X9J|D Chain D, Human DNMT1(729-1600) Bound to Zebularine-Containing 12mer dsDNA and Inhibitor GSK3830052
GCAGGNGGCCTC
>pdb|6X9J|C Chain C, Human DNMT1(729-1600) Bound to Zebularine-Containing 12mer dsDNA and Inhibitor GSK3830052
GAGGCNGCCTGC
>pdb|6X9I|D Chain D, Human DNMT1(729-1600) Bound to Zebularine-Containing 12mer dsDNA
GCAGGNGGCCTC
>pdb|6X9I|C Chain C, Human DNMT1(729-1600) Bound to Zebularine-Containing 12mer dsDNA
GAGGCNGCCTGC
>pdb|7BAI|V Chain V, Structure of RIG-I CTD (I875A) bound to p-RNA
NACGCTAGCGTC
>pdb|7BAI|D Chain D, Structure of RIG-I CTD (I875A) bound to p-RNA
NACGCTAGCGTC
>pdb|7BAI|C Chain C, Structure of RIG-I CTD (I875A) bound to p-RNA
NACGCTAGCGTC
>pdb|7BAH|D Chain D, Structure of RIG-I CTD bound to OH-RNA
GACGCTAGCGTC
>pdb|7BAH|C Chain C, Structure of RIG-I CTD bound to OH-RNA
GACGCTAGCGTC
>pdb|7L69|T Chain T, Crystal structure of human polymerase eta complexed with syn N7-benzylguanine
CATNCTCACACT
>pdb|7FHJ|D Chain D, Crystal structure of BAZ2A with DNA
GCCTANATTCCG
>pdb|7FHJ|C Chain C, Crystal structure of BAZ2A with DNA
CGGAATGTAGGC
>pdb|7OHE|B Chain B, A self-complementary DNA dodecamer duplex contaning 5-hydroxymethylcitosine
CGCGTCGACGCG
>pdb|7OHE|A Chain A, A self-complementary DNA dodecamer duplex contaning 5-hydroxymethylcitosine
CGCGTCGACGCG
>pdb|7OGV|B Chain B, A self-complementary DNA dodecamer duplex contaning 5-hydroxymethylcitosine
CGCGTNGACGCG
>pdb|7OGV|A Chain A, A self-complementary DNA dodecamer duplex contaning 5-hydroxymethylcitosine
CGCGTNGACGCG
>pdb|7OM3|P Chain P, Crystal structure of KOD DNA Polymerase in a binary complex with Hypoxanthine containing template
GACCACGGCCAN
>PA277268.1 WO 2021182587-A/10: Module for searching a new peptide aptamer using photo-cross linking nucleotide
GGGGGAGGCAGC
>PA276990.1 WO 2021177267-A/11: Treatment or prevention of aneurysm by using miR-33b inhibitor
AACAATACTACG
>PA276987.1 WO 2021177267-A/8: Treatment or prevention of aneurysm by using miR-33b inhibitor
AACAGCAATGCA
>PA276986.1 WO 2021177267-A/7: Treatment or prevention of aneurysm by using miR-33b inhibitor
AACTACAATGCA
>PA276984.1 WO 2021177267-A/5: Treatment or prevention of aneurysm by using miR-33b inhibitor
AACAGCAATGCA
>PA276593.1 WO 2021182474-A/19: Oligonucleotide and method for site-directed editing of target RNA
GGGTTTCGACCT
>PA276321.1 WO 2021172370-A/50: Method for detecting single-stranded RNA virus
GAATGTCTGTCC
>PA276311.1 WO 2021172370-A/40: Method for detecting single-stranded RNA virus
AGGGCTATTTCT
>PA276310.1 WO 2021172370-A/39: Method for detecting single-stranded RNA virus
GGCTATTTCTGA
>PA276309.1 WO 2021172370-A/38: Method for detecting single-stranded RNA virus
TTTCTGAGCCCA
>PA276307.1 WO 2021172370-A/36: Method for detecting single-stranded RNA virus
CGGGCAAAGTGG
>PA276306.1 WO 2021172370-A/35: Method for detecting single-stranded RNA virus
GGGCAAAGTGGA
>PA276305.1 WO 2021172370-A/34: Method for detecting single-stranded RNA virus
AAAGTGGAAGGA
>PA276297.1 WO 2021172370-A/26: Method for detecting single-stranded RNA virus
CTCGGAAGCTTG
>PA276296.1 WO 2021172370-A/25: Method for detecting single-stranded RNA virus
ACTCGGAAGCTT
>PA276295.1 WO 2021172370-A/24: Method for detecting single-stranded RNA virus
GACTCGGAAGCT
>pdb|7LO9|D Chain D, RNA dodecamer containing a GNA A residue
CGCGNANTAGCG
>pdb|7LO9|C Chain C, RNA dodecamer containing a GNA A residue
CGCGNANTAGCG
>pdb|7LO9|B Chain B, RNA dodecamer containing a GNA A residue
CGCGNANTAGCG
>pdb|7LO9|A Chain A, RNA dodecamer containing a GNA A residue
CGCGNANTAGCG
>pdb|7M50|WW Chain WW, Crystallographic structure of a cubic crystal form of STMV grown from ammonium sulfate
NTTTTTTTTTTT
>pdb|7M50|e Chain e, Crystallographic structure of a cubic crystal form of STMV grown from ammonium sulfate
NTTTTTTTTTTT
>pdb|7M3T|bb Chain bb, Crystallographic structure of a cubic crystal of STMV (80.7 degree rotation about 111) grown from chloride
NAAAAAAAAAAA
>pdb|7M3T|WW Chain WW, Crystallographic structure of a cubic crystal of STMV (80.7 degree rotation about 111) grown from chloride
NTTTTTTTTTTT
>pdb|7M3T|h Chain h, Crystallographic structure of a cubic crystal of STMV (80.7 degree rotation about 111) grown from chloride
TATTTTTTTTTT
>pdb|7M3T|e Chain e, Crystallographic structure of a cubic crystal of STMV (80.7 degree rotation about 111) grown from chloride
NTTTTTTTTTTT
>pdb|7M2V|zz Chain zz, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|yy Chain yy, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|xx Chain xx, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|ff Chain ff, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|n Chain n, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|Y Chain Y, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|e Chain e, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|P Chain P, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|i Chain i, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|TT Chain TT, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|m Chain m, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|X Chain X, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|U Chain U, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|T Chain T, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|k Chain k, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|ww Chain ww, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|V Chain V, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|h Chain h, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2V|S Chain S, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NAAAAAAAAAAA
>pdb|7M2V|QQ Chain QQ, Crystallographic Structure of the Rhombohedral Crystal Form of STMV Grown from Chloride
NTTTTTTTTTTT
>pdb|7M2T|gg Chain gg, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|ff Chain ff, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|ee Chain ee, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|dd Chain dd, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|cc Chain cc, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|bb Chain bb, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|ZZ Chain ZZ, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|YY Chain YY, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|WW Chain WW, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|VV Chain VV, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|UU Chain UU, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|TT Chain TT, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|SS Chain SS, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|RR Chain RR, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|QQ Chain QQ, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|d Chain d, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|c Chain c, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|b Chain b, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|a Chain a, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|Z Chain Z, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|Y Chain Y, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|X Chain X, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|W Chain W, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|V Chain V, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|U Chain U, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|T Chain T, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|S Chain S, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|R Chain R, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|Q Chain Q, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|7M2T|P Chain P, Crystallographic Structure of the Monoclinic Form of Satellite Tobacco Mosaic Virus
NAAAAAAAAAAA
>pdb|5BKN|qq Chain qq, Crystallographic structure of a cubic crystal form of STMV (84.5 degree rotation) grown from chloride
NTTTTTTTTTTT
>pdb|5BKN|bb Chain bb, Crystallographic structure of a cubic crystal form of STMV (84.5 degree rotation) grown from chloride
NAAAAAAAAAAA
>pdb|5BKN|e Chain e, Crystallographic structure of a cubic crystal form of STMV (84.5 degree rotation) grown from chloride
NTTTTTTTTTTT
>pdb|5BKL|bb Chain bb, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAAA
>pdb|5BKL|UU Chain UU, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAAA
>pdb|5BKL|X Chain X, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAAA
>pdb|5BKL|V Chain V, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAAA
>pdb|5BKL|T Chain T, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAAA
>pdb|5BKL|S Chain S, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAAA
>pdb|5BKL|P Chain P, Crystallographic structure of the cubic crystal form of STMV (77.9 degree rotation) grown from NaCl
NAAAAAAAAAAA
>pdb|7OJK|D Chain D, Lassa virus L protein bound to the distal promoter duplex [DISTAL-PROMOTER]
GGGATCCTAGGC
>OF274802.1 KR 1020210049859-A/1165: METHODS AND COMPOSITIONS FOR MODULATING A GENOME
AAAGCAGTAGAG
>OF232640.1 KR 1020210024010-A/9: CRISPR DOUBLE NICKASE BASED AMPLIFICATION COMPOSITIONS, SYSTEMS, AND METHODS
TCTCGTACGTTC
>OF232305.1 KR 1020210038539-A/63: ENZYMATIC HYDROLYSIS OF FUCANS
GAAATAGAATAA
>OF232263.1 KR 1020210038539-A/21: ENZYMATIC HYDROLYSIS OF FUCANS
GAAATAGAATAA
>OF190779.1 KR 1020210013571-A/25: VACCINE COMPOSITION
CCAGTTACTAAT
>OF148594.1 KR 1020210005057-A/3123: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
TCAAGGAAGATG
>OF147541.1 KR 1020210005057-A/2070: OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
GATGGCATTTCT
>OF268247.1 KR 1020210049119-A/90: IMMUNOTHERAPY TARGETING KRAS OR HER2 ANTIGENS
ATACGTGATGGC
>OF188101.1 KR 1020210005661-A/116: PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED AMINOPEPTIDASE N (ANPEP) GENES
TGTGGAGAATTC
>OF267312.1 KR 1020210045435-A/22: METHODS AND COMPOSITIONS FOR TREATING MITOCHONDRIAL DISEASE OR DISORDERS AND HETEROPLASMY
TACTTGACCACC
>OF267311.1 KR 1020210045435-A/21: METHODS AND COMPOSITIONS FOR TREATING MITOCHONDRIAL DISEASE OR DISORDERS AND HETEROPLASMY
TACTTAACCACC
>OF145170.1 KR 1020210049023-A/115: LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF
AATCCGACCCAT
>OF145169.1 KR 1020210049023-A/113: LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF
TTCATTCGTCTG
>OF145168.1 KR 1020210049023-A/111: LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF
ATGATCGACCGT
>OF144809.1 KR 1020210007959-A/141: KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF
GCTATGGACTAC
>OF266864.1 KR 1020210044253-A/14: METHOD AND KIT FOR DETECTING AND/OR QUANTIFYING A TARGET NUCLEOTIDE SEQUENCE
AACCCATGGAAT
>OF266862.1 KR 1020210044253-A/12: METHOD AND KIT FOR DETECTING AND/OR QUANTIFYING A TARGET NUCLEOTIDE SEQUENCE
AACCCATGGAAT
>OF266859.1 KR 1020210044253-A/9: METHOD AND KIT FOR DETECTING AND/OR QUANTIFYING A TARGET NUCLEOTIDE SEQUENCE
ACTCTTGACTTA
>OF266857.1 KR 1020210044253-A/7: METHOD AND KIT FOR DETECTING AND/OR QUANTIFYING A TARGET NUCLEOTIDE SEQUENCE
ATTCAGTTCTCA
>OF144773.1 KR 1020210007959-A/69: KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF
GCTATGGACTAC
>OF144755.1 KR 1020210007959-A/33: KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF
GCTATGGACTAC
>OF263727.1 KR 1020210039421-A/404: COMPOSITIONS AND METHODS BASED ON PMT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS
TCAACACACAGA
>OF263717.1 KR 1020210039421-A/394: COMPOSITIONS AND METHODS BASED ON PMT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS
CACAGAGAATGG
>OF263706.1 KR 1020210039421-A/383: COMPOSITIONS AND METHODS BASED ON PMT ENGINEERING FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS
ATTCAACATACA
>OF141275.1 KR 1020210053240-A/11: METHOD AND TEST KIT FOR DETECTING PATHOGENIC MICROORGANISM USING NANOPORES
CCTGCTTTTGCT
>OF141007.1 KR 1020210053228-A/53: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTCTTTTCTT
>OF141002.1 KR 1020210053228-A/48: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTCTTTCTTTT
>OF140996.1 KR 1020210053228-A/42: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTCTTTTTTT
>OF140989.1 KR 1020210053228-A/35: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTGTTTTGTT
>OF140984.1 KR 1020210053228-A/30: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTGTTTGTTTT
>OF140978.1 KR 1020210053228-A/24: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTGTTTTTTT
>OF140971.1 KR 1020210053228-A/17: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTATTTTATT
>OF140966.1 KR 1020210053228-A/12: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTATTTATTTT
>OF140960.1 KR 1020210053228-A/6: An engineered guide RNA for the optimized CRISPR/Cas12f1 system and use thereof
TTTTATTTTTTT
>OF140239.1 KR 1020210028134-A/100: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
GCCGCCGCCGCC
>OF140237.1 KR 1020210028134-A/98: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
GGCGGCGGCGGC
>OF138426.1 KR 1020210080071-A/18: Expression cassette for expressing target protein highly and method for using the same
GTTAACGCCACC
>OF260512.1 KR 1020210057019-A/18: CIRCULARIZED ENGINEERED RNA AND METHODS
GGGGAACCTGCA
>OF260510.1 KR 1020210057019-A/16: CIRCULARIZED ENGINEERED RNA AND METHODS
GGGGAACCTGCA
>OF260509.1 KR 1020210057019-A/15: CIRCULARIZED ENGINEERED RNA AND METHODS
GGAGAAGAAGGC
>OF260508.1 KR 1020210057019-A/14: CIRCULARIZED ENGINEERED RNA AND METHODS
CAGGAGTCTACA
>OF260506.1 KR 1020210057019-A/12: CIRCULARIZED ENGINEERED RNA AND METHODS
CTCACTTGGGAG
>OF260504.1 KR 1020210057019-A/10: CIRCULARIZED ENGINEERED RNA AND METHODS
ACCAGGCTTGGA
>OF260503.1 KR 1020210057019-A/9: CIRCULARIZED ENGINEERED RNA AND METHODS
TATGTGGCCATC
>OF260501.1 KR 1020210057019-A/7: CIRCULARIZED ENGINEERED RNA AND METHODS
GGCCAGGGGTTC
>OF260500.1 KR 1020210057019-A/6: CIRCULARIZED ENGINEERED RNA AND METHODS
TCTTCTCGGATT
>OF260499.1 KR 1020210057019-A/5: CIRCULARIZED ENGINEERED RNA AND METHODS
CTTGGAAGCAGA
>OF260497.1 KR 1020210057019-A/3: CIRCULARIZED ENGINEERED RNA AND METHODS
ACCAGGCTTGGA
>OF259563.1 KR 1020210039401-A/58: COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
TGTGTGTGTGTG
>OF135836.1 KR 1020210051313-A/1: SYSTEM FOR SYNTHESIS OF NUCLEIC ACID OR PEPTIDE
ACCCTAACCCTA
>OF135393.1 KR 1020210046277-A/3: On-site diagnostic device for mercury detection and Method for detecting mercury using the same
TTTTTTTTTTTT
>OF134482.1 KR 1020210032095-A/3: Composition for temperature sensors including graphene oxide, DNAzyme and PNA and temperature sensing method using the same
CAACCCGCCCTA
>OF255166.1 KR 1020210021123-A/42: PROTEINS SPECIFIC FOR BAFF AND B7RP1 AND USES THEREOF
GGTGGTGGTGGT
>OF255048.1 KR 1020210021111-A/99: TREATMENT OF AMD USING AAV SFLT-1
CCGGTCGCCACC
>OF291728.1 KR 1020210063450-A/64: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
ACACTGCTCAGC
>OF291727.1 KR 1020210063450-A/63: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
AGGAAGCTGCTG
>OF291657.1 KR 1020210063444-A/7: IMPROVED ASSAY METHODS
ACATCGGTAGTT
>OF288493.1 KR 1020210076952-A/5: PRODUCTS, USES & METHODS
AAAGAGGAGAAA
>OF288346.1 KR 1020210057223-A/9: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TCATAATGCTGG
>OF288350.1 KR 1020210057223-A/13: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTTCATAATGCT
>OF288354.1 KR 1020210057223-A/17: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
ACTTTCATAATG
>OF288358.1 KR 1020210057223-A/21: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TCACTTTCATAA
>OF288359.1 KR 1020210057223-A/22: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTCACTTTCATA
>OF288348.1 KR 1020210057223-A/11: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTCATAATGCTG
>OF288352.1 KR 1020210057223-A/15: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
CTTTCATAATGC
>OF288356.1 KR 1020210057223-A/19: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
CACTTTCATAAT
>OF288360.1 KR 1020210057223-A/23: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
ATTCACTTTCAT
>OF288171.1 KR 1020210061439-A/49: ENGINEERING T-CELL RECEPTORS
CTCGAGATCTGA
>OF209798.1 KR 1020210040911-A/100: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
GCCGCCGCCGCC
>OF209796.1 KR 1020210040911-A/98: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
GGCGGCGGCGGC
>OF209563.1 KR 1020210040910-A/100: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
GCCGCCGCCGCC
>OF209561.1 KR 1020210040910-A/98: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
GGCGGCGGCGGC
>OF287546.1 KR 1020210068487-A/165: NEW IMMUNOCYTOKINES FOR THE TREATMENT OF CANCER
TCAGGCAGATCT
>OF209328.1 KR 1020210040909-A/100: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
GCCGCCGCCGCC
>OF209326.1 KR 1020210040909-A/98: Composition for diagnosis or treatment of a condition associated with increased activity of eIF4E comprising an eIF4E inhibitor
GGCGGCGGCGGC
>OF167874.1 KR 1020210005074-A/116: METHODS FOR PROTECTING PORCINE FETUSES FROM INFECTION WITH VIRUS
TGTGGAGAATTC
>OF247442.1 KR 1020210016078-A/2300: CHIRAL CONTROL
CCAGGTAAGTAT
>OF208267.1 KR 1020210021493-A/177: MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
AGTGGCAGCGGC
>OF208262.1 KR 1020210021493-A/172: MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
CGTGCAAAGCGT
>OF245270.1 KR 1020210016078-A/125: CHIRAL CONTROL
CAGTCTGCTTCG
>OF245253.1 KR 1020210016078-A/108: CHIRAL CONTROL
CAGTCTGCTTCG
>OF245214.1 KR 1020210016078-A/69: CHIRAL CONTROL
TCAGCGTGCGCC
>OF283397.1 KR 1020210068478-A/211: COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
GGGGGGGGGGCG
>OF283396.1 KR 1020210068478-A/210: COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
GGGGGGGGTTCG
>OF283395.1 KR 1020210068478-A/209: COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
GGGGGGTTTTCG
>OF283394.1 KR 1020210068478-A/208: COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
GGGGTTTTTTCG
>OF283393.1 KR 1020210068478-A/207: COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
GGTTTTTTTTCG
>OF283392.1 KR 1020210068478-A/206: COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
TTTTTTTTTTCG
>OF282724.1 KR 1020210060561-A/47: INTRON-BASED UNIVERSAL CLONING METHODS AND COMPOSITIONS
GGTCTCTATAAT
>OF282723.1 KR 1020210060561-A/46: INTRON-BASED UNIVERSAL CLONING METHODS AND COMPOSITIONS
CGCCAGGAGACC
>OF282713.1 KR 1020210060561-A/36: INTRON-BASED UNIVERSAL CLONING METHODS AND COMPOSITIONS
CTTTCATTCCAG
>OF242289.1 KR 1020210043562-A/276: ROR-1 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
AGTGGCAGCGGC
>OF242284.1 KR 1020210043562-A/271: ROR-1 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
CGTGCAAAGCGT
>OF202506.1 KR 1020210018323-A/68: CIRCULAR RNA FOR TRANSLATION IN EUKARYOTIC CELLS
ATTTATCAGATT
>OF202505.1 KR 1020210018323-A/67: CIRCULAR RNA FOR TRANSLATION IN EUKARYOTIC CELLS
AATCTGATAAAT
>OF201756.1 KR 1020210015881-A/33: METHODS FOR THE PRODUCTION OF METHACRYLATES
CTGTCTCTTATA
>OF201291.1 KR 1020210013133-A/16: HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES
GTTGGTGTGTTG
>OF201290.1 KR 1020210013133-A/15: HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES
CAACACACCAAC
>OF201283.1 KR 1020210013133-A/8: HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES
CGTCAGGCAGTC
>OF201282.1 KR 1020210013133-A/7: HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES
GACTGCCTGACG
>OF199266.1 KR 1020210013105-A/29384: SHARED ANTIGENS
GTGAGCTGGCGG
>OF199215.1 KR 1020210013589-A/105: IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
GTGAGCTGGCGG
>OF199196.1 KR 1020210013589-A/64: IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
CGCAAACGGAGA
>OF277210.1 KR 1020210049898-A/6: PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES
CTTTCTCTCTGT
>OF277076.1 KR 1020210039495-A/100: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CAAATTGATTCA
>OF277053.1 KR 1020210039495-A/77: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTGTAAGCTGAT
>OF277047.1 KR 1020210039495-A/71: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AATAAGAAATGT
>OF277045.1 KR 1020210039495-A/69: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTGTAAGCTGAT
>OF277044.1 KR 1020210039495-A/68: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TCTCTTAACTGC
>OF276984.1 KR 1020210039495-A/8: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CTGTTTTTATAG
>OF276981.1 KR 1020210039495-A/5: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CTGTTCTAGCCC
>OF276980.1 KR 1020210039495-A/4: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GACACTTATCCA
>OF277039.1 KR 1020210039495-A/63: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
AACTTTAGTAAC
>OF277038.1 KR 1020210039495-A/62: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
GTCAGGTTGAAG
>OF277028.1 KR 1020210039495-A/52: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CTGAGTGTTCTC
>OF276993.1 KR 1020210039495-A/17: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CTGTTCTAGCCC
>OF276991.1 KR 1020210039495-A/15: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
TTTATGAAATTT
>OF276987.1 KR 1020210039495-A/11: FEEDBACK ENABLED SYNTHETIC GENES, TARGET SEED MATCH CASSETTES, AND THEIR USES
CATTTGCATTAG
>OF275220.1 KR 1020210046747-A/2: NUCLEIC ACID BASED DETECTION METHODS
GATCGAGCCTCA
>OF275046.1 KR 1020210049859-A/1533: METHODS AND COMPOSITIONS FOR MODULATING A GENOME
TGATGATGATGA
>OF275045.1 KR 1020210049859-A/1532: METHODS AND COMPOSITIONS FOR MODULATING A GENOME
TCATCATCATCA
>pdb|7KWR|B Chain B, 1,N6-ethenoadnine (E) in dsDNA sequence (5'-CGCGEATTCGCG-3')
NGCGNATTCGCG
>pdb|7KWR|A Chain A, 1,N6-ethenoadnine (E) in dsDNA sequence (5'-CGCGEATTCGCG-3')
NGCGNATTCGCG
>pdb|7KWL|B Chain B, Deoxyuridine in DNA Structure: Solution Structure of [d(CGUGAATTCGCG)]2
NGNGAATTCGCG
>pdb|7KWL|A Chain A, Deoxyuridine in DNA Structure: Solution Structure of [d(CGUGAATTCGCG)]2
NGNGAATTCGCG
>pdb|7DOI|P Chain P, Structure of COVID-19 RNA-dependent RNA polymerase bound to penciclovir.
NGATTAAGTTAT
>pdb|7B4N|B Chain B, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human wild-type p53DBD bound to DNA and MQ: wt-DNA-MQ (II)
CGGGCATGCCCG
>pdb|7B4H|B Chain B, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human wild-type p53DBD bound to DNA and MQ: wt-DNA-MQ (III)
CGGGCATGCCCG
>pdb|7B4G|B Chain B, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human p53DBD-R282W mutant bound to DNA: R282W-MQ (II)
CGGGCATGCCCG
>pdb|7B4F|B Chain B, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human p53DBD-R282W mutant bound to DNA: R282W-MQ (I)
CGGGCATGCCCG
>pdb|7B4D|C Chain C, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human p53DBD-R273C/S240R double mutant bound to DNA and MQ: R273C/S240R-DNA-MQ
CGGGCATGCCCG
>pdb|7B46|H Chain H, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human wild-type p53DBD bound to DNA and MQ: wt-DNA-MQ (P1)
CGGGCATGCCCG
>pdb|7B46|G Chain G, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human wild-type p53DBD bound to DNA and MQ: wt-DNA-MQ (P1)
CGGGCATGCCCG
>pdb|7B46|F Chain F, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human wild-type p53DBD bound to DNA and MQ: wt-DNA-MQ (P1)
CGGGCATGCCCG
>pdb|7B46|E Chain E, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human wild-type p53DBD bound to DNA and MQ: wt-DNA-MQ (P1)
CGGGCATGCCCG
>pdb|6ZNC|B Chain B, Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human wild-type p53DBD bound to DNA and MQ: wt-DNA-MQ (I)
CGGGCATGCCCG
>MY545203.1 Sequence 152 from patent US 11124842
AGTACTGATTGA
>MY545202.1 Sequence 151 from patent US 11124842
AGTACTCAGTGA
>MY545201.1 Sequence 150 from patent US 11124842
AGGACTGTGTGA
>MY545200.1 Sequence 149 from patent US 11124842
AGGACTGCGTGA
>MY545199.1 Sequence 148 from patent US 11124842
ACGACTGGGTGA
>MY545198.1 Sequence 147 from patent US 11124842
ACGACTGCATGA
>MY545197.1 Sequence 146 from patent US 11124842
ACCCACTGGGTG
>MY545196.1 Sequence 145 from patent US 11124842
ACACTCGGTGAT
>MY545195.1 Sequence 144 from patent US 11124842
AAGACTTCGTGA
>MY545194.1 Sequence 143 from patent US 11124842
TGTACTGCATGA
>MY545193.1 Sequence 142 from patent US 11124842
GTGACTGCGTGA
>MY545192.1 Sequence 141 from patent US 11124842
GGTACTGTGTGA
>MY545191.1 Sequence 140 from patent US 11124842
GGTACTGGTTGA
>MY545190.1 Sequence 139 from patent US 11124842
GGTACTCGGTGA
>MY545189.1 Sequence 138 from patent US 11124842
GGGACTGTGTGA
>MY545188.1 Sequence 137 from patent US 11124842
GGGACTGAGTGA
>MY545187.1 Sequence 136 from patent US 11124842
GGGACTCGTTGA
>MY545186.1 Sequence 135 from patent US 11124842
GCGACTGTGTGA
>MY545185.1 Sequence 134 from patent US 11124842
GAGACTGGGTGA
>MY545184.1 Sequence 133 from patent US 11124842
CGGACTCGGTGA
>MY545183.1 Sequence 132 from patent US 11124842
CCGACTGGCTGA
>MY545182.1 Sequence 131 from patent US 11124842
CAGACTGGGTGA
>MY545181.1 Sequence 130 from patent US 11124842
AGTACTTGCTGA
>MY545180.1 Sequence 129 from patent US 11124842
AGTACTAAGTGA
>MY545179.1 Sequence 128 from patent US 11124842
AGGACTGGGTGA
>MY545178.1 Sequence 127 from patent US 11124842
AGGACTGAGTGA
>MY545177.1 Sequence 126 from patent US 11124842
GTGACTGGGTGA
>MY545176.1 Sequence 125 from patent US 11124842
GGCACTGGGTGA
>MY545175.1 Sequence 124 from patent US 11124842
GGCACTGCGTGA
>MY545174.1 Sequence 123 from patent US 11124842
GGACTGGGTGAT
>MY545173.1 Sequence 122 from patent US 11124842
GCGACTGGGTGA
>MY545172.1 Sequence 121 from patent US 11124842
CGCACTGGGTGA
>MY545171.1 Sequence 120 from patent US 11124842
CCTACTGTCTGA
>MY545170.1 Sequence 119 from patent US 11124842
AGAACTTGGTGA
>MY545169.1 Sequence 118 from patent US 11124842
GGTACTGGGTGA
>MY545168.1 Sequence 117 from patent US 11124842
GGGACTCGGTGA
>MY545167.1 Sequence 116 from patent US 11124842
GGGACTGCGTGA
>MY545166.1 Sequence 115 from patent US 11124842
GACTGGGTGATG
>MY545165.1 Sequence 114 from patent US 11124842
CGGACTGGGTGA
>MY545164.1 Sequence 113 from patent US 11124842
GGGACTGGGTGA
>MY545163.1 Sequence 112 from patent US 11124842
TAAACTGGTTGA
>MY545162.1 Sequence 111 from patent US 11124842
GGTACTGTTTGA
>MY545161.1 Sequence 110 from patent US 11124842
GGTACTGAATGA
>MY545160.1 Sequence 109 from patent US 11124842
GGGGACTGGGGT
>MY545159.1 Sequence 108 from patent US 11124842
GGGACTTGGTGA
>MY545158.1 Sequence 107 from patent US 11124842
GGGACTGTGTGA
>MY545157.1 Sequence 106 from patent US 11124842
GGGACTGGTTGA
>MY545156.1 Sequence 105 from patent US 11124842
GGGACTGCGTGA
>MY545155.1 Sequence 104 from patent US 11124842
GGGACTCGTTGA
>MY545154.1 Sequence 103 from patent US 11124842
GGGACTCCGTGA
>MY545153.1 Sequence 102 from patent US 11124842
GGGACTATGTGA
>MY545152.1 Sequence 101 from patent US 11124842
GGAACTGGGTGA
>MY545151.1 Sequence 100 from patent US 11124842
GCTACTCGGTGA
>MY545150.1 Sequence 99 from patent US 11124842
GCGACTGGCTGA
>MY545149.1 Sequence 98 from patent US 11124842
GACACTACTTGA
>MY545148.1 Sequence 97 from patent US 11124842
CTTACTGTTTGA
>MY545147.1 Sequence 96 from patent US 11124842
CGGACTGGTTGA
>MY545146.1 Sequence 95 from patent US 11124842
CCTACTGTCTGA
>MY545145.1 Sequence 94 from patent US 11124842
CCGACTCGGTGA
>MY545144.1 Sequence 93 from patent US 11124842
AGTACTGATTGA
>MY545143.1 Sequence 92 from patent US 11124842
AGGACTGGTTGA
>MY545142.1 Sequence 91 from patent US 11124842
AGCACTTGTTGA
>MY545141.1 Sequence 90 from patent US 11124842
GGTACTCGGTGA
>MY545140.1 Sequence 89 from patent US 11124842
GCTACTGGGTGA
>MY545139.1 Sequence 88 from patent US 11124842
CGTACTGGCTGA
>MY545138.1 Sequence 87 from patent US 11124842
GTGACTGGGTGA
>MY545137.1 Sequence 86 from patent US 11124842
GGGACTGGCTGA
>MY545136.1 Sequence 85 from patent US 11124842
GGGACTCGGTGA
>MY545135.1 Sequence 84 from patent US 11124842
CGGACTCGGTGA
>MY545134.1 Sequence 83 from patent US 11124842
CCGACTGGGTGA
>MY545133.1 Sequence 82 from patent US 11124842
GGGACTGAGTGA
>MY545132.1 Sequence 81 from patent US 11124842
GACTGGGTGATG
>MY545131.1 Sequence 80 from patent US 11124842
CACTCGGTGATG
>MY545130.1 Sequence 79 from patent US 11124842
GGCACTGGGTGA
>MY545129.1 Sequence 78 from patent US 11124842
GCGACTGGGTGA
>MY545128.1 Sequence 77 from patent US 11124842
GGACTGGGTGAT
>MY545127.1 Sequence 76 from patent US 11124842
GCACTGGGTGAT
>MY545126.1 Sequence 75 from patent US 11124842
GAGACTGGGTGA
>MY545125.1 Sequence 74 from patent US 11124842
CGGACTGGGTGA
>MY545124.1 Sequence 73 from patent US 11124842
GGGACTGGGTGA
>MY545123.1 Sequence 72 from patent US 11124842
AAGACTGCTTGA
>MY545122.1 Sequence 71 from patent US 11124842
AAGACTGCGTGA
>MY545121.1 Sequence 70 from patent US 11124842
AAGACTCCGTGA
>MY545120.1 Sequence 69 from patent US 11124842
AAGACTAACTGA
>MY545119.1 Sequence 68 from patent US 11124842
AACTGAGTGATG
>MY545118.1 Sequence 67 from patent US 11124842
AACACTTGGTGA
>MY545117.1 Sequence 66 from patent US 11124842
AACACTTCGTGA
>MY545116.1 Sequence 65 from patent US 11124842
AACACTGTGATG
>MY545115.1 Sequence 64 from patent US 11124842
AACACTGAGTGA
>MY545114.1 Sequence 63 from patent US 11124842
AAAGACTGCGTG
>MY545113.1 Sequence 62 from patent US 11124842
GGCACCTGCGTG
>MY545112.1 Sequence 61 from patent US 11124842
ATCACTATGTGA
>MY545111.1 Sequence 60 from patent US 11124842
AGCACTATCGTG
>MY545110.1 Sequence 59 from patent US 11124842
AGCACTAGTGTA
>MY545109.1 Sequence 58 from patent US 11124842
GCCCCACTCGCT
>MY545108.1 Sequence 57 from patent US 11124842
GCCCACTCGCTG
>MY545107.1 Sequence 56 from patent US 11124842
GCCACTCGCTGA
>MY545106.1 Sequence 55 from patent US 11124842
AGCACTATGTGA
>MY545105.1 Sequence 54 from patent US 11124842
GGCACTGCGTGA
>MY545104.1 Sequence 53 from patent US 11124842
GGTACTCAGTGA
>MY545103.1 Sequence 52 from patent US 11124842
GCTACGTGAGTG
>MY545102.1 Sequence 51 from patent US 11124842
GCGACTGTGCTG
>MY545101.1 Sequence 50 from patent US 11124842
GCGACTCACTGC
>MY545100.1 Sequence 49 from patent US 11124842
CTGACTGAATGC
>MY545099.1 Sequence 48 from patent US 11124842
CTGACTGAATGC
>MY545098.1 Sequence 47 from patent US 11124842
CTCACTGTGTGA
>MY545097.1 Sequence 46 from patent US 11124842
CTCACTGGCTGC
>MY545096.1 Sequence 45 from patent US 11124842
CTCACTGAATGC
>MY545095.1 Sequence 44 from patent US 11124842
CTCACTCGTTGC
>MY545094.1 Sequence 43 from patent US 11124842
CTCACTCGGTGC
>MY545093.1 Sequence 42 from patent US 11124842
CTAACTGGATGC
>MY545092.1 Sequence 41 from patent US 11124842
CGTACTATGTGC
>MY545091.1 Sequence 40 from patent US 11124842
CGGACTGAATGC
>MY545090.1 Sequence 39 from patent US 11124842
CGGACTACATGC
>MY545089.1 Sequence 38 from patent US 11124842
CGACGTCAGCTG
>MY545088.1 Sequence 37 from patent US 11124842
CGAATGTGTGCA
>MY545087.1 Sequence 36 from patent US 11124842
CGAACTGTGTGC
>MY545086.1 Sequence 35 from patent US 11124842
CGAACTGCATGC
>MY545085.1 Sequence 34 from patent US 11124842
CGAACTATGTGC
>MY545084.1 Sequence 33 from patent US 11124842
CCTGACTGGATG
>MY545083.1 Sequence 32 from patent US 11124842
CCTACTGACTGC
>MY545082.1 Sequence 31 from patent US 11124842
CCGACTGTGTGC
>MY545081.1 Sequence 30 from patent US 11124842
CCGACTACATGC
>MY545080.1 Sequence 29 from patent US 11124842
CATCTGAGTGCA
>MY545079.1 Sequence 28 from patent US 11124842
CATACTGAGTGC
>MY545078.1 Sequence 27 from patent US 11124842
CATACGTGTATG
>MY545077.1 Sequence 26 from patent US 11124842
CAAACTGCATGC
>MY545076.1 Sequence 25 from patent US 11124842
ACTGCCTAACAA
>MY545075.1 Sequence 24 from patent US 11124842
ACTGCCCTAACA
>MY545074.1 Sequence 23 from patent US 11124842
ACTACTGTGTGC
>MY545073.1 Sequence 22 from patent US 11124842
ACGACTGTATGC
>MY545072.1 Sequence 21 from patent US 11124842
ACGACTAGATGC
>MY545071.1 Sequence 20 from patent US 11124842
AAGACTGGGTGC
>MY545070.1 Sequence 19 from patent US 11124842
TTACTGCATGCA
>MY545069.1 Sequence 18 from patent US 11124842
TCGACTGTGTGC
>MY545068.1 Sequence 17 from patent US 11124842
CTTACTGCGTGC
>MY545067.1 Sequence 16 from patent US 11124842
CTGACTGGATGC
>MY545066.1 Sequence 15 from patent US 11124842
CTAACTGAGTGC
>MY545065.1 Sequence 14 from patent US 11124842
CGGACTTGATGC
>MY545064.1 Sequence 13 from patent US 11124842
CGGACTCTGTGC
>MY545063.1 Sequence 12 from patent US 11124842
ACTACTGGATGC
>MY545062.1 Sequence 11 from patent US 11124842
GGGACTGCATGC
>MY545061.1 Sequence 10 from patent US 11124842
GCGACTGTGTGC
>MY545060.1 Sequence 9 from patent US 11124842
GCGACTGGATGC
>MY545059.1 Sequence 8 from patent US 11124842
CTGACTGGCTGC
>MY545058.1 Sequence 7 from patent US 11124842
CTGACTCGATGC
>MY545057.1 Sequence 6 from patent US 11124842
AGGACTGCATGC
>MY545056.1 Sequence 5 from patent US 11124842
CGTACTCGATGC
>MY545055.1 Sequence 4 from patent US 11124842
CGGACTCAGTGC
>MY545054.1 Sequence 3 from patent US 11124842
CGGACTGGATGC
>MY545053.1 Sequence 2 from patent US 11124842
NNNACTNNNTGC
>MY545052.1 Sequence 1 from patent US 11124842
NNNACTNNNTGA
>MY542143.1 Sequence 22 from patent US 11124825
TTGTCGGATTGT
>MY542142.1 Sequence 21 from patent US 11124825
TTGTCGGATTGC
>MY542141.1 Sequence 20 from patent US 11124825
CCGTCGGACCGC
>MY541779.1 Sequence 17 from patent US 11124799
AAGGACGAGCTC
>MY541587.1 Sequence 26 from patent US 11124796
GTTTTAGAGCTA
>MY538642.1 Sequence 1173 from patent US 11123418
TTGAGTGCTTGT
>MY538000.1 Sequence 359 from patent US 11123409
GTTTTAGAGCTA
>MY533774.1 Sequence 40 from patent US 11122017
ATAAGAGACAGG
>MY533773.1 Sequence 39 from patent US 11122017
TATAAGAGACAG
>MY533772.1 Sequence 38 from patent US 11122017
GAATAAGAGACA
>MY533771.1 Sequence 37 from patent US 11122017
TGTATAAGAGAC
>MY533770.1 Sequence 36 from patent US 11122017
GTGTATAAGAGA
>MY533769.1 Sequence 35 from patent US 11122017
TGTGTATAAGAG
>MY533768.1 Sequence 34 from patent US 11122017
ATGTGTATAAGA
>MY533767.1 Sequence 33 from patent US 11122017
GATGTGTATAAG
>MY533766.1 Sequence 32 from patent US 11122017
AGATGTGTATAA
>MY533765.1 Sequence 31 from patent US 11122017
TAGATGTGTATA
>MY533764.1 Sequence 30 from patent US 11122017
CTAGATGTGTAT
>MY533763.1 Sequence 29 from patent US 11122017
TCTAGATGTGTA
>MY533762.1 Sequence 28 from patent US 11122017
ATCTAGATGTGT
>MY533761.1 Sequence 27 from patent US 11122017
CATCTAGATGTG
>MY533760.1 Sequence 26 from patent US 11122017
ACATCTAGATGT
>MY533759.1 Sequence 25 from patent US 11122017
CACATCTAGATG
>MY533758.1 Sequence 24 from patent US 11122017
ACACATCTAGAT
>MY533757.1 Sequence 23 from patent US 11122017
TACACATCTAGA
>MY533756.1 Sequence 22 from patent US 11122017
ATACACATCTAG
>MY533755.1 Sequence 21 from patent US 11122017
TATACACATCTA
>MY533754.1 Sequence 20 from patent US 11122017
TTATACACATCT
>MY533753.1 Sequence 19 from patent US 11122017
CTTATACACATC
>MY533752.1 Sequence 18 from patent US 11122017
TCTTATACACAT
>MY533751.1 Sequence 17 from patent US 11122017
CTCTTATACACA
>MY533750.1 Sequence 16 from patent US 11122017
TCTCTTATACAC
>MY533749.1 Sequence 15 from patent US 11122017
GTCTCTTATACA
>MY533748.1 Sequence 14 from patent US 11122017
TGTCTCTTATAC
>MY533747.1 Sequence 13 from patent US 11122017
CTGTCTCTTATA
>MY533746.1 Sequence 12 from patent US 11122017
AATAAGAGACAG
>MY533745.1 Sequence 11 from patent US 11122017
TAGAATAGACAG
>MY533744.1 Sequence 10 from patent US 11122017
CTTATACACATC
>MY533743.1 Sequence 9 from patent US 11122017
TTATACACATCT
>MY533742.1 Sequence 8 from patent US 11122017
AGATGTGTATAA
>MY533741.1 Sequence 7 from patent US 11122017
GATGTGTATAAG
>MY533740.1 Sequence 6 from patent US 11122017
ATGTGTATAAGA
>MY533739.1 Sequence 5 from patent US 11122017
TGTGTATAAGAG
>MY533738.1 Sequence 4 from patent US 11122017
GTGTATAAGAGA
>MY533737.1 Sequence 3 from patent US 11122017
TGTATAAGAGAC
>MY533736.1 Sequence 2 from patent US 11122017
GTATAAGAGACA
>MY533735.1 Sequence 1 from patent US 11122017
TATAAGAGACAG
>MY533546.1 Sequence 182 from patent US 11120889
GCAGTAACGGCA
>MY533537.1 Sequence 173 from patent US 11120889
TCACCTTGCCCC
>MY533028.1 Sequence 62 from patent US 11118230
ATCGGTTTCGTT
>MY533021.1 Sequence 55 from patent US 11118230
CGGCGTTCGCGA
>MY533012.1 Sequence 46 from patent US 11118230
AACGTAAACCAC
>MY533005.1 Sequence 39 from patent US 11118230
ACGTGGTGGTTT
>MY532997.1 Sequence 31 from patent US 11118230
GACGAACGCACG
>MY532994.1 Sequence 28 from patent US 11118230
GTTGGCGCGGTA
>MY532610.1 Sequence 11 from patent US 11118219
GCATGCATGCAT
>MY532609.1 Sequence 10 from patent US 11118219
ATGCATGCATGC
>MY532429.1 Sequence 91 from patent US 11118207
TTTTTTTTTTTT
>MY532419.1 Sequence 81 from patent US 11118207
AAAAAAAAAAAA
>MY531839.1 Sequence 1075 from patent US 11118194
GTTTTAGAGCTA
>MY524689.1 Sequence 489 from patent US 11118178
GGAGTATCGGAA
>MY524511.1 Sequence 311 from patent US 11118178
AGATAAACTTCA
>MY519616.1 Sequence 232 from patent US 11118168
CGTGCAAAGCGT
>MY519615.1 Sequence 231 from patent US 11118168
AGAGCTAAGAGG
>MY519537.1 Sequence 17 from patent US 11118168
AGTGGCAGCGGC
>MY519483.1 Sequence 15 from patent US 11117977
TGGGTTGACTAC
>MY516670.1 Sequence 72 from patent US 11116851
CAGTTGTAACTG
>MY477501.1 Sequence 9 from patent US 11111535
CAAGGAAAGTTG
>PA274669.1 WO 2021167029-A/7: Bridged nucleoside and nucleotide using the same
AGCAAAAAACGC
>PA274668.1 WO 2021167029-A/6: Bridged nucleoside and nucleotide using the same
AGCAAAAAACGC
>PA274667.1 WO 2021167029-A/5: Bridged nucleoside and nucleotide using the same
GCGTTTTTTGCT
>PA274666.1 WO 2021167029-A/4: Bridged nucleoside and nucleotide using the same
GCGTTTTTTGCT
>PA274665.1 WO 2021167029-A/3: Bridged nucleoside and nucleotide using the same
GCGTTTTTTGCT
>PA274664.1 WO 2021167029-A/2: Bridged nucleoside and nucleotide using the same
GCGTTTTTTGCT
>PA274663.1 WO 2021167029-A/1: Bridged nucleoside and nucleotide using the same
GCGTTTTTTGCT
>PA274214.1 WO 2021157730-A/34: Nucleic acid medicine and use thereof
TTTTATGGCGGG
>PA274213.1 WO 2021157730-A/33: Nucleic acid medicine and use thereof
TTTTTATGGCGG
>PA274212.1 WO 2021157730-A/32: Nucleic acid medicine and use thereof
TTTATGGCGGGA
>PA272980.1 WO 2021153717-A/4: Artificial nucleic acid-based affinity chromatography
NACNATNTANCT
>PA272979.1 WO 2021153717-A/3: Artificial nucleic acid-based affinity chromatography
NACNATNTANCT
>PA272973.1 WO 2021157421-A/16: METHOD FOR PRODUCING PROTEIN
TATCCATACGAT
>PA272274.1 JP 2021119751-A/4: Identification of microorganisms
CCGACGTTGAAG
>PA272272.1 JP 2021119751-A/2: Identification of microorganisms
GACACCGGTGGG
>MQ313522.1 Sequence 4 from Patent WO2021224506
GGSGGSGGSGGS
>MQ311404.1 Sequence 42 from Patent WO2021224809
TTGGGCTGTCTC
>MQ308704.1 Sequence 29 from Patent WO2021224639
CTTCTCGTGTGC
>MQ308685.1 Sequence 10 from Patent WO2021224639
CGTGTGCTCTTC
>MQ301520.1 Sequence 11 from Patent WO2021229473
CTAGGCGGGGGA
>MQ290689.1 Sequence 51 from Patent WO2021213903
CAGTTAAAAACT
>MQ290616.1 Sequence 10 from Patent WO2021220170
CAGATCGAAGCC
>MQ290608.1 Sequence 2 from Patent WO2021220170
GTGAGCTGGCGG
>MQ281621.1 Sequence 30 from Patent WO2021215932
GCCGGCAATTAA
>MQ281620.1 Sequence 29 from Patent WO2021215932
TTAATTGCCGGC
>MQ281619.1 Sequence 28 from Patent WO2021215932
GCCGGCTATCAG
>MQ281618.1 Sequence 27 from Patent WO2021215932
CTGATAGCCGGC
>MQ281617.1 Sequence 26 from Patent WO2021215932
GCCGGGTATCAG
>MQ281616.1 Sequence 25 from Patent WO2021215932
CTGATACCCGGC
>MQ281602.1 Sequence 11 from Patent WO2021215932
GTGCATAGGCCA
>MQ281598.1 Sequence 7 from Patent WO2021215932
CCATGGCCTATG
>MQ281597.1 Sequence 6 from Patent WO2021215932
CCATGGCCTATG
>MQ281537.1 Sequence 56 from Patent WO2021216853
AGAAAAAAAATA
>pdb|7MIB|I Chain I, Half integration complex of Cas4/Cas1/Cas2 with Cas4 still on the Non-PAM side
NGGAAAAGAGCC
>pdb|7MI9|I Chain I, Full integration complex of Cas1/Cas2 from Cas4-containing system
NGGAAAAGAGCC
>pdb|7DFH|T Chain T, Structure of COVID-19 RNA-dependent RNA polymerase bound to ribavirin
NCCCCACATAGC
>pdb|7DFG|P Chain P, Structure of COVID-19 RNA-dependent RNA polymerase bound to favipiravir
NGATTAAGTTAT
>pdb|2Z6A|C Chain C, S-Adenosyl-L-methionine-Dependent Methyl Transfer: Observable Precatalytic Intermediates during DNA Cytosine Methylation
GATAGCGCTATC
>pdb|3D0A|H Chain H, Human p53 core domain with hot spot mutation R249S and second site suppressor mutation H168R in sequence-specific complex with DNA
CGGGCATGCCCG
>pdb|3D0A|G Chain G, Human p53 core domain with hot spot mutation R249S and second site suppressor mutation H168R in sequence-specific complex with DNA
CGGGCATGCCCG
>pdb|3D0A|F Chain F, Human p53 core domain with hot spot mutation R249S and second site suppressor mutation H168R in sequence-specific complex with DNA
CGGGCATGCCCG
>pdb|3D0A|E Chain E, Human p53 core domain with hot spot mutation R249S and second site suppressor mutation H168R in sequence-specific complex with DNA
CGGGCATGCCCG
>pdb|2ZKE|D Chain D, Crystal structure of the SRA domain of mouse Np95 in complex with hemi-methylated CpG DNA
GCAATCNGGTAG
>pdb|2ZKE|C Chain C, Crystal structure of the SRA domain of mouse Np95 in complex with hemi-methylated CpG DNA
CTACCGGATTGC
>pdb|2ZKD|F Chain F, Crystal structure of the SRA domain of mouse Np95 in complex with hemi-methylated CpG DNA
GCAATCNGGTAG
>pdb|2ZKD|E Chain E, Crystal structure of the SRA domain of mouse Np95 in complex with hemi-methylated CpG DNA
CTACCGGATTGC
>pdb|2ZKD|D Chain D, Crystal structure of the SRA domain of mouse Np95 in complex with hemi-methylated CpG DNA
GCAATCNGGTAG
>pdb|2ZKD|C Chain C, Crystal structure of the SRA domain of mouse Np95 in complex with hemi-methylated CpG DNA
CTACCGGATTGC
>pdb|2OPF|C Chain C, Crystal structure of the DNA repair enzyme endonuclease-VIII (Nei) from E. coli (R252A) in complex with AP-site containing DNA substrate
NAGGANGAAGCC
>pdb|2OPF|B Chain B, Crystal structure of the DNA repair enzyme endonuclease-VIII (Nei) from E. coli (R252A) in complex with AP-site containing DNA substrate
GGCTTCATCCTG
>pdb|2ZCJ|C Chain C, Ternary structure of the Glu119Gln M.HhaI, C5-Cytosine DNA methyltransferase, with unmodified DNA and AdoHcy
GATAGCGCTATC
>pdb|2Z6U|C Chain C, Ternary structure of the Glu119Ala M.HhaI, C5-Cytosine DNA methyltransferase, with unmodified DNA and AdoHcy
GATAGCGCTATC
>pdb|2Z6Q|C Chain C, Ternary structure of Arg165Ala M.HhaI C5-Cytosine DNA methyltransferase with unmodified DNA and AdoHcy
GATAGCGCTATC
>pdb|1ZNS|C Chain C, Crystal structure of N-ColE7/12-bp DNA/Zn complex
CGGGATATCCCG
>pdb|1ZNS|B Chain B, Crystal structure of N-ColE7/12-bp DNA/Zn complex
CGGGATATCCCG
>pdb|1YYO|F Chain F, Crystal structure of RNase III mutant E110K from Aquifex aeolicus complexed with double-stranded RNA at 2.9-Angstrom Resolution
CGCGAATTCGCG
>pdb|1YYO|E Chain E, Crystal structure of RNase III mutant E110K from Aquifex aeolicus complexed with double-stranded RNA at 2.9-Angstrom Resolution
CGCGAATTCGCG
>pdb|1YYO|D Chain D, Crystal structure of RNase III mutant E110K from Aquifex aeolicus complexed with double-stranded RNA at 2.9-Angstrom Resolution
CGCGAATTCGCG
>pdb|1YYO|C Chain C, Crystal structure of RNase III mutant E110K from Aquifex aeolicus complexed with double-stranded RNA at 2.9-Angstrom Resolution
CGCGAATTCGCG
>pdb|7KZG|D Chain D, Human MBD4 glycosylase domain bound to DNA containing oxacarbenium-ion analog 1-aza-2'-deoxyribose
GCTGCGCGCTGG
>pdb|7KZG|C Chain C, Human MBD4 glycosylase domain bound to DNA containing oxacarbenium-ion analog 1-aza-2'-deoxyribose
CCAGCGNGCAGC
>pdb|7KZ1|D Chain D, Human MBD4 glycosylase domain bound to DNA containing an abasic site
GCTGCGCGCTGG
>pdb|7KZ1|C Chain C, Human MBD4 glycosylase domain bound to DNA containing an abasic site
CCAGCGNGCAGC
>pdb|7KZ0|D Chain D, Human MBD4 glycosylase domain bound to DNA containing substrate analog 2'-deoxy-pseudouridine
GCTGCGCGCTGG
>pdb|7KZ0|C Chain C, Human MBD4 glycosylase domain bound to DNA containing substrate analog 2'-deoxy-pseudouridine
CCAGCGNGCAGC
>pdb|1B7F|Q Chain Q, SXL-LETHAL PROTEIN/RNA COMPLEX
NTTGTTTTTTTT
>pdb|1AL5|B Chain B, A-TRACT RNA DODECAMER, NMR, 12 STRUCTURES
CGCAAATTTGCG
>pdb|1AL5|A Chain A, A-TRACT RNA DODECAMER, NMR, 12 STRUCTURES
CGCAAATTTGCG
>pdb|2HKC|B Chain B, NMR Structure of the IQ-modified Dodecamer CTCGGC[IQ]GCCATC
GATGGCGCCGAG
>pdb|2HKC|A Chain A, NMR Structure of the IQ-modified Dodecamer CTCGGC[IQ]GCCATC
CTCGGCGCCATC
>pdb|2HKB|B Chain B, NMR Structure of the B-DNA Dodecamer CTCGGCGCCATC
GATGGCGCCGAG
>pdb|2HKB|A Chain A, NMR Structure of the B-DNA Dodecamer CTCGGCGCCATC
CTCGGCGCCATC
>pdb|1FYM|D Chain D, SERENDIPITOUS CRYSTAL STRUCTURE CONTAINING THE HEAT SHOCK TRANSCRIPTION FACTOR'S DNA BINDING DOMAIN AND COGNATE DNA IN A TAIL-TO-TAIL ORIENTATION
GGTTCTAGAACC
>pdb|1FYM|C Chain C, SERENDIPITOUS CRYSTAL STRUCTURE CONTAINING THE HEAT SHOCK TRANSCRIPTION FACTOR'S DNA BINDING DOMAIN AND COGNATE DNA IN A TAIL-TO-TAIL ORIENTATION
GGTTCTAGAACC
>pdb|1FYL|D Chain D, SERENDIPITOUS CRYSTAL STRUCTURE CONTAINING THE HEAT SHOCK TRANSCRIPTION FACTOR'S DNA BINDING DOMAIN AND COGNATE DNA IN A HEAD-TO-HEAD ORIENTATION
AGGAACGTTCCN
>pdb|1FYL|C Chain C, SERENDIPITOUS CRYSTAL STRUCTURE CONTAINING THE HEAT SHOCK TRANSCRIPTION FACTOR'S DNA BINDING DOMAIN AND COGNATE DNA IN A HEAD-TO-HEAD ORIENTATION
AGGAACGTTCCN
>pdb|1EWN|E Chain E, CRYSTAL STRUCTURE OF THE HUMAN AAG DNA REPAIR GLYCOSYLASE COMPLEXED WITH 1,N6-ETHENOADENINE-DNA
NCAATCATGTCA
>pdb|1EWN|D Chain D, CRYSTAL STRUCTURE OF THE HUMAN AAG DNA REPAIR GLYCOSYLASE COMPLEXED WITH 1,N6-ETHENOADENINE-DNA
GACATGNTTGCC
>pdb|1EVW|H Chain H, L116A MUTANT OF THE HOMING ENDONUCLEASE I-PPOI COMPLEXED TO HOMING SITE DNA.
TGACTCTCTTAA
>pdb|1EVW|G Chain G, L116A MUTANT OF THE HOMING ENDONUCLEASE I-PPOI COMPLEXED TO HOMING SITE DNA.
TGGCTACCTTAA
>pdb|1EVW|F Chain F, L116A MUTANT OF THE HOMING ENDONUCLEASE I-PPOI COMPLEXED TO HOMING SITE DNA.
TGACTCTCTTAA
>pdb|1EVW|E Chain E, L116A MUTANT OF THE HOMING ENDONUCLEASE I-PPOI COMPLEXED TO HOMING SITE DNA.
TGGCTACCTTAA
>pdb|1QSY|B Chain B, DDATP-Trapped closed ternary complex of the large fragment of DNA Polymerase I from thermus aquaticus
GACCACGGCGCN
>pdb|1QSS|B Chain B, DDGTP-TRAPPED CLOSED TERNARY COMPLEX OF THE LARGE FRAGMENT OF DNA POLYMERASE I FROM THERMUS AQUATICUS
GACCACGGCGCN
>pdb|1B7F|P Chain P, SXL-LETHAL PROTEIN/RNA COMPLEX
NTTGTTTTTTTT
>pdb|1A66|C Chain C, SOLUTION NMR STRUCTURE OF THE CORE NFATC1/DNA COMPLEX, 18 STRUCTURES
CAATTTTCCTCG
>pdb|1A66|B Chain B, SOLUTION NMR STRUCTURE OF THE CORE NFATC1/DNA COMPLEX, 18 STRUCTURES
CGAGGAAAATTG
>MQ265154.1 Sequence 64 from Patent WO2021209743
ACGTGCACGTGC
>MQ262338.1 Sequence 198 from Patent WO2021209813
BRCCAWWTGKYV
>MQ262337.1 Sequence 197 from Patent WO2021209813
SRCCAWWTGKYS
>pdb|1SEU|C Chain C, Human DNA Topoisomerase I (70 Kda) In Complex With The Indolocarbazole SA315F and Covalent Complex With A 22 Base Pair DNA Duplex
NGAAAAATTTTT
>pdb|1M5V|D Chain D, Transition State Stabilization by a Catalytic RNA
GGCCACCTGACN
>pdb|1M5V|A Chain A, Transition State Stabilization by a Catalytic RNA
GGCCACCTGACN
>pdb|1M5P|D Chain D, Transition State Stabilization by a Catalytic RNA
GGCCACCTGACA
>pdb|1M5P|A Chain A, Transition State Stabilization by a Catalytic RNA
GGCCACCTGACA
>PA268629.1 WO 2021132528-A/7: OLIGODEOXYNUCLEOTIDE CONTAINING SHORT CPG ODN LINKED WITH POLYDEOXYADENYLIC ACID, COMPLEX CONTAINING SAID OLIGODEOXYNUCLEOTIDE, AND USE THEREOF
TCGTTCGTTCTC
>PA268628.1 WO 2021132528-A/6: OLIGODEOXYNUCLEOTIDE CONTAINING SHORT CPG ODN LINKED WITH POLYDEOXYADENYLIC ACID, COMPLEX CONTAINING SAID OLIGODEOXYNUCLEOTIDE, AND USE THEREOF
TCGAGCGTTCTC
>PA268197.1 JP 2021100390-A/6: Method of obtaining the digestion efficiency of nucleases
CCANNNNNNTGG
>MQ255036.1 Sequence 341 from Patent WO2021205453
GTGTTACCGGTT
>MQ255035.1 Sequence 340 from Patent WO2021205453
TGTTAGAAGGTT
>MQ255034.1 Sequence 339 from Patent WO2021205453
ATACCTGGATCT
>MQ255033.1 Sequence 338 from Patent WO2021205453
GATTGTCATACT
>MQ255032.1 Sequence 337 from Patent WO2021205453
CAACATTCAATG
>MQ255031.1 Sequence 336 from Patent WO2021205453
CCACTGGTCCTG
>MQ255030.1 Sequence 335 from Patent WO2021205453
GCTGTAGGAACG
>MQ255029.1 Sequence 334 from Patent WO2021205453
ATCATAGGCTCG
>MQ255028.1 Sequence 333 from Patent WO2021205453
GATTAAGGTGTC
>MQ255027.1 Sequence 332 from Patent WO2021205453
GACGAACAATTC
>MQ255026.1 Sequence 331 from Patent WO2021205453
TCCAAGAATTCC
>MQ255025.1 Sequence 330 from Patent WO2021205453
ATCGCATATGCC
>MQ255024.1 Sequence 329 from Patent WO2021205453
TGCGGTGTTGTA
>MQ255023.1 Sequence 328 from Patent WO2021205453
AGCGGTGGACTA
>MQ255022.1 Sequence 327 from Patent WO2021205453
TGTTCGCATTCA
>MQ255021.1 Sequence 326 from Patent WO2021205453
CGAAGGTTAACA
>MQ255020.1 Sequence 325 from Patent WO2021205453
GGCAGTAGCAGT
>MQ255019.1 Sequence 324 from Patent WO2021205453
CAACCGGAGGGT
>MQ255018.1 Sequence 323 from Patent WO2021205453
TGAGACAGCGAT
>MQ255017.1 Sequence 322 from Patent WO2021205453
CTGGTACACGAT
>MQ255016.1 Sequence 321 from Patent WO2021205453
GTGTGGCGCTGG
>MQ255015.1 Sequence 320 from Patent WO2021205453
GCGAACGCCTGG
>MQ255014.1 Sequence 319 from Patent WO2021205453
GCCTCGGATAAG
>MQ255013.1 Sequence 318 from Patent WO2021205453
GATAACAAGTAG
>MQ255012.1 Sequence 317 from Patent WO2021205453
ACCAAGTTACGC
>MQ255011.1 Sequence 316 from Patent WO2021205453
TTGGTGGTGCGC
>MQ255010.1 Sequence 315 from Patent WO2021205453
CGCGACGATCAC
>MQ255009.1 Sequence 314 from Patent WO2021205453
ACACCGTTAAAC
>MQ255008.1 Sequence 313 from Patent WO2021205453
GTTGGACCGTGA
>MQ255007.1 Sequence 312 from Patent WO2021205453
CCAACAACATGA
>MQ255006.1 Sequence 311 from Patent WO2021205453
TATATTCGAGAA
>MQ255005.1 Sequence 310 from Patent WO2021205453
AGATGGAATTAA
>MQ255004.1 Sequence 309 from Patent WO2021205453
GCTCCGTCACTT
>MQ255003.1 Sequence 308 from Patent WO2021205453
CAATTGGATTTT
>MQ255002.1 Sequence 307 from Patent WO2021205453
CGGTTATTAGTT
>MQ255001.1 Sequence 306 from Patent WO2021205453
GTAGCCATCATT
>MQ255000.1 Sequence 305 from Patent WO2021205453
CTAGTCCGGATG
>MQ254999.1 Sequence 304 from Patent WO2021205453
TTCATCCAACTG
>MQ254998.1 Sequence 303 from Patent WO2021205453
CAACGTCAGCTG
>MQ254997.1 Sequence 302 from Patent WO2021205453
CCTTGTTAATTG
>MQ254996.1 Sequence 301 from Patent WO2021205453
AACCGCATCGTC
>MQ254995.1 Sequence 300 from Patent WO2021205453
CAGTAGTTGTTC
>MQ254994.1 Sequence 299 from Patent WO2021205453
GATACCTCCTTC
>MQ254993.1 Sequence 298 from Patent WO2021205453
ACGCTAATTATC
>MQ254992.1 Sequence 297 from Patent WO2021205453
CGCAATCTAGTA
>MQ254991.1 Sequence 296 from Patent WO2021205453
GGCCAATAAGTA
>MQ254990.1 Sequence 295 from Patent WO2021205453
TCCACGGCCTTA
>MQ254989.1 Sequence 294 from Patent WO2021205453
TAATTCTACCTA
>MQ254988.1 Sequence 293 from Patent WO2021205453
TGAATATTGCGT
>MQ254987.1 Sequence 292 from Patent WO2021205453
CCTTCACGTAGT
>MQ254986.1 Sequence 291 from Patent WO2021205453
GGTAACGCAGGT
>MQ254985.1 Sequence 290 from Patent WO2021205453
CATGAGTACTGT
>MQ254984.1 Sequence 289 from Patent WO2021205453
ATTCCGCTATGG
>MQ254983.1 Sequence 288 from Patent WO2021205453
ATAGGTATTCGG
>MQ254982.1 Sequence 287 from Patent WO2021205453
TTCCTGTACGGG
>MQ254981.1 Sequence 286 from Patent WO2021205453
TATTGCGTTCGG
>MQ254980.1 Sequence 285 from Patent WO2021205453
AACTCCGAACGC
>MQ254979.1 Sequence 284 from Patent WO2021205453
AATATTGGCCGC
>MQ254978.1 Sequence 283 from Patent WO2021205453
ACACAATATCGC
>MQ254977.1 Sequence 282 from Patent WO2021205453
TTCTACAGAAGC
>MQ254976.1 Sequence 281 from Patent WO2021205453
TTCAGCGTGGGA
>MQ254975.1 Sequence 280 from Patent WO2021205453
TAGGAACCGGGA
>MQ254974.1 Sequence 279 from Patent WO2021205453
TAGGTTCTCTGA
>MQ254973.1 Sequence 278 from Patent WO2021205453
ACGATTGCTGGA
>MQ254972.1 Sequence 277 from Patent WO2021205453
GACCGCTGTGCT
>MQ254971.1 Sequence 276 from Patent WO2021205453
TGGTGCCTGGCT
>MQ254970.1 Sequence 275 from Patent WO2021205453
GGCCTGTCCTCT
>MQ254969.1 Sequence 274 from Patent WO2021205453
TTAATAGACCCT
>MQ254968.1 Sequence 273 from Patent WO2021205453
CCTGATACAACG
>MQ254967.1 Sequence 272 from Patent WO2021205453
ACAGAGGCCACG
>MQ254966.1 Sequence 271 from Patent WO2021205453
AATTGGCGGACG
>MQ254965.1 Sequence 270 from Patent WO2021205453
ACATAACGGACG
>MQ254964.1 Sequence 269 from Patent WO2021205453
GTATTCTCTACC
>MQ254963.1 Sequence 268 from Patent WO2021205453
CATAACACCACC
>MQ254962.1 Sequence 267 from Patent WO2021205453
GAACAAGTATCC
>MQ254961.1 Sequence 266 from Patent WO2021205453
CAGGCGCCATCC
>MQ254960.1 Sequence 265 from Patent WO2021205453
ATTCAGAATCCA
>MQ254959.1 Sequence 264 from Patent WO2021205453
CGGCCTCGTTCA
>MQ254958.1 Sequence 263 from Patent WO2021205453
TCGGTCACGGCA
>MQ254957.1 Sequence 262 from Patent WO2021205453
ACATGCATATCA
>MQ254956.1 Sequence 261 from Patent WO2021205453
CTATACGCGGAT
>MQ254955.1 Sequence 260 from Patent WO2021205453
AACGTTACATAT
>MQ254954.1 Sequence 259 from Patent WO2021205453
CTTCGCCGATAT
>MQ254953.1 Sequence 258 from Patent WO2021205453
TCTCCATTGAAT
>MQ254952.1 Sequence 257 from Patent WO2021205453
TAAGGAACGTAG
>MQ254951.1 Sequence 256 from Patent WO2021205453
TCACACCGAAAG
>MQ254950.1 Sequence 255 from Patent WO2021205453
AGAGCTGCCTAG
>MQ254949.1 Sequence 254 from Patent WO2021205453
GCGTGTGAGAAG
>MQ254948.1 Sequence 253 from Patent WO2021205453
AATTGCTGCGAC
>MQ254947.1 Sequence 252 from Patent WO2021205453
TCTTGGCTATAC
>MQ254946.1 Sequence 251 from Patent WO2021205453
TCCAATTCTAAC
>MQ254945.1 Sequence 250 from Patent WO2021205453
GAATTGAGTGAC
>MQ254944.1 Sequence 249 from Patent WO2021205453
GGCCATCATAAA
>MQ254943.1 Sequence 248 from Patent WO2021205453
CGCGCCTAGAAA
>MQ254942.1 Sequence 247 from Patent WO2021205453
CTTGTAATTCAA
>MQ254941.1 Sequence 246 from Patent WO2021205453
CTGACCGGCAAA
>MQ253701.1 Sequence 498 from Patent WO2021205216
GATCTTGACTTG
>MQ252536.1 Sequence 7 from Patent WO2021206561
AACTACGTTCGC
>MQ245375.1 Sequence 2525 from Patent EP3894553
TCCACAGGGTTC
>MQ245374.1 Sequence 2524 from Patent EP3894553
CCATGAAGTGTA
>MQ245373.1 Sequence 2523 from Patent EP3894553
AACATTGCAGGT
>MQ245372.1 Sequence 2522 from Patent EP3894553
AAGTCGACACAT
>MQ245371.1 Sequence 2521 from Patent EP3894553
TCAAGGGACCTT
>MQ245370.1 Sequence 2520 from Patent EP3894553
ACTGGATCTCGC
>MQ245369.1 Sequence 2519 from Patent EP3894553
TGTTGGATCGTG
>MQ245368.1 Sequence 2518 from Patent EP3894553
ACCTACTTGTCT
>MQ245367.1 Sequence 2517 from Patent EP3894553
AAGGTCAATCGT
>MQ245366.1 Sequence 2516 from Patent EP3894553
ACCGCATCAATG
>MQ245365.1 Sequence 2515 from Patent EP3894553
CTTGTCTGGAGC
>MQ245364.1 Sequence 2514 from Patent EP3894553
AGGACCTCGTTC
>MQ245363.1 Sequence 2513 from Patent EP3894553
CTAGGCAATCAA
>MQ245362.1 Sequence 2512 from Patent EP3894553
AAGGCCTTTACG
>MQ245361.1 Sequence 2511 from Patent EP3894553
CCTGTAGGTTGC
>MQ245360.1 Sequence 2510 from Patent EP3894553
AGCCGGAGAGTA
>MQ245359.1 Sequence 2509 from Patent EP3894553
AGATTCGCTCGA
>MQ245358.1 Sequence 2508 from Patent EP3894553
TATTGCAGCAGC
>MQ245357.1 Sequence 2507 from Patent EP3894553
GCTCACAATGTG
>MQ245356.1 Sequence 2506 from Patent EP3894553
AGAAAGGGTGTG
>MQ245355.1 Sequence 2505 from Patent EP3894553
TGTATTGGACAG
>MQ245354.1 Sequence 2504 from Patent EP3894553
TAGGAACTCACC
>MQ245353.1 Sequence 2503 from Patent EP3894553
ACAGTGCGTCCT
>MQ245352.1 Sequence 2502 from Patent EP3894553
GCTTTCTCAATC
>MQ245351.1 Sequence 2501 from Patent EP3894553
GGTAAAGGGTCG
>MQ245350.1 Sequence 2500 from Patent EP3894553
AAGTGCTTGGTA
>MQ245349.1 Sequence 2499 from Patent EP3894553
AATCCGGTCACC
>MQ245348.1 Sequence 2498 from Patent EP3894553
TCCAGATAGCGT
>MQ245347.1 Sequence 2497 from Patent EP3894553
TATAATCCGAGG
>MQ245346.1 Sequence 2496 from Patent EP3894553
TTGGCATTGGCA
>MQ245345.1 Sequence 2495 from Patent EP3894553
CTAATCAGAGTG
>MQ245344.1 Sequence 2494 from Patent EP3894553
TCACTGCTAGGA
>MQ245343.1 Sequence 2493 from Patent EP3894553
ATCACGGGAGAG
>MQ245342.1 Sequence 2492 from Patent EP3894553
ACCGTAAGACAT
>MQ245341.1 Sequence 2491 from Patent EP3894553
ACTCGAAACCAA
>MQ245340.1 Sequence 2490 from Patent EP3894553
CTCGGCACCAAT
>MQ245339.1 Sequence 2489 from Patent EP3894553
GTAATAATGCCG
>MQ245338.1 Sequence 2488 from Patent EP3894553
TGCTCACGTGTG
>MQ245337.1 Sequence 2487 from Patent EP3894553
ACAGGTAGAGAG
>MQ245336.1 Sequence 2486 from Patent EP3894553
CTGATAGCACAC
>MQ245335.1 Sequence 2485 from Patent EP3894553
GTACCGTTGCAA
>MQ245334.1 Sequence 2484 from Patent EP3894553
TCTTAGTCGGGC
>MQ245333.1 Sequence 2483 from Patent EP3894553
CAACCACTCGGT
>MQ245332.1 Sequence 2482 from Patent EP3894553
CCTTGTTCACCT
>MQ245331.1 Sequence 2481 from Patent EP3894553
TGTCTTTACCTG
>MQ245330.1 Sequence 2480 from Patent EP3894553
GTTGAAGCACCT
>MQ245329.1 Sequence 2479 from Patent EP3894553
CGGTGGAAGCAA
>MQ245328.1 Sequence 2478 from Patent EP3894553
GCCGATTGTAAC
>MQ245327.1 Sequence 2477 from Patent EP3894553
TAAGTACTGCAG
>MQ245326.1 Sequence 2476 from Patent EP3894553
AGGTTGCTGTAA
>MQ245325.1 Sequence 2475 from Patent EP3894553
TGCCCATCAGGT
>MQ245324.1 Sequence 2474 from Patent EP3894553
CAAGTGAAGGGA
>MQ245323.1 Sequence 2473 from Patent EP3894553
TCTGATCGAGGT
>MQ245322.1 Sequence 2472 from Patent EP3894553
GAGTTCCATTGG
>MQ245321.1 Sequence 2471 from Patent EP3894553
AATGTGGCTCAC
>MQ245320.1 Sequence 2470 from Patent EP3894553
ACAGCATAGCTC
>MQ245319.1 Sequence 2469 from Patent EP3894553
CCACACGTTTGG
>MQ245318.1 Sequence 2468 from Patent EP3894553
GCGTTAACCCAA
>MQ245317.1 Sequence 2467 from Patent EP3894553
TGTTCCTCTCAC
>MQ245316.1 Sequence 2466 from Patent EP3894553
TAGGAGAGACAG
>MQ245315.1 Sequence 2465 from Patent EP3894553
CTCACTGCTTCT
>MQ245314.1 Sequence 2464 from Patent EP3894553
TCCTTCCCTGCT
>MQ245313.1 Sequence 2463 from Patent EP3894553
TGGCCTAGTCAA
>MQ245312.1 Sequence 2462 from Patent EP3894553
GAGGTGGGAGTT
>MQ245311.1 Sequence 2461 from Patent EP3894553
GTCCTACACAGC
>MQ245310.1 Sequence 2460 from Patent EP3894553
TTCCATCATGTC
>MQ245309.1 Sequence 2459 from Patent EP3894553
TCTCATGTGGAG
>MQ245308.1 Sequence 2458 from Patent EP3894553
TCTTCGCAGCAG
>MQ245307.1 Sequence 2457 from Patent EP3894553
CACACGCCTGAT
>MQ245306.1 Sequence 2456 from Patent EP3894553
GACCATGTAGTA
>MQ245305.1 Sequence 2455 from Patent EP3894553
GCTCAATCAGAA
>MQ245304.1 Sequence 2454 from Patent EP3894553
GAGCGAGTTAGG
>MQ245303.1 Sequence 2453 from Patent EP3894553
GGTTCATGAACA
>MQ245302.1 Sequence 2452 from Patent EP3894553
TGAGCAACATAC
>MQ245301.1 Sequence 2451 from Patent EP3894553
CAGATGTCGCTA
>MQ245300.1 Sequence 2450 from Patent EP3894553
TCCCGTAGCATG
>MQ245299.1 Sequence 2449 from Patent EP3894553
ATAACGGTGTAC
>MQ245298.1 Sequence 2448 from Patent EP3894553
TTGAGAAGCACT
>MQ245297.1 Sequence 2447 from Patent EP3894553
TACTGGTAAGAC
>MQ245296.1 Sequence 2446 from Patent EP3894553
ATTTGCTTTGCC
>MQ245295.1 Sequence 2445 from Patent EP3894553
CTCTGAGGTAAC
>MQ245294.1 Sequence 2444 from Patent EP3894553
GATAATGTGCAC
>MQ245293.1 Sequence 2443 from Patent EP3894553
GGAAGTGGCCAA
>MQ245292.1 Sequence 2442 from Patent EP3894553
CTAATTCTCTGC
>MQ245291.1 Sequence 2441 from Patent EP3894553
CGACCTCGCATA
>MQ245290.1 Sequence 2440 from Patent EP3894553
GCTCTTATGCTT
>MQ245289.1 Sequence 2439 from Patent EP3894553
TGATGAACCCGT
>MQ245288.1 Sequence 2438 from Patent EP3894553
ACGAAAGAGCAG
>MQ245287.1 Sequence 2437 from Patent EP3894553
ACATCGTTGACG
>MQ245286.1 Sequence 2436 from Patent EP3894553
CAAGTTTCCGCG
>MQ245285.1 Sequence 2435 from Patent EP3894553
CAGTAAATCGCA
>MQ245284.1 Sequence 2434 from Patent EP3894553
TGATGTGCTAAG
>MQ245283.1 Sequence 2433 from Patent EP3894553
TCGGACAGTGTT
>MQ245282.1 Sequence 2432 from Patent EP3894553
TAGATCCTCGGA
>MQ245281.1 Sequence 2431 from Patent EP3894553
CATCGTTGGTCG
>MQ245280.1 Sequence 2430 from Patent EP3894553
TCTGAATGGTAG
>MQ245279.1 Sequence 2429 from Patent EP3894553
CTGATTACGAGA
>MQ245278.1 Sequence 2428 from Patent EP3894553
TCTCCGTTCCCT
>MQ244777.1 Sequence 1927 from Patent EP3894553
CCTGTGTTGGTG
>MQ244776.1 Sequence 1926 from Patent EP3894553
CTCTACGAACAG
>MQ244775.1 Sequence 1925 from Patent EP3894553
AGTTGGTTACGA
>MQ244774.1 Sequence 1924 from Patent EP3894553
GCTTACGTAGGT
>MQ244773.1 Sequence 1923 from Patent EP3894553
CGCTATCCAGAC
>MQ244772.1 Sequence 1922 from Patent EP3894553
TGGTCCTACAAG
>MQ244771.1 Sequence 1921 from Patent EP3894553
GCTCTAGTAACG
>MQ244770.1 Sequence 1920 from Patent EP3894553
AGCTGATAGTTG
>MQ244769.1 Sequence 1919 from Patent EP3894553
CCTCACTAGCGA
>MQ244768.1 Sequence 1918 from Patent EP3894553
GTGCGGTTCACT
>MQ244767.1 Sequence 1917 from Patent EP3894553
ATGTGGCGTGTT
>MQ244766.1 Sequence 1916 from Patent EP3894553
CAGGCATAACAT
>MQ244765.1 Sequence 1915 from Patent EP3894553
CTTCTTCGCCCT
>MQ244764.1 Sequence 1914 from Patent EP3894553
TGATCCGGGTAT
>MQ244763.1 Sequence 1913 from Patent EP3894553
TCGTTCAGGACC
>MQ244762.1 Sequence 1912 from Patent EP3894553
TACGGTCTGGAT
>MQ244761.1 Sequence 1911 from Patent EP3894553
TATCGCGCGATA
>MQ244760.1 Sequence 1910 from Patent EP3894553
GGCAATCATCTG
>MQ244759.1 Sequence 1909 from Patent EP3894553
CAACATCGTAGC
>MQ244758.1 Sequence 1908 from Patent EP3894553
CATCCTGAGCAA
>MQ244757.1 Sequence 1907 from Patent EP3894553
ACTGTCGCAGTA
>MQ244756.1 Sequence 1906 from Patent EP3894553
GGTACAATGATC
>MQ244755.1 Sequence 1905 from Patent EP3894553
GTGGATAAACTC
>MQ244754.1 Sequence 1904 from Patent EP3894553
CAAGCTAGCTGT
>MQ244753.1 Sequence 1903 from Patent EP3894553
ACCTGATCCGCA
>MQ244752.1 Sequence 1902 from Patent EP3894553
TCAGCTGACTAG
>MQ244751.1 Sequence 1901 from Patent EP3894553
GCGGTACTACTA
>MQ244750.1 Sequence 1900 from Patent EP3894553
ACGAGGAGTCGA
>MQ244749.1 Sequence 1899 from Patent EP3894553
AAGGCAAGAAGA
>MQ244748.1 Sequence 1898 from Patent EP3894553
GACTCCTAGACC
>MQ244747.1 Sequence 1897 from Patent EP3894553
GCCATGTGTGTA
>MQ244746.1 Sequence 1896 from Patent EP3894553
CAATACGACCGT
>MQ244745.1 Sequence 1895 from Patent EP3894553
AGGATATTCGTG
>MQ244744.1 Sequence 1894 from Patent EP3894553
CGATTTAGGCCA
>MQ244743.1 Sequence 1893 from Patent EP3894553
GACACCACAATA
>MQ244742.1 Sequence 1892 from Patent EP3894553
GTTCAGACTAGC
>MQ244741.1 Sequence 1891 from Patent EP3894553
TCCATACCGGAA
>MQ244740.1 Sequence 1890 from Patent EP3894553
AACCCTAACTGG
>MQ244739.1 Sequence 1889 from Patent EP3894553
GAGAATGGAAAG
>MQ244738.1 Sequence 1888 from Patent EP3894553
CCGCATGACCTA
>MQ244737.1 Sequence 1887 from Patent EP3894553
TAGAACACCATG
>MQ244736.1 Sequence 1886 from Patent EP3894553
CATCAGTACGCC
>MQ244735.1 Sequence 1885 from Patent EP3894553
CTTAGTGCAGAA
>MQ244734.1 Sequence 1884 from Patent EP3894553
TGAAGTCACAGT
>MQ244733.1 Sequence 1883 from Patent EP3894553
TCTTCTGCCCTA
>MQ244732.1 Sequence 1882 from Patent EP3894553
AGATTACAACCG
>MQ244731.1 Sequence 1881 from Patent EP3894553
GAAGGCTCCTTA
>MQ244730.1 Sequence 1880 from Patent EP3894553
TTGTCTACCTAC
>MQ244729.1 Sequence 1879 from Patent EP3894553
CTGTGGGATTCA
>MQ244728.1 Sequence 1878 from Patent EP3894553
GTCCGATCCTAG
>MQ244727.1 Sequence 1877 from Patent EP3894553
GGAGGCCATAAG
>MQ244726.1 Sequence 1876 from Patent EP3894553
TCATACAGCCAG
>MQ244725.1 Sequence 1875 from Patent EP3894553
ACTAATACGCGA
>MQ244724.1 Sequence 1874 from Patent EP3894553
AGGGATGGACCA
>MQ244723.1 Sequence 1873 from Patent EP3894553
TACCATCCATCT
>MQ244722.1 Sequence 1872 from Patent EP3894553
GGTCTTAGCACC
>MQ244721.1 Sequence 1871 from Patent EP3894553
AGCTAGCGTTCA
>MQ244720.1 Sequence 1870 from Patent EP3894553
ATGCTCTAGAGA
>MQ244719.1 Sequence 1869 from Patent EP3894553
GTATGACTAGCA
>MQ244718.1 Sequence 1868 from Patent EP3894553
CACAATACACCG
>MQ244717.1 Sequence 1867 from Patent EP3894553
TAGAATCAACGC
>MQ244716.1 Sequence 1866 from Patent EP3894553
TCCCAACCTAGG
>MQ244715.1 Sequence 1865 from Patent EP3894553
TTCGTGAGGATA
>MQ244714.1 Sequence 1864 from Patent EP3894553
TGTCATGGCTGA
>MQ244713.1 Sequence 1863 from Patent EP3894553
TTGCAGTGCAAC
>MQ244712.1 Sequence 1862 from Patent EP3894553
ACTGTGACGTCC
>MQ244711.1 Sequence 1861 from Patent EP3894553
TCAGAAGCTCAA
>MQ244710.1 Sequence 1860 from Patent EP3894553
TTGTAGCCGACA
>MQ244709.1 Sequence 1859 from Patent EP3894553
ATATCCTGGGAC
>MQ244708.1 Sequence 1858 from Patent EP3894553
AGGTTAAGTGCT
>MQ244707.1 Sequence 1857 from Patent EP3894553
ACTAGACGACTA
>MQ244706.1 Sequence 1856 from Patent EP3894553
CGCCCTCTTCTT
>MQ244705.1 Sequence 1855 from Patent EP3894553
GTAAACGACTTG
>MQ244704.1 Sequence 1854 from Patent EP3894553
GCTGCTACAAGT
>MQ244703.1 Sequence 1853 from Patent EP3894553
CCTTAAGGGCAT
>MQ244702.1 Sequence 1852 from Patent EP3894553
GGAGCTCTGTAT
>MQ244701.1 Sequence 1851 from Patent EP3894553
CACCACAGAATC
>MQ244700.1 Sequence 1850 from Patent EP3894553
GATGCAACTTCG
>MQ244699.1 Sequence 1849 from Patent EP3894553
GACCAAATGTCC
>MQ244698.1 Sequence 1848 from Patent EP3894553
TCAGAGTAGACT
>MQ244697.1 Sequence 1847 from Patent EP3894553
GACACTCACCGT
>MQ244696.1 Sequence 1846 from Patent EP3894553
TTCGCTAACCTT
>MQ244695.1 Sequence 1845 from Patent EP3894553
AACCACTAACCG
>MQ244694.1 Sequence 1844 from Patent EP3894553
AGTCGCTACACA
>MQ245782.1 Sequence 2932 from Patent EP3894553
GCCGCATTCGAT
>MQ245781.1 Sequence 2931 from Patent EP3894553
TTCCCACCCATT
>MQ245780.1 Sequence 2930 from Patent EP3894553
TTGTACTCACTC
>MQ245779.1 Sequence 2929 from Patent EP3894553
CGTTTATCCGTT
>MQ245778.1 Sequence 2928 from Patent EP3894553
CGCCTTGATAAG
>MQ245777.1 Sequence 2927 from Patent EP3894553
GGTATCACCCTG
>MQ245776.1 Sequence 2926 from Patent EP3894553
CTTAAATGGGCA
>MQ245775.1 Sequence 2925 from Patent EP3894553
TGCTTGTAGGCA
>MQ245774.1 Sequence 2924 from Patent EP3894553
TGGAGGTTCTCA
>MQ245773.1 Sequence 2923 from Patent EP3894553
ATCGCGACTGCT
>MQ245772.1 Sequence 2922 from Patent EP3894553
AGCGTCTGAACT
>MQ245771.1 Sequence 2921 from Patent EP3894553
AGTCACATCCGC
>MQ245770.1 Sequence 2920 from Patent EP3894553
GCGTGGTCATTA
>MQ245769.1 Sequence 2919 from Patent EP3894553
CCTATGCACGGT
>MQ245768.1 Sequence 2918 from Patent EP3894553
GCATGTCGAAAT
>MQ245767.1 Sequence 2917 from Patent EP3894553
TGGTAGTCTGAA
>MQ245766.1 Sequence 2916 from Patent EP3894553
AGTTGCCTGAAC
>MQ245765.1 Sequence 2915 from Patent EP3894553
GTCTCAAAGCAC
>MQ245764.1 Sequence 2914 from Patent EP3894553
TAGTTGAGCTGA
>MQ245763.1 Sequence 2913 from Patent EP3894553
CAACAGGTAACT
>MQ245762.1 Sequence 2912 from Patent EP3894553
TTCAGGAACTAG
>MQ245761.1 Sequence 2911 from Patent EP3894553
GACTATAATGGC
>MQ245760.1 Sequence 2910 from Patent EP3894553
GACAGGTTGTAT
>MQ245759.1 Sequence 2909 from Patent EP3894553
AATGGCGACTAT
>MQ245758.1 Sequence 2908 from Patent EP3894553
CCATGCTTAGAG
>MQ245757.1 Sequence 2907 from Patent EP3894553
CAACGAACCATC
>MQ245756.1 Sequence 2906 from Patent EP3894553
GGTTGTAAGTGT
>MQ245755.1 Sequence 2905 from Patent EP3894553
TACCAGGATTGC
>MQ245754.1 Sequence 2904 from Patent EP3894553
AACTCGCGCTAC
>MQ245753.1 Sequence 2903 from Patent EP3894553
CGTTCAAGCTAG
>MQ245752.1 Sequence 2902 from Patent EP3894553
TACACCTTACCT
>MQ245751.1 Sequence 2901 from Patent EP3894553
CGAGTATACAAC
>MQ245750.1 Sequence 2900 from Patent EP3894553
TATGTTGACGGC
>MQ245749.1 Sequence 2899 from Patent EP3894553
ACAGCCACCCAT
>MQ245748.1 Sequence 2898 from Patent EP3894553
TAGTGATGACCA
>MQ245747.1 Sequence 2897 from Patent EP3894553
TGATAATGCACG
>MQ245746.1 Sequence 2896 from Patent EP3894553
GAACCAGTACTC
>MQ245745.1 Sequence 2895 from Patent EP3894553
TCAACGTGCTGC
>MQ245744.1 Sequence 2894 from Patent EP3894553
AGTTTGCGAGAT
>MQ245743.1 Sequence 2893 from Patent EP3894553
AGTCCTTTATCC
>MQ245742.1 Sequence 2892 from Patent EP3894553
CTATGAGTCCAG
>MQ245741.1 Sequence 2891 from Patent EP3894553
TCTATGCGAACG
>MQ245740.1 Sequence 2890 from Patent EP3894553
ACAGACGACGGA
>MQ245739.1 Sequence 2889 from Patent EP3894553
TAGCCTGTCGTG
>MQ245738.1 Sequence 2888 from Patent EP3894553
GTACGTCACTGA
>MQ245737.1 Sequence 2887 from Patent EP3894553
AATGGACCGTTC
>MQ245736.1 Sequence 2886 from Patent EP3894553
GCGATCACACCT
>MQ245735.1 Sequence 2885 from Patent EP3894553
GTGCTAATAGGT
>MQ245734.1 Sequence 2884 from Patent EP3894553
AACAGGTCTCTG
>MQ245733.1 Sequence 2883 from Patent EP3894553
TGCAATGGTACC
>MQ245732.1 Sequence 2882 from Patent EP3894553
TTACGGCTGGTC
>MQ245731.1 Sequence 2881 from Patent EP3894553
ACGCTAGATTGA
>MQ245730.1 Sequence 2880 from Patent EP3894553
TCCCAGAAGCTC
>MQ245729.1 Sequence 2879 from Patent EP3894553
TGTGCACGCCAT
>MQ245728.1 Sequence 2878 from Patent EP3894553
CGTTACCGGACT
>MQ245727.1 Sequence 2877 from Patent EP3894553
TTGTGTCTCCCT
>MQ245726.1 Sequence 2876 from Patent EP3894553
GAGTGCTCTAAC
>MQ245725.1 Sequence 2875 from Patent EP3894553
GACAAGAAGGTG
>MQ245724.1 Sequence 2874 from Patent EP3894553
TGTTGACGATGC
>MQ245723.1 Sequence 2873 from Patent EP3894553
TGACACGACATC
>MQ245722.1 Sequence 2872 from Patent EP3894553
CTTTGCACTTTG
>MQ245721.1 Sequence 2871 from Patent EP3894553
GCATAAACGACT
>MQ245720.1 Sequence 2870 from Patent EP3894553
TACTTGCCACGG
>MQ245719.1 Sequence 2869 from Patent EP3894553
AAGCCTCTACGA
>MQ245718.1 Sequence 2868 from Patent EP3894553
TCCTGAACACAG
>MQ245717.1 Sequence 2867 from Patent EP3894553
GGATGTCTTCGC
>MQ245716.1 Sequence 2866 from Patent EP3894553
AGACTTCTCAGG
>MQ245715.1 Sequence 2865 from Patent EP3894553
ACGATGGTTGAT
>MQ245714.1 Sequence 2864 from Patent EP3894553
AGGTCTCCCGAT
>MQ245713.1 Sequence 2863 from Patent EP3894553
GACAATTCCGAA
>MQ245712.1 Sequence 2862 from Patent EP3894553
GCGCTGTTTAAG
>MQ245711.1 Sequence 2861 from Patent EP3894553
AAGTTCCGGCCT
>MQ245710.1 Sequence 2860 from Patent EP3894553
GGAGTCTCTTGC
>MQ245709.1 Sequence 2859 from Patent EP3894553
CGCTCTTAACGG
>MQ245708.1 Sequence 2858 from Patent EP3894553
CTGAACAGTTGC
>MQ245707.1 Sequence 2857 from Patent EP3894553
CACCGCTCACAA
>MQ245706.1 Sequence 2856 from Patent EP3894553
CTTCGTTTCGTA
>MQ245705.1 Sequence 2855 from Patent EP3894553
AAGTGTGGTTGT
>MQ245704.1 Sequence 2854 from Patent EP3894553
TGACGGTTTAGC
>MQ245703.1 Sequence 2853 from Patent EP3894553
GCAACGAACGAG
>MQ245702.1 Sequence 2852 from Patent EP3894553
TAGGACGGGAGT
>MQ245701.1 Sequence 2851 from Patent EP3894553
AGGATCAGGGAA
>MQ245700.1 Sequence 2850 from Patent EP3894553
GTTACGTGGTTG
>MQ245699.1 Sequence 2849 from Patent EP3894553
TGTAAACAGGTC
>MQ245698.1 Sequence 2848 from Patent EP3894553
GGTCGAATTGCT
>MQ245697.1 Sequence 2847 from Patent EP3894553
TAGGTAACCGAT
>MQ245696.1 Sequence 2846 from Patent EP3894553
CACATGGGTTTG
>MQ245695.1 Sequence 2845 from Patent EP3894553
GAAGGTGAAGGT
>MQ245694.1 Sequence 2844 from Patent EP3894553
TCACGTATTCTC
>MQ245693.1 Sequence 2843 from Patent EP3894553
ACGGTGAAAGCG
>MQ245692.1 Sequence 2842 from Patent EP3894553
CTGTCGTGTCAG
>MQ245691.1 Sequence 2841 from Patent EP3894553
ATGCGCCCGTAT
>MQ245690.1 Sequence 2840 from Patent EP3894553
CGGGTAGGGTAA
>MQ245689.1 Sequence 2839 from Patent EP3894553
GTTCGTATACGG
>MQ245688.1 Sequence 2838 from Patent EP3894553
GGACAAGTGCGA
>MQ245687.1 Sequence 2837 from Patent EP3894553
CGCTAGGATGTT
>MQ245686.1 Sequence 2836 from Patent EP3894553
GCTTGTACCGAC
>MQ245685.1 Sequence 2835 from Patent EP3894553
CTGAGTGAGTAT
>MQ245684.1 Sequence 2834 from Patent EP3894553
ATACAGCATACG
>MQ245683.1 Sequence 2833 from Patent EP3894553
CGTAGCCAACAT
>MQ245682.1 Sequence 2832 from Patent EP3894553
CAGCAGTCTTCG
>MQ245681.1 Sequence 2831 from Patent EP3894553
GGATTACGCTGT
>MQ245680.1 Sequence 2830 from Patent EP3894553
ATTGAAGTCTGG
>MQ245679.1 Sequence 2829 from Patent EP3894553
GCTACAAGCCCT
>MQ245678.1 Sequence 2828 from Patent EP3894553
CGCAATGAGGGA
>MQ245677.1 Sequence 2827 from Patent EP3894553
CCATCCGCAACA
>MQ245676.1 Sequence 2826 from Patent EP3894553
GGCTTACTTGGA
>MQ245675.1 Sequence 2825 from Patent EP3894553
TCGCTTTAACCT
>MQ245674.1 Sequence 2824 from Patent EP3894553
AGTTCATACGGC
>MQ245673.1 Sequence 2823 from Patent EP3894553
GGTGAGCAAGCA
>MQ245672.1 Sequence 2822 from Patent EP3894553
AGTGACTGTCAA
>MQ245671.1 Sequence 2821 from Patent EP3894553
TCGTACCAGGAT
>MQ245670.1 Sequence 2820 from Patent EP3894553
CCATATCCCGGA
>MQ245669.1 Sequence 2819 from Patent EP3894553
GTCAGTATGGCT
>MQ245668.1 Sequence 2818 from Patent EP3894553
TACGCTACGACC
>MQ245667.1 Sequence 2817 from Patent EP3894553
TCCCACGAAACA
>MQ245666.1 Sequence 2816 from Patent EP3894553
TGTAGGTGTGCT
>MQ245665.1 Sequence 2815 from Patent EP3894553
CCTTTATAGTCC
>MQ245664.1 Sequence 2814 from Patent EP3894553
TCTCTGAACAGG
>MQ245663.1 Sequence 2813 from Patent EP3894553
TATGACGTACGA
>MQ245662.1 Sequence 2812 from Patent EP3894553
CCGTATATGCGC
>MQ245661.1 Sequence 2811 from Patent EP3894553
CTTAGAACGTGC
>MQ245660.1 Sequence 2810 from Patent EP3894553
AACTCAATAGCG
>MQ245659.1 Sequence 2809 from Patent EP3894553
AACTAAGGACTC
>MQ245658.1 Sequence 2808 from Patent EP3894553
TCGAAACATGCA
>MQ245657.1 Sequence 2807 from Patent EP3894553
AGAACACGGAAG
>MQ245656.1 Sequence 2806 from Patent EP3894553
TGGTGGAGTTTC
>MQ245655.1 Sequence 2805 from Patent EP3894553
TCACTCTTGTAC
>MQ245654.1 Sequence 2804 from Patent EP3894553
TGCAGATCCAAC
>MQ245653.1 Sequence 2803 from Patent EP3894553
GTGCCATAATCG
>MQ245652.1 Sequence 2802 from Patent EP3894553
TTCGGCATAGTG
>MQ245651.1 Sequence 2801 from Patent EP3894553
TACTCCAGGCTG
>MQ245650.1 Sequence 2800 from Patent EP3894553
AGGTTTGGCTTG
>MQ245649.1 Sequence 2799 from Patent EP3894553
TGCTCGATGTGC
>MQ245648.1 Sequence 2798 from Patent EP3894553
CAGGAACCAGGA
>MQ245647.1 Sequence 2797 from Patent EP3894553
TAGGTTGCTTGG
>MQ245646.1 Sequence 2796 from Patent EP3894553
TGGGTTAACACA
>MQ245645.1 Sequence 2795 from Patent EP3894553
GGTTTGCACATG
>MQ245644.1 Sequence 2794 from Patent EP3894553
TGCGCAAAGGAG
>MQ245643.1 Sequence 2793 from Patent EP3894553
AGTCTAGAGTAC
>MQ245642.1 Sequence 2792 from Patent EP3894553
GGTCATCACGAT
>MQ245641.1 Sequence 2791 from Patent EP3894553
CATGAGACTGTA
>MQ245640.1 Sequence 2790 from Patent EP3894553
GGCACGAAAGGT
>MQ245639.1 Sequence 2789 from Patent EP3894553
TGATCACTCTTC
>MQ245638.1 Sequence 2788 from Patent EP3894553
GGTCCACCTAAC
>MQ245637.1 Sequence 2787 from Patent EP3894553
GGTATTCAAAGC
>MQ245636.1 Sequence 2786 from Patent EP3894553
AATCCATGACAG
>MQ245635.1 Sequence 2785 from Patent EP3894553
TCTCTCGATCAT
>MQ245634.1 Sequence 2784 from Patent EP3894553
TTCTTCTACCGC
>MQ245633.1 Sequence 2783 from Patent EP3894553
GTTCGAGTGAAT
>MQ245632.1 Sequence 2782 from Patent EP3894553
CTGCTTCTTACA
>MQ245631.1 Sequence 2781 from Patent EP3894553
CTGGTTGGCATC
>MQ245630.1 Sequence 2780 from Patent EP3894553
AGATAGCTCGCT
>MQ245629.1 Sequence 2779 from Patent EP3894553
TTACGAAGTTGG
>MQ245628.1 Sequence 2778 from Patent EP3894553
AACCGTCGCCTA
>MQ245627.1 Sequence 2777 from Patent EP3894553
TAGGCCATGTAA
>MQ245626.1 Sequence 2776 from Patent EP3894553
GAGGGACGCAAT
>MQ245625.1 Sequence 2775 from Patent EP3894553
CAGTTACCCAAG
>MQ245624.1 Sequence 2774 from Patent EP3894553
GGAACTTACTCG
>MQ245623.1 Sequence 2773 from Patent EP3894553
GGCCGTTCGATT
>MQ245622.1 Sequence 2772 from Patent EP3894553
CGCTAATCGTGA
>MQ245621.1 Sequence 2771 from Patent EP3894553
ACGTCCACTGTG
>MQ245620.1 Sequence 2770 from Patent EP3894553
CACAGCGTCCTA
>MQ245619.1 Sequence 2769 from Patent EP3894553
ACTGCCCGATAC
>MQ245618.1 Sequence 2768 from Patent EP3894553
AGCTACTGCGTC
>MQ245617.1 Sequence 2767 from Patent EP3894553
ACAGTTGTACGC
>MQ245616.1 Sequence 2766 from Patent EP3894553
ATGCTTGCTCTT
>MQ245615.1 Sequence 2765 from Patent EP3894553
ACCAGAAATGTC
>MQ245614.1 Sequence 2764 from Patent EP3894553
ACCACTTGCCAG
>MQ245613.1 Sequence 2763 from Patent EP3894553
ACTGCTATCGCG
>MQ245612.1 Sequence 2762 from Patent EP3894553
CTCCGCTATAGG
>MQ245611.1 Sequence 2761 from Patent EP3894553
GTAAGCCTCGAT
>MQ245610.1 Sequence 2760 from Patent EP3894553
CACCTCCAAGGT
>MQ245609.1 Sequence 2759 from Patent EP3894553
GTTGCCTCTGAG
>MQ245608.1 Sequence 2758 from Patent EP3894553
CGTCGATTGCAC
>MQ245607.1 Sequence 2757 from Patent EP3894553
CACTTCTTTGTG
>MQ245606.1 Sequence 2756 from Patent EP3894553
TCGAAGACGTAT
>MQ245605.1 Sequence 2755 from Patent EP3894553
TCAGATACCAGC
>MQ245604.1 Sequence 2754 from Patent EP3894553
AAGTTAGTCCGC
>MQ245603.1 Sequence 2753 from Patent EP3894553
TCCCTCTGAGAG
>MQ245602.1 Sequence 2752 from Patent EP3894553
CTCTCGGCGTAA
>MQ245601.1 Sequence 2751 from Patent EP3894553
CCGTTCAATGGA
>MQ245600.1 Sequence 2750 from Patent EP3894553
AATCGGTCCGAT
>MQ245599.1 Sequence 2749 from Patent EP3894553
ACAGTCTGCATG
>MQ245598.1 Sequence 2748 from Patent EP3894553
AGAGCATCCACT
>MQ245597.1 Sequence 2747 from Patent EP3894553
TAGAGAATGCTC
>MQ245596.1 Sequence 2746 from Patent EP3894553
AGAGGGTGATCG
>MQ245595.1 Sequence 2745 from Patent EP3894553
GAGACTATATGC
>MQ245594.1 Sequence 2744 from Patent EP3894553
TCACAGACAATG
>MQ245593.1 Sequence 2743 from Patent EP3894553
ATCGTCCGCGAT
>MQ245592.1 Sequence 2742 from Patent EP3894553
AACGGCTGGAAG
>MQ245591.1 Sequence 2741 from Patent EP3894553
AAGATTTGCAGC
>MQ245590.1 Sequence 2740 from Patent EP3894553
CTTTCCCTTCGA
>MQ245589.1 Sequence 2739 from Patent EP3894553
GCGTAACTCTCG
>MQ245588.1 Sequence 2738 from Patent EP3894553
TACGACTCTGGC
>MQ245587.1 Sequence 2737 from Patent EP3894553
TCGAGAGTTTGC
>MQ245586.1 Sequence 2736 from Patent EP3894553
GTGGTTCGATGT
>MQ245585.1 Sequence 2735 from Patent EP3894553
GGCCTCACTGAT
>MQ245584.1 Sequence 2734 from Patent EP3894553
CTGAATCTGGTG
>MQ245583.1 Sequence 2733 from Patent EP3894553
TGTTGTTGGGAA
>MQ245582.1 Sequence 2732 from Patent EP3894553
AGGCCCGTTTAC
>MQ245581.1 Sequence 2731 from Patent EP3894553
CGCGGTTACTAA
>MQ245580.1 Sequence 2730 from Patent EP3894553
GTGAGATACCTA
>MQ245579.1 Sequence 2729 from Patent EP3894553
GGATTCGTGTCC
>MQ245578.1 Sequence 2728 from Patent EP3894553
CTAGTGACCTAG
>MQ245577.1 Sequence 2727 from Patent EP3894553
ACCACACGTAGT
>MQ245576.1 Sequence 2726 from Patent EP3894553
CTGGATTACGGT
>MQ245575.1 Sequence 2725 from Patent EP3894553
CGACCCATACGT
>MQ245574.1 Sequence 2724 from Patent EP3894553
CCTTTGGCTGAG
>MQ245573.1 Sequence 2723 from Patent EP3894553
CAAGAGCGGATG
>MQ245572.1 Sequence 2722 from Patent EP3894553
CTATAGACACGA
>MQ245571.1 Sequence 2721 from Patent EP3894553
AACACCATCGAC
>MQ245570.1 Sequence 2720 from Patent EP3894553
CGCCTAAACCGT
>MQ245569.1 Sequence 2719 from Patent EP3894553
AGCGTTGTCCAA
>MQ245568.1 Sequence 2718 from Patent EP3894553
GCGCAATAGTAT
>MQ245567.1 Sequence 2717 from Patent EP3894553
GTCTGGATTGAA
>MQ245566.1 Sequence 2716 from Patent EP3894553
CCAGTTCCAAAG
>MQ245565.1 Sequence 2715 from Patent EP3894553
GTGATACCCGCT
>MQ245564.1 Sequence 2714 from Patent EP3894553
CGCTGGCTTTAG
>MQ245563.1 Sequence 2713 from Patent EP3894553
CGACAACTTGTG
>MQ245562.1 Sequence 2712 from Patent EP3894553
TAAAGCGAGGAG
>MQ245561.1 Sequence 2711 from Patent EP3894553
AGCTTGAATCAG
>MQ245560.1 Sequence 2710 from Patent EP3894553
ACACTGGTCCTG
>MQ245559.1 Sequence 2709 from Patent EP3894553
CCTTACCTCCTC
>MQ245558.1 Sequence 2708 from Patent EP3894553
ACATGCACATGC
>MQ245557.1 Sequence 2707 from Patent EP3894553
AGCGAACCTGTT
>MQ245556.1 Sequence 2706 from Patent EP3894553
GGTAACCTCTGA
>MQ245555.1 Sequence 2705 from Patent EP3894553
GATTCGAGTGTC
>MQ245554.1 Sequence 2704 from Patent EP3894553
CAACCGAGATTA
>MQ245553.1 Sequence 2703 from Patent EP3894553
CTCTAACCTCTA
>MQ245552.1 Sequence 2702 from Patent EP3894553
CCAGCTGGACTT
>MQ245551.1 Sequence 2701 from Patent EP3894553
ATCTGGACGATC
>MQ245550.1 Sequence 2700 from Patent EP3894553
AACGCGAAATTC
>MQ245549.1 Sequence 2699 from Patent EP3894553
GCGCGTGTATCT
>MQ245548.1 Sequence 2698 from Patent EP3894553
ATCTCGCTGGGT
>MQ245547.1 Sequence 2697 from Patent EP3894553
ATAGCACCAGAT
>MQ245546.1 Sequence 2696 from Patent EP3894553
TGTTCTGAGACG
>MQ245545.1 Sequence 2695 from Patent EP3894553
TCATCACGGGCT
>MQ245544.1 Sequence 2694 from Patent EP3894553
GAAACCAAGCTT
>MQ245543.1 Sequence 2693 from Patent EP3894553
GTCTGACGGTCT
>MQ245542.1 Sequence 2692 from Patent EP3894553
AGGAAAGCCAGA
>MQ245541.1 Sequence 2691 from Patent EP3894553
CGGAAACTCCAT
>MQ245540.1 Sequence 2690 from Patent EP3894553
AGTGCTAGGTTA
>MQ245539.1 Sequence 2689 from Patent EP3894553
CTAAAGTAGCAC
>MQ245538.1 Sequence 2688 from Patent EP3894553
TGCCAACAACAA
>MQ245537.1 Sequence 2687 from Patent EP3894553
AGTATTCGCGCA
>MQ245536.1 Sequence 2686 from Patent EP3894553
GATTGAACGCTA
>MQ245535.1 Sequence 2685 from Patent EP3894553
GCCCGACATATA
>MQ245534.1 Sequence 2684 from Patent EP3894553
CAACAATGCCAA
>MQ245533.1 Sequence 2683 from Patent EP3894553
TCGCATGGATAC
>MQ245532.1 Sequence 2682 from Patent EP3894553
ATATTGGCAGCC
>MQ245531.1 Sequence 2681 from Patent EP3894553
TTAATGGATCGG
>MQ245530.1 Sequence 2680 from Patent EP3894553
AGAGACGCGTAG
>MQ245529.1 Sequence 2679 from Patent EP3894553
GTCATTGGGCTA
>MQ245528.1 Sequence 2678 from Patent EP3894553
GGTGGCATGGAA
>MQ245527.1 Sequence 2677 from Patent EP3894553
GTAATCTGCCGA
>MQ245526.1 Sequence 2676 from Patent EP3894553
TAACCTTCGCTT
>MQ245525.1 Sequence 2675 from Patent EP3894553
CCATTAGTTCCT
>MQ245524.1 Sequence 2674 from Patent EP3894553
TATTCCCACGTT
>MQ245523.1 Sequence 2673 from Patent EP3894553
GCTATATCCAGG
>MQ245522.1 Sequence 2672 from Patent EP3894553
GGACTATCGTTG
>MQ245521.1 Sequence 2671 from Patent EP3894553
ACAAACATGGTC
>MQ245520.1 Sequence 2670 from Patent EP3894553
GAAGGAAAGTAG
>MQ245519.1 Sequence 2669 from Patent EP3894553
ACAAATCGTTGG
>MQ245518.1 Sequence 2668 from Patent EP3894553
GCTCCGACCATA
>MQ245517.1 Sequence 2667 from Patent EP3894553
CCTGTTAGCGAA
>MQ245516.1 Sequence 2666 from Patent EP3894553
TTACCCGCACAG
>MQ245515.1 Sequence 2665 from Patent EP3894553
ATGATCGGTACA
>MQ245514.1 Sequence 2664 from Patent EP3894553
CGAAATGCATGT
>MQ245513.1 Sequence 2663 from Patent EP3894553
TGCGTCAGCTAC
>MQ245512.1 Sequence 2662 from Patent EP3894553
TAACCACCAACG
>MQ245511.1 Sequence 2661 from Patent EP3894553
TCCGCGCAAGTT
>MQ245510.1 Sequence 2660 from Patent EP3894553
CGCGCCTTAAAC
>MQ245509.1 Sequence 2659 from Patent EP3894553
GCAGTTGCCTCA
>MQ245508.1 Sequence 2658 from Patent EP3894553
AGAGCGGAACAA
>MQ245507.1 Sequence 2657 from Patent EP3894553
CTAGTACAAGCC
>MQ245506.1 Sequence 2656 from Patent EP3894553
CAGCAAGAGGAC
>MQ245505.1 Sequence 2655 from Patent EP3894553
AATGGTTCAGCA
>MQ245504.1 Sequence 2654 from Patent EP3894553
TTAGCCCAGCGT
>MQ245503.1 Sequence 2653 from Patent EP3894553
CTGGAACATTAG
>MQ245502.1 Sequence 2652 from Patent EP3894553
GCCAATCCAACA
>MQ245501.1 Sequence 2651 from Patent EP3894553
GCAACTTCGGTA
>MQ245500.1 Sequence 2650 from Patent EP3894553
CACTTGCTCTCT
>MQ245499.1 Sequence 2649 from Patent EP3894553
CCTTGGAATCGC
>MQ245498.1 Sequence 2648 from Patent EP3894553
CATAGGCCATCA
>MQ245497.1 Sequence 2647 from Patent EP3894553
TTCGCAGATACG
>MQ245496.1 Sequence 2646 from Patent EP3894553
ATTGTCAAGCAG
>MQ245495.1 Sequence 2645 from Patent EP3894553
AGGTGTATCACC
>MQ245494.1 Sequence 2644 from Patent EP3894553
GCGCTTAGAATA
>MQ245493.1 Sequence 2643 from Patent EP3894553
TGGTAAGAGTCT
>MQ245492.1 Sequence 2642 from Patent EP3894553
GGTGAAACCTAT
>MQ245491.1 Sequence 2641 from Patent EP3894553
AAGCCCAGCATT
>MQ245490.1 Sequence 2640 from Patent EP3894553
GGAGATTGGAGA
>MQ245489.1 Sequence 2639 from Patent EP3894553
ACGAGTTTACCG
>MQ245488.1 Sequence 2638 from Patent EP3894553
CCGCTGATGTCA
>MQ245487.1 Sequence 2637 from Patent EP3894553
ACATGGGCGGAA
>MQ245486.1 Sequence 2636 from Patent EP3894553
CGTGTAGTAGAT
>MQ245485.1 Sequence 2635 from Patent EP3894553
TATGCTCTCTCA
>MQ245484.1 Sequence 2634 from Patent EP3894553
CCATCTTACCAT
>MQ245483.1 Sequence 2633 from Patent EP3894553
CCTCATGCTATT
>MQ245482.1 Sequence 2632 from Patent EP3894553
TAGCGGAAGACG
>MQ245481.1 Sequence 2631 from Patent EP3894553
ATGGTTCACCCG
>MQ245480.1 Sequence 2630 from Patent EP3894553
AACGAATACCAC
>MQ245479.1 Sequence 2629 from Patent EP3894553
TTCACTGTGCGG
>MQ245478.1 Sequence 2628 from Patent EP3894553
CACGCAGTCTAC
>MQ245477.1 Sequence 2627 from Patent EP3894553
GTGACCCTGTCA
>MQ245476.1 Sequence 2626 from Patent EP3894553
GTGTGGCAGAAG
>MQ245475.1 Sequence 2625 from Patent EP3894553
TGCAACTTGCAG
>MQ245474.1 Sequence 2624 from Patent EP3894553
AGCGCATATCCA
>MQ245473.1 Sequence 2623 from Patent EP3894553
GGAACACATGTT
>MQ245472.1 Sequence 2622 from Patent EP3894553
AGTCAATGGCCT
>MQ245471.1 Sequence 2621 from Patent EP3894553
CTGTGCAACGTC
>MQ245470.1 Sequence 2620 from Patent EP3894553
CCGGCTTATGTG
>MQ245469.1 Sequence 2619 from Patent EP3894553
ATGGAAGGTGGC
>MQ244693.1 Sequence 1843 from Patent EP3894553
GTGAATGTTCGA
>MQ244692.1 Sequence 1842 from Patent EP3894553
TGAAGCACACTA
>MQ244691.1 Sequence 1841 from Patent EP3894553
ACATCCCTACTT
>MQ244690.1 Sequence 1840 from Patent EP3894553
CGGTGACCTACT
>MQ244689.1 Sequence 1839 from Patent EP3894553
CAGTGTCATGAA
>MQ244688.1 Sequence 1838 from Patent EP3894553
ATGGCAATTCAG
>MQ244687.1 Sequence 1837 from Patent EP3894553
AATACGTCAAGC
>MQ244686.1 Sequence 1836 from Patent EP3894553
AGACACCAATGT
>MQ244685.1 Sequence 1835 from Patent EP3894553
AGAGTAAGCCGG
>MQ244684.1 Sequence 1834 from Patent EP3894553
CTTGTGCGACAA
>MQ244683.1 Sequence 1833 from Patent EP3894553
AACACGGTTTGA
>MQ244682.1 Sequence 1832 from Patent EP3894553
TCGGTGTACCAA
>MQ244681.1 Sequence 1831 from Patent EP3894553
TCGCTACAGATG
>MQ244680.1 Sequence 1830 from Patent EP3894553
CAGACGAGGAAC
>MQ244679.1 Sequence 1829 from Patent EP3894553
AGCATCCCTAAG
>MQ244678.1 Sequence 1828 from Patent EP3894553
GGAGTTGAGGTG
>MQ244677.1 Sequence 1827 from Patent EP3894553
CATCGACGAGTT
>MQ244676.1 Sequence 1826 from Patent EP3894553
AGACCTGACCCT
>MQ244675.1 Sequence 1825 from Patent EP3894553
AGGCATCTGCTC
>MQ244674.1 Sequence 1824 from Patent EP3894553
CTGATGTACACG
>MQ244673.1 Sequence 1823 from Patent EP3894553
CGCGATATCGTC
>MQ244672.1 Sequence 1822 from Patent EP3894553
CTAAGTTGCAAG
>MQ244671.1 Sequence 1821 from Patent EP3894553
GGATACTCGCAT
>MQ244670.1 Sequence 1820 from Patent EP3894553
CAGTAGCGATAT
>MQ244669.1 Sequence 1819 from Patent EP3894553
ACGCATCGCACT
>MQ244668.1 Sequence 1818 from Patent EP3894553
TTCAGACCAGCC
>MQ244667.1 Sequence 1817 from Patent EP3894553
GAACGATCATGT
>MQ244666.1 Sequence 1816 from Patent EP3894553
TGGGACATATCC
>MQ244665.1 Sequence 1815 from Patent EP3894553
GTCCCTATTATC
>MQ244664.1 Sequence 1814 from Patent EP3894553
AGGTACGCAATT
>MQ244663.1 Sequence 1813 from Patent EP3894553
GCCCTATCTTCT
>MQ244662.1 Sequence 1812 from Patent EP3894553
TCGAGTATCGAA
>MQ244661.1 Sequence 1811 from Patent EP3894553
GCCGAGATAATT
>MQ244660.1 Sequence 1810 from Patent EP3894553
TGCTTCCAATTC
>MQ244659.1 Sequence 1809 from Patent EP3894553
ATGTAGGCTTAG
>MQ244658.1 Sequence 1808 from Patent EP3894553
TCTGCGAGTCTG
>MQ244657.1 Sequence 1807 from Patent EP3894553
GGTCCCGAAATT
>MQ244656.1 Sequence 1806 from Patent EP3894553
GCCATAGTGTGT
>MQ244655.1 Sequence 1805 from Patent EP3894553
ACAATGTCACAG
>MQ244654.1 Sequence 1804 from Patent EP3894553
GGTATGGCTACT
>MQ244653.1 Sequence 1803 from Patent EP3894553
CAGCGTTTAGCC
>MQ244652.1 Sequence 1802 from Patent EP3894553
CCTGACACACAC
>MQ244651.1 Sequence 1801 from Patent EP3894553
GAATCCTCACCG
>MQ244650.1 Sequence 1800 from Patent EP3894553
GCTACTGGTATG
>MQ244649.1 Sequence 1799 from Patent EP3894553
TTCTCGGTTCTC
>MQ244648.1 Sequence 1798 from Patent EP3894553
TGACGCCTCCAA
>MQ244647.1 Sequence 1797 from Patent EP3894553
TCGTAAGCCGTC
>MQ244646.1 Sequence 1796 from Patent EP3894553
GTATAGTCCGTG
>MQ244645.1 Sequence 1795 from Patent EP3894553
TTACACAAAGGC
>MQ244644.1 Sequence 1794 from Patent EP3894553
CGTCACTCCAAG
>MQ244643.1 Sequence 1793 from Patent EP3894553
ACGACGCATTTG
>MQ244642.1 Sequence 1792 from Patent EP3894553
AGGGAAAGGATC
>MQ244641.1 Sequence 1791 from Patent EP3894553
AAGGAGTGCGCA
>MQ244640.1 Sequence 1790 from Patent EP3894553
GCTCCACAACGT
>MQ244639.1 Sequence 1789 from Patent EP3894553
ATCAGCCAGCTC
>MQ244638.1 Sequence 1788 from Patent EP3894553
CCTTTCACCTGT
>MQ244637.1 Sequence 1787 from Patent EP3894553
ATACGGGTTCGT
>MQ244636.1 Sequence 1786 from Patent EP3894553
GGACTCAACTAA
>MQ244635.1 Sequence 1785 from Patent EP3894553
GTCCTGACACTG
>MQ244634.1 Sequence 1784 from Patent EP3894553
ACCTAGCTAGTG
>MQ244633.1 Sequence 1783 from Patent EP3894553
ATAGGTGTGCTA
>MQ244632.1 Sequence 1782 from Patent EP3894553
GCAGCCATATTG
>MQ244631.1 Sequence 1781 from Patent EP3894553
ACGGTTTCTGGA
>MQ244630.1 Sequence 1780 from Patent EP3894553
GTCAGCCGTTAA
>MQ244629.1 Sequence 1779 from Patent EP3894553
GATTTAGAGGCT
>MQ244628.1 Sequence 1778 from Patent EP3894553
GTCCACTTGGAC
>MQ244627.1 Sequence 1777 from Patent EP3894553
TTCTGGTCTTGT
>MQ244626.1 Sequence 1776 from Patent EP3894553
TCTCGCACTGGA
>MQ244625.1 Sequence 1775 from Patent EP3894553
CGGACTCGTTAC
>MQ244624.1 Sequence 1774 from Patent EP3894553
GTTACAGTTGGC
>MQ244623.1 Sequence 1773 from Patent EP3894553
CATGTCTTCCAT
>MQ244622.1 Sequence 1772 from Patent EP3894553
CATCGGATCTGA
>MQ244621.1 Sequence 1771 from Patent EP3894553
TTGGTGCCTGTG
>MQ244620.1 Sequence 1770 from Patent EP3894553
ACGCCTTTCTTA
>MQ244619.1 Sequence 1769 from Patent EP3894553
ACTTACGCCACG
>MQ244618.1 Sequence 1768 from Patent EP3894553
GAATGACGTTTG
>MQ244617.1 Sequence 1767 from Patent EP3894553
CACGGTCCTATG
>MQ244616.1 Sequence 1766 from Patent EP3894553
GGACCGCTTTCA
>MQ244615.1 Sequence 1765 from Patent EP3894553
GACGGAACAGAC
>MQ244614.1 Sequence 1764 from Patent EP3894553
GAAGATCTATCG
>MQ244613.1 Sequence 1763 from Patent EP3894553
CACCGTGACACT
>MQ244612.1 Sequence 1762 from Patent EP3894553
CACAAAGCGATT
>MQ244611.1 Sequence 1761 from Patent EP3894553
TCACGAGTCACA
>MQ244610.1 Sequence 1760 from Patent EP3894553
ACACACCCTGAC
>MQ244609.1 Sequence 1759 from Patent EP3894553
CCGCGATTTCGA
>MQ244608.1 Sequence 1758 from Patent EP3894553
AGTCCGAGTTGT
>MQ244607.1 Sequence 1757 from Patent EP3894553
TGGAAACCATTG
>MQ244606.1 Sequence 1756 from Patent EP3894553
AGTAGACTTACG
>MQ244605.1 Sequence 1755 from Patent EP3894553
GAAGAGGGTTGA
>MQ244604.1 Sequence 1754 from Patent EP3894553
ACCTCCCGGATA
>MQ244603.1 Sequence 1753 from Patent EP3894553
ACACTTCGGCAA
>MQ244602.1 Sequence 1752 from Patent EP3894553
TGCTGTGACCAC
>MQ244601.1 Sequence 1751 from Patent EP3894553
AGGTCATCTTGG
>MQ244600.1 Sequence 1750 from Patent EP3894553
TAGTAGCACCTG
>MQ244599.1 Sequence 1749 from Patent EP3894553
ACGTCTCAGTGC
>MQ244598.1 Sequence 1748 from Patent EP3894553
CGATTAGGAATC
>MQ244597.1 Sequence 1747 from Patent EP3894553
CGTCCGTATGAA
>MQ244596.1 Sequence 1746 from Patent EP3894553
ACCCGGATTTCG
>MQ244595.1 Sequence 1745 from Patent EP3894553
AGTAGGAGGCAC
>MQ244594.1 Sequence 1744 from Patent EP3894553
GTGCTGCGCTTA
>MQ244593.1 Sequence 1743 from Patent EP3894553
CTTGGTAGTGCC
>MQ244592.1 Sequence 1742 from Patent EP3894553
GGCTCAGATTCC
>MQ244591.1 Sequence 1741 from Patent EP3894553
CTAAGACGTCGT
>MQ244590.1 Sequence 1740 from Patent EP3894553
TTATCCAGTCCT
>MQ244589.1 Sequence 1739 from Patent EP3894553
CAGAGCTAATTG
>MQ244588.1 Sequence 1738 from Patent EP3894553
CACGTACACGTA
>MQ244587.1 Sequence 1737 from Patent EP3894553
GACTCTGCTCAG
>MQ244586.1 Sequence 1736 from Patent EP3894553
ATGAATGCGTCC
>MQ244585.1 Sequence 1735 from Patent EP3894553
CGCTTGTGTAGC
>MQ244584.1 Sequence 1734 from Patent EP3894553
ATGCGAGACTTC
>MQ244583.1 Sequence 1733 from Patent EP3894553
GATCAACCCACA
>MQ244582.1 Sequence 1732 from Patent EP3894553
ACTAGTTGGACC
>MQ244581.1 Sequence 1731 from Patent EP3894553
CCACGGTACTTG
>MQ244580.1 Sequence 1730 from Patent EP3894553
AGCACTTTGAGA
>MQ244579.1 Sequence 1729 from Patent EP3894553
TGGTTCATCCTT
>MQ244578.1 Sequence 1728 from Patent EP3894553
ATTCCTCTCCAC
>MQ244577.1 Sequence 1727 from Patent EP3894553
TCGCGCAACTGT
>MQ244576.1 Sequence 1726 from Patent EP3894553
GTCCAGCTATGA
>MQ244575.1 Sequence 1725 from Patent EP3894553
GGCACACCCTTA
>MQ244574.1 Sequence 1724 from Patent EP3894553
GAGTTTACGGTC
>MQ244573.1 Sequence 1723 from Patent EP3894553
TACTGCCAGTGA
>MQ244572.1 Sequence 1722 from Patent EP3894553
ACACATAAGTCG
>MQ244571.1 Sequence 1721 from Patent EP3894553
CAAATGGTCGTC
>MQ244570.1 Sequence 1720 from Patent EP3894553
AAGTATCCTGCG
>MQ244569.1 Sequence 1719 from Patent EP3894553
TGAGACCCTACA
>MQ244568.1 Sequence 1718 from Patent EP3894553
CCTGGAATTAAG
>MQ244567.1 Sequence 1717 from Patent EP3894553
TTGCCCTTTGAT
>MQ244566.1 Sequence 1716 from Patent EP3894553
ATAAGGTCGCCT
>MQ244565.1 Sequence 1715 from Patent EP3894553
TTGACACACGAC
>MQ244564.1 Sequence 1714 from Patent EP3894553
CGCGTCAAACTA
>MQ244563.1 Sequence 1713 from Patent EP3894553
CGAGATAGTTTG
>MQ244562.1 Sequence 1712 from Patent EP3894553
GCTTCTCTCACT
>MQ244561.1 Sequence 1711 from Patent EP3894553
TTGCAAGTACCG
>MQ244560.1 Sequence 1710 from Patent EP3894553
CAGCCTGCAAAT
>MQ244559.1 Sequence 1709 from Patent EP3894553
AATGTCACCAGA
>MQ244558.1 Sequence 1708 from Patent EP3894553
CAGTTCGAGATA
>MQ244557.1 Sequence 1707 from Patent EP3894553
TTGTTACGTTCC
>MQ244556.1 Sequence 1706 from Patent EP3894553
GTCAAGACCTCA
>MQ244555.1 Sequence 1705 from Patent EP3894553
GTTCTGCTTGTT
>MQ244554.1 Sequence 1704 from Patent EP3894553
GTCTCTGAAAGA
>MQ244553.1 Sequence 1703 from Patent EP3894553
GCTATTCCTCAT
>MQ244552.1 Sequence 1702 from Patent EP3894553
ATGGGACCTTCA
>MQ244551.1 Sequence 1701 from Patent EP3894553
CATGTTGGAACA
>MQ244550.1 Sequence 1700 from Patent EP3894553
TCAAGCAATACG
>MQ244549.1 Sequence 1699 from Patent EP3894553
CACTGAGTACGT
>MQ244548.1 Sequence 1698 from Patent EP3894553
GTACCTAGCCTG
>MQ244547.1 Sequence 1697 from Patent EP3894553
CTCAAGTCAAAG
>MQ244546.1 Sequence 1696 from Patent EP3894553
AGAATCCACCAC
>MQ244545.1 Sequence 1695 from Patent EP3894553
GCACTTCATTTC
>MQ244544.1 Sequence 1694 from Patent EP3894553
CCACTTGAGAGT
>MQ244543.1 Sequence 1693 from Patent EP3894553
GGATGCAGGATG
>MQ244542.1 Sequence 1692 from Patent EP3894553
AGTACCTAAGTG
>MQ244541.1 Sequence 1691 from Patent EP3894553
TCGTTTCTTCAG
>MQ244540.1 Sequence 1690 from Patent EP3894553
CCAGTATCGCGT
>MQ244539.1 Sequence 1689 from Patent EP3894553
CTCTCATATGCT
>MQ244538.1 Sequence 1688 from Patent EP3894553
GCGAACCTATAC
>MQ244537.1 Sequence 1687 from Patent EP3894553
CTCGTTTCAGTT
>MQ244536.1 Sequence 1686 from Patent EP3894553
ACGCTGTCGGTT
>MQ244535.1 Sequence 1685 from Patent EP3894553
CCTTCTGTATAC
>MQ244534.1 Sequence 1684 from Patent EP3894553
GTATGGAGCTAT
>MQ244533.1 Sequence 1683 from Patent EP3894553
GTTAATGGCAGT
>MQ244532.1 Sequence 1682 from Patent EP3894553
CTAGCAGTATGA
>MQ244531.1 Sequence 1681 from Patent EP3894553
ATCGAATCGAGT
>MQ244530.1 Sequence 1680 from Patent EP3894553
GGTACTGTACCA
>MQ244529.1 Sequence 1679 from Patent EP3894553
CGGATTGCTGTA
>MQ244528.1 Sequence 1678 from Patent EP3894553
CTATCGGAAGAT
>MQ244527.1 Sequence 1677 from Patent EP3894553
TCAATGACCGCA
>MQ244526.1 Sequence 1676 from Patent EP3894553
TAGTGCATTCGG
>MQ244525.1 Sequence 1675 from Patent EP3894553
AATATCGGGATC
>MQ244524.1 Sequence 1674 from Patent EP3894553
TCTACCACGAAG
>MQ244523.1 Sequence 1673 from Patent EP3894553
GTCGCTTGCACA
>MQ244522.1 Sequence 1672 from Patent EP3894553
GAATATACCTGG
>MQ244521.1 Sequence 1671 from Patent EP3894553
GAAAGGTGAGAA
>MQ244520.1 Sequence 1670 from Patent EP3894553
TCAGGACGTATC
>MQ244519.1 Sequence 1669 from Patent EP3894553
GGTCTAGGTCTA
>MQ244518.1 Sequence 1668 from Patent EP3894553
GTGCACGATAAT
>MQ244517.1 Sequence 1667 from Patent EP3894553
CTTGCATACCGG
>MQ244516.1 Sequence 1666 from Patent EP3894553
TTAAACCGCGCC
>MQ244515.1 Sequence 1665 from Patent EP3894553
CCAATGATAAGC
>MQ244514.1 Sequence 1664 from Patent EP3894553
TCTGGGCATTGA
>MQ244513.1 Sequence 1663 from Patent EP3894553
GCACTATACGCA
>MQ244512.1 Sequence 1662 from Patent EP3894553
CTTCCGCAGACA
>MQ244511.1 Sequence 1661 from Patent EP3894553
ATCGTGTGTTGG
>MQ244510.1 Sequence 1660 from Patent EP3894553
TATAGGCTCCGC
>MQ244509.1 Sequence 1659 from Patent EP3894553
CTGCAGTAAGTA
>MQ244508.1 Sequence 1658 from Patent EP3894553
TGAATCGAAGCT
>MQ244507.1 Sequence 1657 from Patent EP3894553
ACGTGAGGAACG
>MQ244506.1 Sequence 1656 from Patent EP3894553
CCAAACTCGTCG
>MQ244505.1 Sequence 1655 from Patent EP3894553
GTGTATCGCCAC
>MQ244504.1 Sequence 1654 from Patent EP3894553
AGCCTCATGATG
>MQ244503.1 Sequence 1653 from Patent EP3894553
GTTATGACGGAT
>MQ244502.1 Sequence 1652 from Patent EP3894553
AAGCGTACATTG
>MQ244501.1 Sequence 1651 from Patent EP3894553
AGAATAGCGCTT
>MQ244500.1 Sequence 1650 from Patent EP3894553
AGACGTTGCTAC
>MQ244499.1 Sequence 1649 from Patent EP3894553
ATTCCCAGAACG
>MQ244498.1 Sequence 1648 from Patent EP3894553
AGGTGGTGGAGT
>MQ244497.1 Sequence 1647 from Patent EP3894553
CGGCACTATCAC
>MQ244496.1 Sequence 1646 from Patent EP3894553
GGCGAACTGAAG
>MQ244495.1 Sequence 1645 from Patent EP3894553
GACCGATAGGGA
>MQ244494.1 Sequence 1644 from Patent EP3894553
TTAGACTCGGAA
>MQ244493.1 Sequence 1643 from Patent EP3894553
CAAACTGCGTTG
>MQ244492.1 Sequence 1642 from Patent EP3894553
TGCGGGATTCAT
>MQ244491.1 Sequence 1641 from Patent EP3894553
TTAAGCGCCTGA
>MQ244490.1 Sequence 1640 from Patent EP3894553
CATTTCGCACTT
>MQ244489.1 Sequence 1639 from Patent EP3894553
ACCACCGTAACC
>MQ244488.1 Sequence 1638 from Patent EP3894553
TCCGTTCGTTTA
>MQ244487.1 Sequence 1637 from Patent EP3894553
ACCCTATTGCGG
>MQ244486.1 Sequence 1636 from Patent EP3894553
CTCGGTCAACCA
>MQ244485.1 Sequence 1635 from Patent EP3894553
GCAAGTGTGAGG
>MQ244484.1 Sequence 1634 from Patent EP3894553
CAAGTCGAATAC
>MQ244483.1 Sequence 1633 from Patent EP3894553
CTGGTCTTACGG
>MQ244482.1 Sequence 1632 from Patent EP3894553
CTTTAGCGCTGG
>MQ244481.1 Sequence 1631 from Patent EP3894553
ACATGTCACGTG
>MQ244480.1 Sequence 1630 from Patent EP3894553
ATGTTTAGACGG
>MQ244479.1 Sequence 1629 from Patent EP3894553
CGTACCAGATCC
>MQ244478.1 Sequence 1628 from Patent EP3894553
CGTGGGCTCATT
>MQ244477.1 Sequence 1627 from Patent EP3894553
GTGAGGGCAAGT
>MQ244476.1 Sequence 1626 from Patent EP3894553
AATCAACTAGGC
>MQ244475.1 Sequence 1625 from Patent EP3894553
TGTACGGATAAC
>MQ244474.1 Sequence 1624 from Patent EP3894553
CAATGCCTCACG
>MQ244473.1 Sequence 1623 from Patent EP3894553
TTACGTGGCGAT
>MQ244472.1 Sequence 1622 from Patent EP3894553
TGAGTTCGGTCC
>MQ244471.1 Sequence 1621 from Patent EP3894553
GTCTGTTGAGTG
>MQ244470.1 Sequence 1620 from Patent EP3894553
AACATGCATGCC
>MQ244469.1 Sequence 1619 from Patent EP3894553
TCGTCGCCAAAC
>MQ244468.1 Sequence 1618 from Patent EP3894553
GAGTCTTGGTAA
>MQ244467.1 Sequence 1617 from Patent EP3894553
GTGACGTTAGTC
>MQ244466.1 Sequence 1616 from Patent EP3894553
GACTTATGCCCG
>MQ244465.1 Sequence 1615 from Patent EP3894553
CAAGCGTTGTCC
>MQ244464.1 Sequence 1614 from Patent EP3894553
CGTCGTCTAAGA
>MQ244463.1 Sequence 1613 from Patent EP3894553
GGTCGTGTCTTG
>MQ244462.1 Sequence 1612 from Patent EP3894553
GAAACGGAAACG
>MQ244461.1 Sequence 1611 from Patent EP3894553
CACGTTTATTCC
